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ABSTRACT. 
T lymphocytes play an important role in recovery from virus infection. 
These cells can be both directly cytolytic and release cytokines. The 
cytokines support proliferation of the cells responding to infection, and 
also function to recruit other cell populations, which themselves 
secrete cytokines. Several of these cytokines have demonstrated 
antiviral activity. The experiments described in this thesis were 
designed to examine the production of the antiviral cytokines TNF, 
IFN-y and IL-6 in an immune response to virus infection. 
An in vitro model was established to investigate the kinetics of 
cytokine production by virus immune spleen cells. Vaccinia virus 
primed spleen cells from CBA/H mice were stimulated in vitro with 
virus infected UV -irradiated syngeneic cells. Both CD4 + and COB+ T 
cells proliferated following restimulation. TNF, IL-6 and IFN-y were 
detected within 12 h of restimulation, with maximal levels reached by 
24 h. The virus immune responder cells co-operated to provide 
costimulatory signals which were not presented by the UV -irradiated 
stimulator cells. 
Depletion of subpopulations of cells provided information on the cells 
producing the cytokines. The virus immune adherent cells were the 
major producers of TNF and IL-6. The production of these cytokines 
did not require T cells and was not antigen specific. In contrast, IFN-y 
production was T cell dependent, particularly CD4+ T cell dependent, 
and production was antigen specific. 
Cytokine interaction was examined by the addition of specific 
antibodies and exogenous cytokine. The results suggested that the 
production of IFN-y and TNF was influenced by the presence of other 
cytokines, whereas IL-6 was not. Neutralization of TNF in cultures 
reduced IFN-y production, indicating that at least a portion of IFN-y 
production was dependent on TNF. IFN-y production was also shown 
to be dependent on IL-2, as neutralization of IL-2 led to decreased IFN-y 
levels, whereas levels increased upon addition of recombinant IL-2. 
The IL-2-induced IFN-y production was dependent on the presence ofT 
cells. Neither IL-2 nor IL-4 were detectable in the culture supernatant, 
although neutralization of IL-4 led to a decrease in both TNF and IFN-y 
lV 
levels. The antibody to IL-10 had no effect on cytokine production yet 
IL-10 was detected after 24 h incubation. 
Virus immune cells were restimulated with UV-irradiated cells 
infected with recombinant vaccinia viruses which encode cytokine 
genes. The virus constructs continued to produce the encoded cytokine 
after UV-irradiation. TNF production by the responder cells was 
enhanced when restimulated with the TNF-encoding virus. Similarly, 
enhanced production of IFN-y was observed following restimulation 
with the IFN-y encoding virus. In addition, increased IFN-y levels were 
produced following restimulation with the IL-2-, TNF-, IL-4- and IL-10 
encoding viruses. 
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1 Introduction 
The host defence to a primary virus infection occurs in three phases 
(Janeway, 1989). Initially, there is an innate non-specific resistance that 
is non-inducible. This natural resistance to infection consists of those 
mechanisms which are triggered immediately upon entry of a 
pathogen. This is followed by an early, inducible phase that is largely 
antigen non-specific. Finally, there is a late, T-cell dependent phase 
that is inducible, highly antigen-specific and generates immunological 
memory. 
The T cell-specific 1mmune response takes several days to become 
effective, whereas the innate resistance mechanisms are immediately 
effective upon contact with the invading pathogen. Once activated, 
this initial defence system sets out to confine the infection, eradicate 
the pathogen and limit host tissue damage (Mi.iller-Eberhard, 1989). 
The components of this system include monocytes/macrophages, NK 
cells, interferons and secretory products of macrophages. 
It is the later T cell-specific immune response that is responsible for 
prot~ctive immunity following infection. This involves the induction 
and interaction of specific antibody and cell-mediated responses 
through the activation of clonally specific T and B cells. Cytotoxic T 
lymphocytes (CTL) are believed to be important in the control of and 
recovery from most primary viral infections (Blanden, 1971), although 
an antibody response may be a contributing factor. An immune 
response must be tightly regulated to ensure the response is of the right 
magnitude and quality. The mechanism of regulation is mediated 
through the profile of cytokines secreted by various cell populations 
(Coffman et al., 1988). 
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2 Innate immunity 
The innate non-specific host defences to an infection are an immediate 
response, triggered by entry of the pathogen. The responses are 
important in determining the outcome of a viral infection as they 
interfere with the early stages of viral invasion, subsequent 
multiplication and the spread of virus to susceptible organs . 
Macrophages and natural killer cells are active participants in the 
innate and early inducible phases of the response (Mims, 1964). An 
inflammatory focus develops around the site of invasion, with the 
accumulation of phagocytes. Macrophages recognise the pathogen 
through interaction between pathogen-surface molecules and receptors 
on the macrophage, and once stimulated begin the process of 
endocytosis and release TNF, IL-l and interferons (Miiller-Eberhard, 
1989). NK cells may become stimulated to lyse infected cells and 
produce IFN-y (Trinchieri, 1989). 
2.1 Macrophages 
Macrophages are placed strategically throughout the body to meet 
foreign particles and are widely distributed in major organs of the body. 
They respond to stimulation with secretion of some 100 substances, 
which range in biologic activity from induction of cell growth to cell 
death (Nathan, 1987). Therefore, macrophages may be decisive in 
determining the susceptibility or resistance of an animal to a virus 
infection (Mims, 1964). If a virus is taken up by a macrophage which 
does not support virus replication, the outcome is that the virus 
infection is delayed or prevented from spreading to susceptible cells. 
However, due to the mobile nature of macrophages, replication of the 
virus in these cells will result in dissemination of the virus 
throughout the body (Blanden, 1982). Stimulated macrophages have 
been demonstrated to inactivate viruses extracellularly in a non-
antigen specific manner (Morahan et al., 1977). Growth of HSV, MHV 
and VSV have all been inhibited by macrophages. The mechanism 
responsible may differ depending upon the particular macrophage and 
the particular virus. Reported mechanisms include inhibition of virus 
adsorption and penetration into permissive cells, and direct 
inactivation by macrophage secreted products such as interferons and 
TNF (reviewed by Morahan et al. , 1985). 
2 
2.2 NK Cells 
NK cells are CD3- T-cell receptor (TCRt, large granular lymphocytes 
(Hercend and Schmidt, 1988) which are cytotoxic to a variety of target 
cells in a MHC-non-restricted fashion (Trinchieri, 1989). There is 
experimental evidence to suggest a role for NK cells in defense against 
many virus infections (Welsh et al., 1991). NK cells are activated and 
numbers increase at the site of virus infection (Biron et al., 1983), and 
treatment of mice with anti-asialo GM1 antibody to deplete NK cells 
results in increased titres of several viruses, compared to control mice 
(Bukowski et al., 1983). NK cells are present in the peripheral blood 
and spleen in a resting state, and can be triggered to lyse a target cell 
within minutes of binding (Trinchieri, 1989). NK cells have also been 
shown to produce IFN-y, TNF, GM-CSF, colony-stimulating factor 
(CSF) and IL-3 when appropriately stimulated (Cuturi et al., 1989). 
Both IFN-y and TNF have been shown to have direct antiviral activity 
(refer to section 2.3), while another important function of these 
cytokines is to activate phagocytes. 
Information about the receptor used by NK cells to distinguish between 
normal cells, tumour cells and virus infected cells has not been 
available until very recently. It has been shown that sensitivity to NK 
cells is inversely correlated with class I MHC expression on target cells 
(Karre et al., 1986). A recent proposal suggests that NK cell triggering is 
inhibited when target cells encode a specific natural ligand bound in 
the class I MHC peptide groove. Loss of either the class I MHC 
molecule or the ligand from the target cell surface would render the 
cell NK sensitive (Raulet, 1992). Either of these events could take place 
in a virus infected cell; viruses are known to switch off cellular protein 
synthesis or a viral peptide may displace the NK ligand from the MHC 
peptide groove. 
The ability of the NK cell population to respond without preactivation 
allows them to participate in the first line of defence against infection 
by viruses, before the humoral and cellular effects of the adaptive 
immune response are activated. The rapid release of cytokines by NK 
cells also enhances their role in the non-adaptive resistance phase by 
enabling the recruitment of other relevant effector cells . 
3 
2.3 Antiviral cytokines 
2.3.1 Interferons 
Interferon was first identified in 1957 as a secreted factor able to transfer 
a virus-resistant state (Isaacs and Lindenmann, 1957). This interferon is 
a family of related proteins which have been classified into two groups, 
Type I and Type II interferons. Type I interferons, IFNa and IFNp, are 
induced by virus infection and are produced by leukocytes and 
fibroblasts, respectively. Type II IFN, or IFN-y, also known as immune 
IFN, is induced by mitogenic or specific antigenic stimulation of T 
lymphocytes and NK cells (Pestka and Baron, 1981). Both Type I and 
Type II IFNs have antiviral activity in vivo, demonstrated by increased 
virus growth in animals treated with antibodies to IFN (Gresser et al., 
1976; Klavinskis et al., 1989; Leist et al., 1989). There are differences in 
the sensitivity of · various viruses to the effect of IFNs (Rubin and 
Gupta, 1980; Stewart, 1979) and there may be synergistic amplification of 
IFN-mediated protection against virus infection when there is a 
combination of IFN types present (Fleischmann et al., 1979). 
All three IFNs, a, p, and y, up-regulate the expression of class I MHC, 
while only IFN-y increases the rate of expression of class II MHC (Wong 
et al., 1983). The IFN-enhanced expression of MHC may contribute to 
the antiviral actions of IFNs by making the cells more susceptible to 
lysis by cytotoxic T cells in the later T cell-dependent phase of response. 
2.3.2 Tumour Necrosis Factor 
Tumour Necrosis Factor (TNF) was first described as a tumoricidal 
protein found in the serum of bacillus Calmette-Guerin (BCG)-infected 
mice following endotoxin treatment (Carswell et al., 1975). It has been 
demonstrated that TNF-a and lymphotoxin (TNF-P) have antiviral 
activity against various RNA and DNA viruses (Mestan et al., 1986; 
Wong and Goeddel, 1986). These cytokines induce resistance in 
uninfected cells and are also able to selectively kill virus-infected cells, 
thus preventing further viral spread. Virus-infected cells are more 
susceptible to the cytolytic action of TNF than uninfected cells (Wong 
and Goeddel, 1986). Virus infection has been shown to induce the 
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production of TNF by monocytes (Aderka et al., 1986), indicating the 
importance of TNF in a physiologic antiviral response. 
Interestingly, the antiviral activity of TNF and IFN was found to be 
enhanced if used in combination (Feduchi et al ., 1989; Wong and 
Goeddel, 1986). 
3 Immune response 
The third phase in the host defense against virus infection is a late, 
antigen-specific, T cell-dependent phase leading to immunological 
memory. The host T cells recognise viral components as foreign in the 
context of major histocompatability complex (MHC) antigens on the 
surface of antigen presenting cells. Following recognition, a cascade of 
cellular and humoral responses to the virus is set in motion. Virtually 
all adaptive immune responses involve clonal expansion of naive 
CD4 + T cells. These cells and the cytokines they produce play an 
important regulatory role in the responses of B cells, other T cells and 
NK cells (Coffman et al., 1988). 
Swain et al. (1990a) have identified three developmentally distinct 
subsets of CD4 + T cells: precursors, effectors and memory cells. 
Precursor and memory cells are resting CD4 + T cells, while the effector 
cells are large, activated CD4 + T cells. The development of effector cells 
from precursors requires an activation signal, cytokines and a source of 
APC. The activation signal may be a mitogen or, as in a natural 
infection, antigen in the presence of MHC molecules expressed on the 
cell surface of a specialized antigen-presenting cell. 
3.1 MHC 
MHC class I molecules are present on nearly all cells. MHC class II 
molecules are restricted to a specialized set of antigen presenting cells, 
ie. macrophages, dendritic cells and B cells (Harding, 1991). T cells 
recognise proteolytic fragments of antigen that are presented at the cell 
surface in association with either class I or class II MHC molecules. 
This was first demonstrated by Zinkernagel and Doherty (1974) using 
virus-specific CTLs which recognised viral antigens in association with 
MHC molecules. Later, it was shown the CTL recognised viral antigens 
that are not normally present on the cell surface, such as nucleoprotein, 
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indicating the CTL may recognise degraded forms of the antigen bound 
to an MHC class I molecule (Townsend et al., 1985). 
The immune system must be able to present both intracellular and 
extracellular antigens and elicit the correct immune response. It would 
appear this has led to the evolution of the two classes of MHC 
molecule. Peptides derived from intracellular antigens are generally 
presented by MHC class I molecules, whereas extracellular antigen-
derived peptides are presented by MHC class II molecules (Braciale et 
al., 1987). There has been intense research in the area of processing 
pathways for antigen presentation by MHC molecules recently 
(reviewed by Monaco, 1992; Neefjes and Ploegh, 1992). The current 
model of MHC class-I-restricted antigen processing is that intracellular 
proteins are degraded in the cytoplasm to, preferentially, nine amino 
acid peptides. The peptides are delivered to the endoplasmic reticulum 
(ER) lumen and bind to newly synthesized MHC class I molecules, 
inducing a conformational change that may facilitate their export to the 
cell surface (Monaco, 1992). Thus, any protein synthesized within the 
cytoplasm, including viral protein, is able to be processed and presented 
by class I molecules. 
The processing and presentation of extracellular antigens is more 
complex. MHC class II molecules are assembled in the ER. The 
functional unit is a heterodimer, a~ . A third chain, y, is associated with 
the a~ dimer to prevent peptides binding to the dimers in the ER, and 
to help in the transport process from the ER through the Golgi. 
Antigen enters the cell, through endocytosis, and is degraded into 
peptides. Peptide fragments associate with class II molecules after the 
release of they chain. The class II-peptide complex is then transported 
to the cell surface (Neefjes and Ploegh, 1992). 
There are examples, however, where endogenous antigens, which 
according to the above model should be presented by class I MHC, are 
presented by class II MHC molecules (Sekaly et al., 1988). This suggests 
that the models for endogenous and exogenous antigens being 
presented by class I and class II MHC molecules, respectively, may not 
hold for all antigens (Nuchtern et al., 1990). 
6 
3.2 Antigen presenting cells and immune induction 
The three situations in which antigen is presented to T cells are the 
stimulation of resting T cells in the primary response, the expansion of 
memory cells on secondary stimulation, and the interaction between 
cytotoxic effector cells and their targets. 
In primary T cell responses, naive T cells need to be selected from the T 
cell pool and stimulated. Naive, or resting, T cells distribute 
preferentially from blood to the lymphoid tissues. This means that on 
primary exposure, antigen must be transported to lymphoid tissue for 
presentation to the local T cell population. Bone marrow derived 
dendritic cells (DC) are believed to be the specialized cells that acquire 
antigen and transport it to lymph nodes (Knight and Stagg, 1993). An 
increase of DC movement into lymph nodes following peripheral 
exposure to antigen has been observed (Hill et al., 1990), and dendritic 
cells are capable of processing and presenting even large antigen (De 
Bruijn et al., 1992a), despite being nonphagocytic. Once antigen has 
been carried to the lymph nodes the DCs mature, up-regulate MHC 
class II expression and become specialized at clustering and activating T 
cells. These clusters are not seen when antigens are presented on 
macrophages or lymphocytes (Inaba et al., 1987). Clustering could 
provide the time required for products on two opposing cell surfaces, 
such as MHC molecules and receptors, to align and interact. DCs as 
antigen-presenting cells are able to induce primary anti-viral CTL 
responses, whereas spleen cells and LPS-induced B cell blasts are not 
(De Bruijn et al., 1992b). Macrophages are also important APC for CTL 
induction as demonstrated by the inability of mice to mount CTL 
following depletion of phagocytes, which was dramatically reversed by 
infusion of a macrophage hybridoma (Debrick et al., 1991). 
T cells, particularly CD4+ T cells, play an important regulatory role 
within the immune system. Expansion of these cells is critical for 
development of cytotoxic responses, antibody responses and the 
generation of delayed-type-hypersensitivity (DTH) responses. 
Therefore, the proliferation of these cells must itself be tightly regulated 
to protect against the development of an inappropriate immune 
response. In 1970, Bretscher and Cohn proposed a two-signal model of 
lymphocyte activation for B cells to solve the problem of self-nonself 
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discrimination. It was postulated that signal one was the occupancy of 
the antigen-specific receptor. Signal one alone induced tolerance. 
Upon receiving the second signal, however, the cell became activated. 
Lafferty et al. (1977) extended this model to T cell activation, with 
binding of antigen to the T cell receptor providing signal 1, and the 
second signal, a nonspecific inductive stimulus, provided by the 
stimulator cell. 
The nature of this costimulatory activity required for the delivery of 
signal 2 is yet to be fully determined. A review by Mueller et al. (1989) 
outlined a number of experiments which defined signal 2 as a cell-
bound or short-range acting costimulatory factor which was rapidly 
induced on the APC surface. Most candidates for molecules mediating 
the costimulatory pathways are lymphoid adhesion molecules (van 
Seventer et al., 1991). Using monoclonal antibodies it has been 
demonstrated that CD28 is a costimulatory molecule (June et al., 1990) 
and thus it may provide the second signal. CD28 is a cell surface 
glycoprotein, expressed on all murine CD4 + and COS+ T cells (Gross et 
al., 1992). The ligand for CD28 has been identified as B7 (Linsley et al., 
1991a), which is expressed constitutively on splenic and blood dendritic 
cells, is induced on B cells and monocytes, and is not expressed on 
resting T cells (reviewed by Jenkins and Johnson, 1993). The 
physiologic signal for inducing B7 expression on B cells is thought to be 
contact between the TCR and the MHC/ antigen complex on the B cell 
(Nabavi et al., 1992). Engagement of the CD28 surface receptor results 
in stabilization of T cell cytokine mRNA and an increased rate of 
cytokine gene transcription (reviewed by Schwartz, 1992). A second 
receptor for B7 also exists, CTLA-4, an activation molecule on both 
CD4 +and COB+ T cells (Linsley et al., 1991b ). It is unclear why there are 
two receptors for B7, although they may act co-operatively to give 
maximum CD4 + T cell proliferation (Schwartz, 1992). Delivery of both 
TCR ligand and the B7 molecule on one cell is at least 30 times more 
efficient at inducing primary T cell proliferation than a mixture of cells 
expressing either one of these two molecules alone (Liu and Janeway, 
1992). In contrast, cloned or activated T cells are capable of receiving 
costimulatory signals from bystander cells such as B cells and 
macrophages (Jenkins et al., 1988). 
A number of other molecules on the APC augment the proliferative 
effects of TCR stimulation by interacting with a specific counter-
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receptor on the T cell (reviewed by Liu & Linsley, 1992, see Figure 1.1). 
For example, lymphocyte function associated antigen (LFA)-3 which 
binds to the CD2 receptor on T cells plays an important role in 
signalling. Intercellular adhesion molecule (ICAM)-1 and ICAM-2 are 
counter receptors for the integrin LF A -1. Their binding enhances T cell 
activation. Heat stable antigen (HSA), expressed on different APC, has 
costimulatory activity for murine CD4+ T cells, although the T cell 
receptor has not been identified. These receptor-ligand pairs may act by 
promoting T cell-APC adhesion, allowing other signalling molecules, 
such as the TCR and CD28, to interact more efficiently with their 
ligands. 
On secondary exposure to antigen, memory cells and antibodies are 
present in the periphery. The memory T cells enter tissues and it is 
possible to have activation at peripheral sites. Primed T cells can 
interact with many types of presenting cells (Inaba and Steinman, 1986), 
including macrophages, B lymphocytes and Langerhans cells, although 
the antigen presenting function of dendritic cells is more efficient 
(Nonacs et al., 1992). Activated T cells can be triggered by peptide-MHC 
on planar membranes (Watts et al., 1984), and thus do not have to 
interact with viable APCs. 
Any cell that is infected with v1rus 1s potentially able to present 
antigens to MHC class !-restricted CD8+ T cells, as all cells have MHC 
class I molecules. In contrast, stimulation of CD4 + T cells requires viral 
entry into cells that constitutively express class II MHC molecules. 
4 Effector response 
A cascade of cellular and humoral responses is initiated following 
activation of T cells in a virus infection. These responses include 
generation of cytotoxic T lymphocytes (CTL), activation of macrophages 
to produce reactive nitrogen intermediates and other secreted factors, 
and at a later stage, neutralization of pathogen with antibodies. T cell-
mediated immunity is usually measurable systemically within 4 - 6 
days after general spread of the virus, at a time when the viral titres are 
beginning to decline. In contrast, neutralizing antibodies can be 
detected much later, often measurable days or weeks after the virus has 
disappeared (Zinkernagel and Hengartner, 1985). 
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4.1 Regulation of response by T cell cytokines 
There are a wide variety of different effector mechanisms possible 
within an immune response, each of which is particularly effective 
against a certain set of pathogens. For example, a cytotoxic response 
will be effective in a virus infection, whereas antibodies are required to 
neutralize soluble toxins. Thus, the regulation of the type of immune 
response is crucial to the well-being of the host. During the last five 
years it has become apparent that subsets of T cells secreting distinct 
patterns of cytokines have a major role in this regulation. Two major 
patterns of cytokine secretion by T cells have been identified among 
murine T cell clones (Mosmann et al., 1986), and these patterns appear 
to be associated with the induction of either CMI or help for antibody 
production, thus providing a possible explanation for the separate and 
often reciprocal regulation of these two responses (Parish, 1972). 
4.2 Cytokine secretion phenotypes of T cells 
Mosmann et al. (1986) defined two types of CD4+ T cell, based on studies 
of CD4+ T cell clones. CD4+ T cells are commonly referred to as helper 
T cells, hence the two groups were named T helper 1 (Th1) and T 
helper 2 (Th2). It must be stressed, however, that CD4 + T cells have a 
variety of functions, only one of which is to activate antigen-specific B 
cells, the original definition of T cell help (Bottomly, 1988). Upon 
activation, Th1 clones synthesize IL-2, IFN-y and lymphotoxin (LT) 
while Th2 clones synthesize IL-4, IL-5, IL-6 and IL-10. Both types of 
clone synthesize IL-3 and GM-CSF (reviewed by Mosmann and 
Coffman, 1989b). CD8+ T cell clones express a pattern of cytokines that 
corresponds to the Th1 pattern (Fong and Mosmann, 1990). 
Th2 clones cultured with antigen-specific B cells enhance the growth 
and differentiation of the B cells and induce significant IgE responses. 
In contrast, Th1 clones may suppress B cell responses, although they 
are able to induce IgG2a production (Stevens et al., 1988). The 
production of IgG2a antibody, the major opsonising isotype, would be 
appropriate when CMI is induced. Only Th1 clones are able to elicit 
DTH, which may be mediated through the production of IFN-y 
(Mosmann and Coffman, 1989a). 
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The Th1 and Th2 cytokine synthesis patterns have been defined using 
long-term mouse T cell clones. Cytokine secretion by T cell clones at 
short times after establishment do not follow a pure Th1 or Th2 
pattern, as a broad spectrum of cytokines are produced (Firestein et al., 
1989; Mosmann and Coffman, 1989a), although Th1 or Th2 clones can 
develop with prolonged culture. Experiments by Kelso and Gough 
(1988) have also demonstrated that the eo-expression of GM-CSF, IL-3, 
IFN-y and IL-4 was random in both CD4+ and CD8+ T cells in short term 
clones. Thus, it is uncertain whether normal activated T cells display 
the Th1 or Th2 phenotype. Some of the strongest evidence for the 
existence of Th1 and Th2 cells in vivo comes from studies with several 
mouse models of parasite infections. Host-parasite models have been 
used extensively to study the effects of cytokine patterns in vivo 
(reviewed by Sher et al., 1992) because T cell subset and cytokine 
responses tend to polarize in many experimental parasitic infections. 
4.2.1 The murine model of Leishmania major infection 
The murine response to infection with the protozoan parasite 
Leishmania major has been well characterized. In most inbred strains 
of m.ice, subcutaneous infection with L. major is resolved due to the 
induction of a strong cell-mediated immune response. In contrast, 
BALB/ c mice develop a progressive and ultimately fatal disease 
(reviewed by Muller et al., 1989). An important difference between 
resistant and susceptible mice is the nature of the CD4+ T cell response. 
Healing of infection in resistant mice is associated with stimulation of 
Th1 type cells (Heinzel et al., 1989) and expression of IFN-y and IL-2 by 
these cells (Heinzel et al., 1991), whereas susceptiblity is associated with 
preferential stimulation of the Th2 subset and expression of IL-4 and IL-
10. Furthermore, adoptive transfer of Th1 and Th2 cell lines into 
nonhealer BALB/ c mice provided direct evidence that the Th1 cells 
mediate resistance (Scott et al., 1988). 
4.2.2 Regulation of Thl or Th2 phenotype generation 
A question that is still not resolved is what mechanisms operate to 
regulate the generation of either Th1 or Th2 cell phenotypes from a 
naive T cell population. There is recent evidence to suggest that the 
cytokines present during primary stimulation are the most important 
influence on naive Th cell differentiation (Scott, 1993). However, there 
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are studies which have indicated that the antigen presenting cell and 
the antigen dose are also important factors . Many of the studies have 
used the L. major model, and are discussed below. 
Both in vivo and in vitro studies of the response of mice to L. maJor 
have given clear evidence of the importance of certain cytokines in the 
regulation of differentiation of naive T cells into Th1 or Th2 cells . 
Treatment of resistant mice with anti-IFN-y mAb led to increased 
susceptibility, with enhanced production of IL-4 and IL-5 (Scott, 1991), 
whereas treatment of BALB/c mice with anti-IL-4 mAb during the first 
two weeks of infection allowed these previously susceptible mice to 
develop healing Th1-like responses (Chatelain et al., 1992). The 
development of a Th1 or Th2 response is induced soon after infection 
as lymph node T cells taken from infected mice could be restimulated 
in vitro with L. major antigens as early as 3 days after initial infection. 
Cells from BALB/c mice produced substantial IL-4 and IL-5, while 
resistant mice secreted IFN-y (Scott, 1991). The early timing of this 
response indicates the production of these cytokines is part of the 
innate response, ie. the cytokines are produced by cells which can 
respond immediately to antigen, without clonal proliferation, and are 
present ih relatively large numbers. 
NK cells appear to be a major source of IFN-y as shown in a study using 
scid mice, where a host source of IFN-y appeared to drive transferred 
naive T cells towards a Th1 phenotype in L. major infected mice 
(Varkila et al., 1993). This would suggest that antigens which activate 
NK cells may preferentially induce a Th1-like response. Alternatively, 
antigens which activate macrophages to produce cytokines which then 
stimulate NK cell production of IFN-y may also lead to a Th1-like 
response. NK cells are stimulated by IFN-a (Kasaian and Biron, 1990) 
and IL-12 (Kobayashi et al., 1989), cytokines which are produced 
predominantly by macrophages (D'Andrea et al., 1992). It has been 
proposed that viruses induce specific immune responses of the Th1 
type because they either directly stimulate NK cells to produce IFN-y, or 
because they induce macrophage production of IL-12 and IFN-a, which 
in turn stimulate NK cell growth and IFN-y production (Romagnani, 
1992). 
The presence of IL-4 at the early stages of infection appear to be critical 
in the development of a Th2-type response. The cellular source of IL-4 
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during the innate stage of infection has not been identified. As T cells 
are not able to differentiate into IL-4 producing cells in the absence of 
IL-4 (Le Gros et al., 1990), IL-4 must be produced by another cell. Non-T 
cells from mouse spleen, probably belonging to the mast cell/basophil 
lineage, can secrete significant levels of IL-4 (Ben-Sasson et al., 1990), 
thus antigens which are able to activate mast cells may induce the 
production of a Th2-type response. Recent studies by Morris et al. 
(1992) demonstrate that both resistant and susceptible mice synthesize 
IL-4 and IFN-y early in the response to L. major infection. However, 
the outcome of infection is determined by the number of L. major-
specific CD4+ cells secreting IL-4 (Morris et al., 1993). Removal of CD4+ 
cells or treatment with anti-IL4 led to a decreased precursor frequency 
of cells secreting IL-4 and reduction in parasite number, with no change 
in IFN-y secreting precursors. This indicates that IL-4 or associated 
cytokines down-regulate the effectiveness of IFN-y, and removal of IL-4 
secreting cells allows IFN-y to exert its protective effects. 
The dose of antigen has also been shown to be crucial in determining 
whether a Th1 or Th2 type of response is induced. A concentration of 
antigen that is subimmunogenic for the induction of antibody (Th2 
type response) can induce DTH (Th1 type response) (Parish, 1972). 
Recent studies by Bretscher et al. (1992) have demonstrated that 
"susceptible" BALB/ c mice mount a cell-mediated Th1 type response 
when injected with a small number of L. major parasites, and aquire 
systemic resistance. This may have important implications in the 
design of vaccines for use in a genetically diverse human population. 
Another mechanism of differential activation of Th1 or Th2 cells may 
be at the level of the APC. Using OVA-specific Th1 and Th2 clones 
derived from the same lymph node cell preparation, Gajewski et al. 
(1991) have demonstrated the two phenotypes proliferate optimally in 
response to distinct antigen-presenting cell populations. Purified B 
cells stimulated optimal proliferation of Th2 clones, whereas adherent 
cells (macrophages/ dendritic cells) stimulated optimal proliferation of 
Th1 clones. This suggests that a cofactor is necessary for optimal 
proliferation of each Th subset, and that these cofactors are 
preferentially expressed by distinct APC populations. 
As described above, the Th1 and Th2 phenotypes do exist in vzvo 
following priming. However, short term clones exhibit a number of 
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other cytokine secretion phenotypes. Firestein et al. (1989) described a 
third phenotype, ThO, with cells in this subset having an unrestricted 
pattern of cytokine production. It has been proposed that the Th1 and 
Th2 cells represent phenotypes that have differentiated in response to 
strong and repeated stimulation during an immune response, while 
the ThO phenotype may represent an intermediate stage of 
differentiation (Mosmann and Coffman, 1989a), although this still does 
not account for the range of cytokine secretion phenotypes which have 
been described (Kelso et al., 1991). 
4.2.3 Cross-regulation of immune response 
There is an inverse relationship between the induction of antibody and 
DTH responses in an immune response (Katsura, 1977; Parish, 1972). 
As these two responses are associated with preferential expansion of 
Th2 and Th1 cells, respectively, this reciprocal behaviour could be 
explained by cross regulatory effects between Th1 and Th2 cells. IFN-y, 
a product of Th1 cells, inhibits the proliferation of Th2 but not Th1 cells 
(Gajewski and Fitch, 1988). An activity produced by a Th2 clone, D10, 
inhibited Th1 proliferation (Horowitz et al., 1986). Fiorentino et al. 
(1989) characterized a cytokine, IL-10, which is produced by Th2 cells 
and inhibits synthesis of several cytokines by Th1 clones. IL-10 has 
been shown to inhibit the APC function of purified macrophages, but 
not B cells (Fiorentino et al., 1991a). IL-10 also inhibits the production 
of IFN-y by NK cells (Tripp et al., 1993). These results indicate that 
subsets of Th cells can cross-regulate the growth and activities of one 
another. 
4.3 Cytotoxic T Lymphocytes 
Adoptive transfer of immune lymphocytes into m1ce with varying 
virus infections, including influenza, HSV-1 and LCMV, promotes 
their recovery and reduces virus titres. The cells with this effector 
activity are Thy.1 + and Lyt.2+, require class I homology between donor 
and recipient, and exhibit virus-specific cytotoxicity in vitro (Byrne and 
Oldstone, 1984; Sethi et al., 1983; Yap and Ada, 1978). Two possible 
mechanisms by which these virus-specific T cells mediate their 
antiviral activity have been suggested. Firstly, the cytotoxic T cells lyse 
virus-infected cells before infectious progeny is assembled and released. 
This suggestion has been supported by the work of Zinkernagel and 
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Althage (1977), where 90°/o of vaccinia infected target cells were lysed by 
immune cells before progeny virus could be assembled. The second 
mechanism suggested is that the T cells release soluble mediators 
which then indirectly prevent virus spread, eg. the release of IFN-y or 
other lymphokines that activate macrophages to increased virucidal 
capacity (Blanden, 1982). This is also supported by the demonstration 
that the antiviral activity of vaccinia virus immune CD8+ T cells is 
dependent on IFN-y (Ruby and Ramshaw, 1991). 
The process of CTL activation occurs in 2 - 7 days after mitogen or 
antigen stimulation and involves a differentiation event and, usually, 
proliferation. This multistep process requires transmembrane signals 
delivered by cytokines, in addition to signals delivered by the antigen 
specific T cell receptors (Plate, 1976). Raulet and Bevan (1982) identified 
a factor, called CDF (CTL differentiation factor), which is required for 
CTL differentiation. CDF was later identified as IL-6 (Takai et al., 1988). 
The in vitro cytokine requirements for CTL induction differ for 
thymocytes and spleen cell responders (Takai et al., 1986), as thymocytes 
required IL-2, IFN-y and IL-6 for optimal induction, while spleen cell 
responders only required IL-2. The importance for IL-6 in the 
generation of CTL in vivo has been demonstrated using IL-6 knockout 
mice (IL-6 -I-). The generation of CTL against vaccinia virus (WR 
strain) was compromised in IL-6 -/-mice, with increased virus titres in 
ovaries and lungs (A. Ramsay, personal communication). IL-4 is 
another cytokine required for CTL induction. IL-4 added late to a 
culture augments the cytotoxicity, providing a late signal in CTL 
generation. Conversely, exposure of cells to IL-4 before antigen results 
in suppression of the CTL response (Horohov et al., 1988). A recent 
development has been the demonstration that IL-6, which is required 
for CTL differentiation, acts by inducing Th1 cells to produce IL-2 and 
IL-4, the mediators for the final differentiation of CD8+ T cells to active 
CTL (Quentmeier et al., 1992). These studies indicate that the 
generation of CTL is dependent not only on presentation of antigen in 
the context of class I MHC, but also the presence of CD4 + T cell-derived 
cytokines at the site of stimulation. 
There has been a great deal of research in the field of cell-mediated 
cytotoxicity, yet there is still no consensus about the way in which CTL 
induce target cell death. It would seem that there are multiple 
mechanisms and mediators. Nevertheless, these mechanisms show 
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exquisite specificity, as demonstrated by Lukacher et al. (1984) . When 
mice were simultaneously infected with two different subtypes of 
influenza the adoptive transfer of a CTL specific for only one sub type 
did not promote recovery of the mice. The subtype specific clone was 
only able to reduce the virus titre of the strain which it recognised. 
Two general models have been developed to explain the mechanisms 
by which cytolytic T cells kill target cells (Berke, 1991). The first model, 
the membrane attack model, can be resolved into three steps. First, 
CTLs recognise an appropriate target cell and bind. The second step is 
the delivery of a "lethal hit", through granule exocytosis by the effector 
cell. The final step is disintegration and lysis of the cell. Purification of 
proteins stored in the granules led to the discovery of a membranolytic 
protein named perforin and a series of serine esterases (reviewed by 
Lowin et al , 1992). There is a great deal of in vitro evidence to support 
this model, although criticism against it is a question of how the killer 
cell is able to protect itself against its own lethal machinery (Tschopp 
and Nabholz, 1990). In the second model, the suicide model, the 
cytotoxic cell is assumed to trigger a self-destructive process in the target 
cell, with DNA fragmentation occurring within minutes of target cell 
contact with an effector cell (Golstein et al., 1991). 
' 
It appears that a mixture of cytotoxic mechanisms is used by different 
killer cell types and that any given target cell may be susceptible to 
multiple effector mechanisms (Smyth et al., 1992). The mechanism 
may depend on the nature of the target cell, the presence of accessory 
cells or the lymphokines at the site. Elucidation of the importance of 
these various mechanisms may depend on strategies such as those 
recently employed by Lowin et al. (1992). His group is generating 
transgenic mice with a homozygous non-functional perforin gene to 
determine whether there is an absolute requirement for perforin in cell 
lysis. The work from these mice has not yet been published. However, 
two recent studies using sensitive PCR or molecular probes have 
demonstrated that CTL hybridomas are able to kill targets effectively in 
the complete absence of perforin transcripts (Berke et al., 1993; Helgason 
et al., 1992). These results support the argument that populations of 
lymphocytes do exist which have a perforin-independent CTL lytic 
mechanism. 
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4.4 Interactions between CD4 + T cells and B cells 
Resting B cells require contact-dependent, antigen-specific MHC class IT-
restricted interactions with Th cells for the induction of their growth 
and differentiation. C D4 + T cells provide "help" to B cells through 
physical contact and through secretion of cytokines. To initiate T-B cell 
interaction, the B cell must take up and re-express antigen in 
association with MHC molecules. Antigen binds to membrane IgM 
and IgD on B cells and is endocytosed. Following processing the 
antigen is re-expressed on the cell surface in a complex with class II 
MHC molecules, for CD4 + T cell recognition (Noelle and Snow, 1990). 
Once recognised, a T-B cell conjugate forms. TCR cross-linking results 
in a rapid and transient increase in affinity of adhesion molecules, such 
as LFA-1, for their ligands on the B cell (Dustin and Springer, 1989) 
which increases the stability of the conjugate. The interaction of 
CD4/TCR with the class II-Ag complex activates the T cell, resulting in 
T cell expression of a novel protein, CD40 ligand, on the cell surface 
(Noelle et al., 1992). Once a T cell is activated, the effector mechanisms 
mediating the activation of the B cells are genetically unrestricted, non-
antigen specific, requiring only contact between the Th cell and B cell 
(Noelle et al., 1992). Binding of the ligand to the receptor, CD40, on the 
B cell activates the cognate B cell to proliferate (Banchereau et al., 1991) 
and induces the cell to become responsive to the cytokines released by 
the T cell. IL-4, a product of Th2 cells is necessary for Th cell dependent 
B-cell growth (Hodgkin et al., 1990; Noelle et al., 1991). Differentiation 
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of the B cell to immunoglobulin synthesis requires both IL-4 and IL-5. 
IL-4 enhances secretion of IgG1 and IgE, while IL-5 enhances I gM and 
IgA secretion (Snapper et al., 1988; Takatsu et al., 1988). The isotype 
pattern induced by Th2 cells is modified by the intervention of Th1 
cells, as IFN-y is a switch factor for production of IgG2a, resulting in 
secretion of larger amounts of IgG2a and reduced secretion of IgG1 and 
IgE (Snapper and Paul, 1987). 
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4.5 Neutralization by antibody 
Neutralization is the loss of virus infectivity caused by antibody. It is of 
major importance in limiting viremia to prevent the spread of virus to 
susceptible organs and in controlling reinfection (Daniels, 1975). The 
mechanism of neutralization is complex as several components are 
involved. IgG can cause virus neutralization by inhibiting fusion of 
enveloped viruses with cell membranes, while other antibodies can 
neutralize virus after it has attached to a cell, although a limiting factor 
in this situation is the rate at which the attached virus is neutralized. It 
appears that each virus may be neutralized by a mechanism which is 
determined by some of the following factors: the virus, the 
neutralization antigen, the Ig isotype and the cell receptor (Dimmock, 
1993). 
4.6 Activation of Macrophages 
IFN-y has been described as a potent macrophage activating factor 
(Nathan et al., 1983). This description has been modified to suggest that 
IFN-y only primes the macrophage to respond to a second stimulus, 
such as LPS, and then will become activated (Pace et al., 1983). Primed 
macrophages are not cytolytic; a second signal is required (Pace et al., 
1983). IFN-y induces the presentation of TNF-a receptors (Ruggiero et 
al., 1986; Tsujimoto et al., 1986), so that TNF-a produced by the 
macrophage can then act in an autocrine manner (Philip and Epstein, 
1986), amplifying cytokine secretion and begin the signal cascade 
leading to antimicrobial effector functions. The majority of studies use 
LPS as a stimulating agent. These do not reflect the mechanism of 
macrophage activation in non-septic inflammatory responses, where 
LPS is not present. A series of studies, reviewed by Stout (1993), have 
shown there are various mechanisms by which T cells could mediate 
macrophage activation through production of TNF-a and IFN-y, in the 
absence of LPS. Both contact-dependent and independent mechanisms 
have been demonstrated. The supernatant from cultured Th1 cells 
containing soluble TNF-a and IFN-y can activate macrophages, by non-
cognate signalling. Macrophages, primed by IFN-y, are also able to 
receive a second signal through contact with either Th1 or activated 
Th2 cells. The Th2 mediated signalling of macrophage activation 
closely resembles that of T cell mediated B cell activation, where 
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activated T cells deliver non-specific cognate signals to the B cell (see 
section 4.4) (Stout, 1993). Despite the ability of Th2 cells to activate 
primed macrophages in vitro, it is probably the Thl cells that are 
involved in macrophage activtion in situ. Th2 cells do not produce 
macrophage activating cytokines; rather, they produce cytokines, such 
as IL-4 and IL-10, which will inhibit the production of the macrophage-
priming cytokine IFN-y and prevent activation of macrophages (Sher et 
al., 1992). 
Activated macrophages secrete a number of cytokines, such as IL-l and 
TNF, that are thought to play an important role in inflammation 
(Beutler and Cerami, 1986; Oppenheim and Gery, 1982). IFN-y released 
by antigen-stimulated T cells enhances the transcription of these genes 
in murine macrophages (Collart et al., 1986). IFN-y has also been 
shown to prime macrophages for an enhanced oxidative burst (Nathan 
et al., 1983), tumour cytolysis (Pace et al., 1983), as well as activate 
macrophages for enhanced microbial killing (Nathan et al., 1983). 
There has been a recent discovery of a new antimicrobial mechanism of 
activated macrophages - the production of reactive nitrogen 
intermediates (RNI). Studies from 1985 - 1987 demonstrated that 
macrophages could generate broadly cytotoxic molecules from the 
guanidino moiety of L-arginine, and form nitrate and nitrite (reviewed 
by Nathan, 1991). Further studies led to evidence that RNis contribute 
to the ability of macrophages to inhibit a wide variety of intracellular 
and extracellular pathogens. Importantly, IFN-y can induce nitric oxide 
synthase (NOS), the enzyme responsible for generation of RNis, and 
there is dramatic synergy between IFN-y and TNF-a or LT in this 
production (Ding et al., 1988). This suggests that RNI synthesis occurs 
during any immune response involving T cell-mediated macrophage 
activation. Two recent reports have demonstrated that nitric oxide 
(NO) has antiviral activity. Croen (1993) reported that NO inhibited the 
replication of HSV-1 virus in vitro, and Karupiah et al. (1993) 
demonstrated that the IFN-y induced antiviral activity of mouse 
macrophages correlated with the cells' production of NO. This group 
also restricted viral replication in cells with no detectable NO synthesis 
by transfecting the cells with a complementary DNA encoding 
inducible NO synthase. NO has been described as being able to inhibit 
several cellular ribonucleotide reductases (Lepoivre et al., 1991), thus 
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inhibition of cellular and viral ribonucleotide reductases may explain 
the sensitivity of viruses to NO. 
4.7 Immunological Memory 
A feature of the late T cell-dependent response to infection is the 
generation of memory. Immunological memory is the term used to 
describe the rapid and more vigorous response to pathogens that have 
been encountered previously. Memory T cells can now be 
distinguished from naive cells by their expression of certain cell surface 
molecules. In humans, antibodies against different isoforms of the 
leukocyte common antigen (CD45) distinguish between naive and 
memory cells (Sanders et al., 1988). CD45RO+ T cells respond to a recall 
antigen in vitro, and are thus memory cells, whereas CD45RA + T cells 
are naive. In the mouse, anti-CD44 (Pgp-1) antibodies are used to 
distinguish memory cells (Cerottini and MacDonald, 1989). In both 
humans and mice, naive cells synthesize greater levels of IL-2 than 
memory cells, whereas IFN-y, IL-3 and IL-6 are preferentially 
synthesized by memory cells (Akbar et al., 1991). 
Naive and memory T cells migrate along different pathways· through 
the circulation (reviewed by Mackay, 1991). Memory T cells localize to 
nonlymphoid tissues, such as the skin and gut, whereas naive T cells 
generally migrate to lymph nodes. The frequency of naive T cells 
reactive to a given antigen is very low, and their presence in the lymph 
node increases the likelihood of a cell encountering its cognate antigen 
in the presence of appropriate stimulatory signals . Pre-activated 
(memory) cells, on the other hand, serve their best function when 
situated in areas of likely antigen encounter, such as epithelial sites . 
This will ensure that an immediate response is possible when a recall 
antigen enters the host. 
Several virus infections and vaccinations result in lifelong immunity. 
Whether such immunity is due to persistence of the initially primed T 
cells and their progeny, or due to subsequent re-exposure to virus and 
priming of new T cells, has been the focus of a recent study. Jamieson 
and Ahmed (1989) report that virus-specific CTL can persist indefinitely 
in vivo. Transferred CD8+ T cells eliminated virus and persisted in 
small numbers in the recipient. Upon re-exposure to antigen, these 
resting CD8+ T cells proliferated, independently of CD4+ T cell help . 
The transferred cells were recovered a year later and still retained 
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antigen specificity and biological function. These results suggest that 
virus-specific CTL (memory cells) are present in small numbers in a 
resting stage, throughout the life of the host, and are capable of 
expansion after re-exposure to antigen. The possibility cannot be ruled 
out, however, that the virus-specific CTL were maintained through 
antigenic stimulation by minute amounts of antigen not detectable by 
conventional assays. A study into the longevity of memory T cell help 
by Roost et al. (1990) has demonstrated that memory T cell help in the 
generation of antibody is short-lived, ie. 14 days. These results support 
the idea that T cell memory is dependent on the presence of antigen. 
The results of the two studies discussed may indicate that the longevity 
ofT cell memory is different according to the type ofT cell. 
5 Cytokines 
5.1 Common characteristics 
Cytokines are a group of proteins which are extremely heterogeneous, 
with a diverse array of functions, yet have a number of common 
characteristics. These include low molecular weight, transient and 
local production, potent activity, high affinity binding to receptors, and 
overlapping cell regulatory actions (Balkwill and Burke, 1989). Most 
cytokines are glycoproteins with a monomeric molecular mass of 15-25 
kDa (Clark and Kamen, 1987). Each cytokine interacts with high 
affinity cell surface receptors specific for each cytokine or cytokine 
group (Balkwill and Burke, 1989). The number of receptors on normal 
cells is low (10 - 10000 per cell), although only 10 - 100 receptors need to 
be occupied by the cytokine to induce a biological response (Mita et al., 
1988; Tsujimoto et al., 1985). The extracellular event of the cytokine 
interacting with the receptor is transduced into internal signals, often 
involving a cascade of kinases (Aderem, 1993). These signals then alter 
the behaviour of the effector cell. Another feature of these proteins is 
that each cytokine has multiple functions (pleiotropic), and that more 
than one cytokine can mediate the same function (redundancy; Paul, 
1989). Finally, cytokines do not appear to work alone, they interact in a 
network by: inducing each other, transmodulating cytokine cell surface 
receptors and by synergistic, additive or antagonistic interactions on cell 
function (Balkwill and Burke, 1989). 
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Cytokines produced by T cells are not antigen-specific, although their 
production is both antigen specific and MHC restricted (Conta et al., 
1985). They appear to function as paracrine hormones as they are both 
produced and consumed at the site of immune reaction (Kelso, 1989). 
In contrast, cytokine production by non-lymphoid cells can be triggered 
without antigen specificity, for example by other cytokines or bacterial 
products. These cytokines are able to travel via the circulation to exert 
their effects at distant sites in the body. 
As mentioned earlier in this review, cytokines play a major role in 
mediating the immunoregulatory role of T cells in an immune 
response. Cytokines have a wide range of effects, both beneficial and 
inhibitory. Therefore, mechanisms must exist to ensure that the 
cytokines produced stimulate a beneficial host immune response at the 
site of infection, and once this has been established, the cytokines must 
be removed or down-regulated to prevent inappropriate responses. 
Several mechanisms for such regulation have been identified in in 
vitro studies (reviewed by Kelso, 1989). Firstly, cytokine synthesis by 
activated T cells is short-lived and tightly regulated by antigen 
concentration. For example, the IL-2 mRNA induced in primary 
splenic lymphocytes by Con A has a t1;2 of only about 30 min and the 
expression of IL-2 and IL-4 mRNA rapidly disappears following 
removal of the stimulating signal (Swoboda et al., 1991). Many 
cytokines have AU-rich sequences in the 3'-untranslated regions of 
their mRNAs (Shaw and Kamen, 1986) and it has been shown that 
mRNA instability is correlated with the abundance of 3' AU sequences 
(Wreschner and Rechavi, 1988). A second mechanism to regulate 
cytokine production has been demonstrated using cells cultured with a 
variety of mitogens (Carding et al., 1989). The different stimuli induced 
synthesis of different combinations of cytokines. Finally, cytokine 
secretion can be localized and directional (Kupfer et al., 1991; Poo et al., 
1988). This would allow concentration of limiting amounts of cytokine 
in the vicinity of the interacting cells, and prevent stimulation of non-
target cells. 
A large number of cytokines are involved in a host response to virus 
infection. In the following sections of this review some of the major 
characteristics and functions of several of these cytokines will be 
outlined. The cytokines discussed bear particular relevance to the work 
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described in this thesis. As cytokines rarely function alone this 
discussion will also include information on cytokine interaction and 
the cytokine network (Balkwill and Burke, 1989). 
5.2 Macrophage-derived cytokines 
The two cytokines discussed in this section are synthesized by a large 
number of cell types, however, they were originally thought to be 
macrophage-derived. In the early innate stage of a host response, 
cytokines produced by NK cells and macrophages signal the adaptive 
immune response how to react appropriately (Romagnani, 1992). They 
may also have direct activity on the pathogen itself. TNF and IL-6 
secretion are induced upon infection with virus, indicating they play 
an important role in the host response to this type of invading 
pathogen. 
5.2.1 Tumour Necrosis Factor 
In 1975, Carswell et al. reported the existence of a serum factor derived 
from BCG-primed, endotoxin-treated animals which was able to elicit 
haemorrhagic necrosis of a transplantable tumour in another animal 
(Carswell et al., 1975). The molecule responsible for this was called 
Tumour Necrosis Factor (TNF). 
TNF is a 17 kDa polypeptide when released by the cell and interacts 
with its receptor as a trirner (Jones et al., 1989). A 26 kDa membrane 
form of TNF also exists on activated macrophages (Kriegler et al., 1988), 
but this represents only a small fraction of all TNF contained by 
stimulated cells (Lonnemann et al., 1989). Virtually all types of 
nucleated cells can respond to TNF as they all have receptors. Two 
types of TNF receptor have been identified, a low and a higher 
molecular weight form, called p55 and p75, respectively. Some cells 
have both receptors, eg NK cells, while others have only one or the 
other (Vassalli, 1992). The interaction of TNF with its receptor puts in 
motion a cascade of biological responses, which can continue for up to 
36 hours (Cerami, 1992). The half-life of TNF in the circulation is short, 
estimated to be 6 min (Beutler et al., 1985) which prevents active 
diffusion and widescale cytotoxicity throughout the body. 
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TNF is made primarily by activated macrophages (Beutler and Cerami, 
1989), although T lymphocytes and NK cells represent a large potential 
source of TNF. Other cell types, including mast cells, keratinocytes, 
astrocytes and smooth muscle cells, can also be stimulated to produce 
TNF (Vassalli, 1992). 
Although monocytes and macrophages are a major source of TNF, they 
are also one of its main targets. TNF is important in the activation of 
macrophages, in synergy with IFN-y as outlined in section 4.6, 
potentially resulting in further TNF release. In addition, TNF is 
chemotactic for monocytes and may serve to recruit monocytes from 
the blood compartment to amplify resistance against infectious agents 
(Ming et al., 1987). Resting T cells do not have TNF receptors, and 
therefore will not respond to TNF. Receptors are induced upon 
primary activation, and on exposure to TNF these activated T cells 
increase their expression of IL-2 receptor. As a consequence, the cells 
show an enhanced proliferative response to IL-2 (Scheurich et al., 1987). 
Costimulation of T cells with TNF and IL-2 leads to increased IFN-y 
production by these cells. Similarly, in the presence of IL-2, TNF 
increases IL-2 receptor expression on NK cells and augments their 
cytolytic activity (0stensen et al., 1987). Thus, TNF enhances the ability 
of T and NK cells to respond to IL-2. The endothelial cells are another 
major target of TNF, as shown by the multiple responses of these cells 
to TNF in vitro. These responses have been reviewed by Vassalli 
(1992), and include the release of growth factors and cytokines, 
enhanced blood clotting, increased cell adhesion molecules and class I 
MHC antigens. 
TNF is not cytotoxic to most normal cells in vitro. In contrast, tumour 
cell lines can be either a) insensitive to TNF, b) rapidly killed by TNF, 
or c) prevented from growing by TNF. TNF is able to kill susceptible 
cells simply by binding to receptors. The probable mechanism is that 
this induces superoxides and exposes the cells to an oxidative stress. 
Cell survival depends on the efficiency of its protective mechanisms. 
Those tumour lines most sensitive to TNF are those with the lowest 
radical scavenging capacity (Zimmerman et al., 1989). 
TNF release can be induced by several cytokines, including TNF itself 
(Philip and Epstein, 1986). IL-2, GM-CSF and CSF-1 have been reported 
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to induce TNF release (Vassalli, 1992), while IFN-y has a strong 
potentiating activity in many conditions involving TNF. 
TNF mediates a large array of activities which are beneficial during a 
response to an infection. These include direct antiviral activity, and 
enhancement of responses by T and NK cells, and also macrophages. 
However, the production of TNF must be tightly regulated as high 
levels of TNF will induce wasting, fever and even death (Beutler and 
Cerami, 1986). 
5.2.2 Interleukin 6 
IL-6 is a pleiotropic cytokine that acts on a variety of cells. This is 
apparent when the history of IL-6 is considered. During the 1980's 
several research groups worked on cloning what seemed to be a series 
of unique molecules. Following the publication of the sequence data of 
these molecules, however, it was discovered that IFN-~2 (an antiviral 
factor), BSF-2 (B-cell stimulatory factor 2), HPGF (hybridoma/ 
plasmacytoma growth factor), HSF (hepatocyte-stimulating factor) and 
CDF (cytotoxic T-cell differentiation factor) were all the same molecule 
(Van Snick, 1990), and it was designated IL-6. 
IL-6 is produced by a large number of cells, including fibroblasts, 
endothelial cells, monocytes/macrophages, keratinocytes, T cell lines 
and mast cells (Van Snick, 1990). The major source of IL-6 in fresh cells 
is the monocyte population (Aarden et al., 1987), while T and B cells 
produce IL-6 to a lesser degree (Horii et al., 1988). IL-6 is not produced 
constitutively by normal cells, but its expression is readily induced by a 
number of factors, including viral infections (Sehgal et al., 1988), LPS 
(Ulich et al., 1991) and other cytokines such as TNF or TNF in 
combination with IFN-y (Van Snick, 1990). 
Macrophages, T cells and B cells have been found to express IL-6 
receptors. IL-6 receptors are constitutively expressed on resting T cells 
and are down-regulated upon activation. In contrast, normal B cells 
only acquire IL-6 receptors upon activation (Taga et al., 1987). It is not 
necessary for normal B cells to constitutively express IL-6 receptors as 
IL-6 acts at a late stage of B cell maturation. It has been shown that IL-6 
induces the terminal differentiation of B cells into plasma cells . IL-6 
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acts late (4 days) in the response (Muraguchi et al ., 1988) to induce Ig 
production without further proliferation (Beagley et al., 1989). IL-6 
knockout mice (IL-6 -I-) have similar total serum immunoglobulin 
levels as their normal littermates. However, the mutants have 
impaired serum IgG and mucosal IgA antibody responses to virus 
infection (M. Kopf, A. Ramsay, personal communication). Antibody 
secretion by naive B cells is dependent on IL-6, whereas antigen-primed 
B cell responsiveness is essentially IL-6 independent (Hilbert et al., 
1989). Thus, T cell-derived IL-6 plays a critical role in regulation of B 
cell responses; it is essential for primary B cell differentiation into 
antibody-secreting cells and it enhances secretion by any antibody 
secreting cell. 
Normal T cells constitutively express IL-6 receptors. The activation of 
these cells is controlled by IL-6, in synergy with IL-l (Van Snick, 1990). 
IL-6 acts early, predominantly by enhancing IL-2 responsiveness, 
whereas IL-l acts at the later stage of IL-2 production. The synergistic 
action between IL-l and IL-6 is also seen in the induction of CTL 
responses in allogeneic mixed lymphocyte reactions (Renauld et al., 
1989). These cytokines act on the CD8+ T cells capable of secreting IL-2. 
IL-6 appears to be an essential early accessory signal in the activation of 
fresh T -cells, and thus is an important factor in the regulation of an 
Immune response. 
IL-6 has been reported to down-regulate LPS-induced expression of 
TNF and IL-l, suggesting it may be part of a negative feedback 
mechanism in the cytokine cascade (Aderka, 1989). This could be 
described as an anti-inflammatory activity. IL-6 has a range of other 
functions, including induction of the acute phase response and 
inducing fever (Van Snick, 1990), which are beyond the scope of this 
review. 
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5.3 T cell-derived cytokines 
Unlike the secretion of cytokines by macrophages, cytokine synthesis by 
T cells requires antigen specific and MHC-restricted stimulation of the 
T cell. The production of cytokines is tightly regulated, and upon 
removal of the stimulating antigen, cytokine synthesis ceases. T cell-
derived cytokines have multiple biological activities on different target 
cells. The discussion below has been limited to those cytokines which 
have direct relevance to the work discussed in this thesis. 
5.3.1 Interleukin 2 
Interleukin 2 was first identified as a soluble mitogenic factor released 
by T lymphocytes with activity on T cells, and was called T cell growth 
factor (TCGF) (Gillis et al., 1978). At the Second International 
Lymphokine Workshop, in 1979, TCGF was designated IL-2 (Smith, 
1988). This was to clarify the terminology, and to distinguish it from a 
macrophage-derived factor also with mitogenic activity, which had 
been known as lymphocyte activating factor (LAF) (Gery et al., 1972), 
and was designated IL-l. 
T cells are the principal producers of IL-2 (Smith, 1988). T cells also 
respond to IL-2 and, during the response, IL-2 is consumed by the T cell. 
T cells express IL-2 receptors which remove or "consume" IL-2 by 
internalization of the receptor /IL-2 complex. High-affinity IL-2 
receptors consist of two polypeptide chains, the 75 kDa chain (a) and 
the 55 kDa chain (~), each of which contains a distinct binding site. 
When expressed individually the chains react with IL-2 quite 
differently, and bind with distinct affinities. Co-operation of the two 
chains leads to formation of a heterodimeric receptor with an increased 
affinity for IL-2. 
IL-2 activates a wide range of cell types, including monocytes (Halter et 
al., 1987), B cells (Mingari et al., 1985), NK cells (Handa et al., 1983), as 
well as T cells (Morgan et al., 1976). IL-2 also has a stimulatory action 
on IFN-y secretion by NK cells (Handaet al., 1983) and CTL CFarrar et al., 
1981). 
It is the action of IL-2 on T cells which is pivotal for the induction of an 
immune response (Smith, 1988). Resting T cells do not produce IL-2, 
27 
nor do they respond to IL-2. Upon receiving the signal from T cell 
antigen-receptor complex, these cells begin transcription of both the 
IL-2 gene and the IL-2 receptor genes. For 3 days the levels of IL-2 
receptor on T cells increase, and then decline progressively, 
proliferation ceases and by 12 - 14 days the cells are back in the resting 
phase (Smith, 1988). IL-2 receptor expression is dependent on the 
presence of antigen (Cantrell and Smith, 1983), and thus, as antigen is 
cleared in vivo the receptor expression is reduced, the T cells are no 
longer able to respond to IL-2, and the T cell dependent immune 
response subsides. 
5.3.2 Interferon-y 
The production of interferon-y (immune interferon) is a function of 
activated COB+ T cells, Th1 type CD4 + T cells and NK cells. Human 
IFN -y is 17 kDa and the usual biological form is as a dimer (Ealick et al., 
1991). IFN receptors (103 to 104 per cell) exist on most cells and, 
following binding of the IFN-y dimer, a series of signals leads to the 
synthesis of many new mRNAs and up-regulation of others (Borden, 
1992). 
IFN-y was initially characterized by its ability to render homologous 
cells resistant to virus infection, a property it shares with IFN-a and 
IFN-P (Isaacs and Lindenmann, 1957). IFN-y also exerts a number of 
other effects, including various immunomodulatory activities. For 
example, IFN-y is a powerful inducer of MHC antigens, is essential in 
the activation of macrophages and NK cells, and has an important role 
in antibody production (Dijkmans and Billiau, 1988). 
IFN -y enhances the expression of both class I and class II MHC antigens 
in a large number of cell types and is thus of prime importance in 
adaptive cellular immune responses. Increased class I expression could 
improve recognition of targets by CTL, while up-regulation of class II 
MHC expression by IFN-y may enhance the antigen-presenting 
function of macrophages. IFN-y activates a number of other 
macrophage functions, including cytotoxicity against tumours, 
induction of reactive oxygen intermediates and RNis, and production 
of TNF and IL-l. Macrophages are also stimulated to mediate antibody-
dependent cell mediated cytotoxicity (ADCC) by enhancing the 
expression of IgG-Fc receptors (Perussia et al., 1983). NK cell killing 
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activity is enhanced by IFN-y (Weigent et al., 1983). Exposure of 
activated B cells to IFN-y stimulates the secretion of IgG2a (Snapper and 
Paul, 1987) and a decrease in secretion of other isotypes. IgG2a is the 
predominant antibody response to viral infections (Coutelier et al., 
1987), is the major opsonising isotype in the mouse, and is the 
preferred ligand for the macrophage IgG-Fc receptor (Coffman et al., 
1988). 
IFN -y has antiviral activity in vitro on a large number of cell types 
including fibroblasts, macrophages and some lymphoid cells (Stewart, 
1979). The in vivo antiviral role of IFN-y has been demonstrated by 
blocking IFN-y activity with administration of mAb (Leist et al., 1989). 
This method has been improved upon in the last year with the 
generation of IFN-y knockout mice (Barinaga, 1993). Studies have 
revealed that although these mice made a normal cytotoxic T cell 
response, IFN-y was essential for clearance of vaccinia virus. IFN-y was 
also shown to be needed for production of nitric oxide by macrophages. 
These mice will help provide answers to many basic questions about 
the role of IFN-y in the immune system. 
IFN-y is able to modulate expression of other cytokines. It increases 
TNF-a production by activating macrophages and enhances their TNF 
receptor expression (Ruggiero et al., 1986; Tsujimoto et al., 1986). IFN-y 
is a Th1-type cytokine and inhibits the proliferation of Th2 clones 
(Gajewski and Fitch, 1988). This leads to a down-regulation of Th2-type 
cytokines, eg. IL-4, IL-5, and IL-10. Finally, IFN-y up-regulates its own 
gene expression (Hardy and Sawada, 1989), which may serve to amplify 
the amount of IFN-y expressed at the site of inflammation. At this 
stage it is not known whether this represents autocrine superinduction 
of IFN-y in T cells, or whether an initial source of IFN-y induces greater 
expression by NK cells (Cockfield et al., 1993). 
The main function of IFN-y was thought to be its antiviral activity. 
However, as described above, IFN-y is an important immune 
modulator, acting on T and B cells, NK cells, and macrophages. 
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5.3.3 Lymphotoxin 
Lymphotoxin (LT), also known as TNF-p, belongs to the same gene 
family as TNF-a, binds to the same cell surface receptors, yet has only 
limited sequence homology (34°/o) (Ruddle, 1992). LT has generally 
been thought to be produced by T cells while TNF-a was a macrophage 
product. Recent studies, however, have shown both TNF-a and LT can 
be produced by T cell populations (English et al., 1991). They appear to 
be under different regulation, as shown by different kinetics in mRN A 
accumulation. TNF-a has a higher baseline transcription rate, and 
short (30 min) mRNA half life, whereas LT has a lower baseline rate 
and a mRNA half life of 5.5 hours. TNF-a and LT have structural 
similarities, as both form trimer molecules (Schoenfeld et al., 1991) 
which are able to bind to both TNF receptors. As LT binds to the same 
receptors, it is believed to induce similar responses as TNF-a. There is 
strong evidence that LT is a mediator of CTL killing and it may play a 
role in defence against virus infection. LT production is induced by 
virus infection and LT kills virus infected cells more efficient! y than 
normal cells (Paul and Ruddle, 1988). 
5.3.4 Interleukin-10 
As outlined in an earlier section, CD4+ T cells can be divided into 
different subsets that are distinguished by their cytokine production 
profiles. Th1 clones produce IL-2 and IFN-y, whereas Th2 clones 
produce IL-4 and IL-5 (Mosmann et al., 1986). Th1 cells are effective in 
the generation of a DTH response, and Th2 cells are more efficient in 
mediating help for antibody synthesis. These two responses are often 
mutually exclusive (Parish, 1972), suggesting there is a cross-regulatory 
mechanism involved. This was supported by evidence showing that 
IFN-y inhibits proliferation of Th2 cells (Gajewski and Fitch, 1988). 
With the expectation of there being a similar Th2 product which would 
inhibit proliferation and effector function of Th1 cells, the cytokine 
synthesis inhibitory factor (CSIF) was discovered (Fiorentino et al., 
1989). CSIF inhibited synthesis of IFN-y and other cytokines produced 
by Th1 clones. This was then cloned and, as it was thought to be 
pleiotropic, was designated IL-10 (Moore et al., 1990). Both mouse 
(m)-IL-10 and human (h)-IL-10 have been cloned and their primary 
structures determined (Moore et al., 1993). They show a high degree of 
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homology and, interestingly, have strong homology with an open 
reading frame in the Epstein-Barr (EBV) genome, BCRFI (Moore et al., 
1990). It has been proposed that BCRFI may represent a cellular 
cytokine gene captured by the EBV during evolution. BCRFI displays 
some of the biological activities of IL-10 and has been designated viral 
IL-10 (v-IL-10) (Moore et al., 1993). 
IL-10 is not strictly a Th2-specific cytokine. Mouse IL-10 is produced by 
Th2 cells (Fiorentino et al., 1989), macrophages (Fiorentino et al., 1991b ), 
Ly.l B cells and keratinocytes (Moore et al., 1993). In comparison to 
other T cell derived cytokines, IL-10 is produced relatively late 
following activation, which may be an important aspect of IL-lO's 
ability to inhibit macrophage and T cell activation. The maximal 
production of IL-10 protein by CD4+ T cell clones was observed 24 hours 
after activation (Yssel et al., 1992). 
The inhibitory effect of m-IL-10, produced by Th2 cells, on Thl cell 
cytokine synthesis is indirect. Antigen-specific Thl cytokine synthesis 
was inhibited when macrophages, but not B cells, were used as APC 
(Fiorentino et al., 1991a). The inhibitory effects were most pronounced 
for IFN-y and IL-3, which are produced relatively late after activation. 
Levels of IL-2, GM-CSF and LT, which are produced at an early stage, 
are only slightly affected (Moore et al., 1993). IL-10 also inhibits 
proliferation ofT cells in the presence of monocyte/macrophage APC. 
This indicates that IL-10 is exerting its effect at the T cell activation 
stage. Although the mechanism has not been determined, the current 
view is that IL-10 inhibits the production or function of a membrane-
bound costimulator required for T and NK cell activation. Studies are 
now addressing the possibility that IL-10 interferes with B7 function or 
expression on macrophages (Moore et al., 1993). 
Production of monokines is strongly inhibited by IL-10. Mouse IL-10 
inhibits production of IL-6, IL-l and TNF-a by LPS or IFN-y stimulated 
macrophages (Fiorentino et al., 1991b ). Blocking studies with 
antibodies revealed that endogenous IL-10 production by macrophages 
suppresses IL-6 production. Mouse IL-10 also inhibited production of 
reactive nitrogen intermediates (NO) by macrophages following 
activation by IFN-y (Gazzinelli et al., 1992). 
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In contrast to these immunosuppressive activities, IL-10 has been 
shown to costimulate a strong proliferative response of most 
thymocyte subsets in the presence of IL-2/IL-4 (Moore et al., 1993). In 
addition to promoting proliferation, IL-10 augmented the 
differentiation of cytotoxic T -cell precursors into antigen-specific CD8+ 
cytotoxic T cells (Chen and Zlotnik, 1991). 
IL-10 -plays an important role in the regulation of the immune 
response. It is a powerful immunosuppressive factor, able to inhibit 
antigen presentation by macrophages and thus prevent antigen-specific 
T cell proliferation and cytokine production. On the other hand, it has 
an enhancing effect on T cell proliferation, and acts as a cytotoxic 
differentiation factor. It also acts directly on the macrophage to inhibit 
monokine and NO release, thus it has strong anti-inflammatory 
activities. 
5.3.5 Interleukin-4 
IL-4 was originally described by its ability to enhance DNA synthesis by 
purified resting mouse B cells stimulated with anti-IgM antibodies 
(Howard et al., 1982). For this reason it was designated B-cell growth 
factor (BCGF). It was later designated IL-4 when it was realised that the 
molecule was pleiotropic in its action, with non-B cells being important 
targets (Noma et al., 1986). 
Murine IL-4 is a 19 kDa glycoprotein produced by Th2 cell clones 
(Mosmann et al., 1986), ThO cell clones (Firestein et al., 1989) and mast 
cells (Plaut et al., 1989). Resting T cells isolated from lymph nodes of 
normal mice produce very little IL-4 in response to stimulation with 
mitogen (Swain et al., 1988), but the IL-4 producing capacity can be 
markedly enhanced by in vitro culture of these cells in the presence of 
IL-2 and IL-4 (Le Gros et al., 1990). Both CD4 + and CD8+ T cells produce 
IL-4 following this priming (Seder et al., 1992). These studies indicate 
that IL-4 producing capacity is mainly found in the activated T cell 
population. 
Receptors for IL-4 have been reported to exist on freshly prepared Band 
T lymphocytes, macrophages and a variety of nonhaematopoietic cells 
(Lowenthal et al., 1988; Ohara and Paul, 1987), and are increased upon 
activation of the cell (Ohara and Paul, 1988). IL-4 itself is able to 
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increase IL-4 receptor expression on resting T and B cells (Renz et al., 
1991). The ability of IL-4 to regulate receptor expression provides an 
important mechanism for amplification of IL-4-dependent activation 
pathways. 
IL-4 was first recognized for its ability to enhance B cell growth in 
response to anti-IgM antibody (Howard et al., 1982). It also has a 
number of effects on resting B cells, including induction of an increase 
in MHC class II molecule expression (Noelle et al., 1984) which will 
improve their antigen presenting ability. IL-4 plays an important role 
in immunoglobulin isotype regulation, as it stimulates secretion of 
IgGl and IgE and suppresses secretion of other Ig isotypes (Snapper et 
al., 1988). A recent study has demonstrated that IL-4 induces motile 
morphology and migration of murine B cells, indicating that IL-4 may 
play a role as a chemoattractant factor that enhances cell contact 
between CD4+ T cells and B cells (Clinchy et al., 1991). 
IL-4 acts as an autocrine growth factor for long-term Th2 cell clones 
(Kurt-Jones et al., 1987). Th2 cells proliferate in response to IL-2 and 
IL-4, but this proliferation is dependent on IL-l as an accessory signal. 
Normal resting T cells proliferate in response to PMA plus IL-4, but not 
IL-4 alone (Hu-Li et al., 1987). The IL-4 must be present early in the T 
cell response, for the resting cells to become sensitive to the growth 
promoting effects of IL-4, but also is needed late in culture to cause the 
cells to enter 5-phase (Paul and Ohara, 1987). IL-4 is able to suppress T 
cell subsets involved in a cell-mediated (Thl-type) response. A recent 
study has demonstrated this regulation may be through down-
regulation of IL-2 production, necessary for Thl proliferation, by 
inhibiting factors required for transcription of the IL-2 gene (Schwarz et 
al., 1993). 
IL-4 is a potent murine macrophage activation factor. Macrophages 
treated with IL-4 increased expression of class-II MHC molecules and 
exhibited increased cytotoxicity against tumour cells (Crawford et al., 
1987). IL-4 is also chemotactic for mouse macrophages, whereas IL-2 is 
not (Hiester et al., 1992). Conversely, human IL-4 has also been shown 
to modulate macrophage behaviour by down-regulating expression of 
IL-l and TNF genes (Essner et al., 1989; Hart et al., 1989). This indicates 
that IL-4 not only has stimulatory activity on monocytes/ macrophages, 
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it may also be an anti-inflammatory agent. Thus, IL-4 is yet another 
cytokine with demonstrated stimulatory and suppressive activity. 
6 Thl/Th2 responses in infectious diseases. 
There is an increasing volume of evidence suggesting that the failure 
to control or resolve infectious diseases often results from 
inappropriate rather than insufficient immune responses (Powrie and 
Coffman, 1993). There are a number of host-parasite models where T 
cell derived cytokines may influence the course of infection by down-
regulating the host cell-mediated immune response. These cytokines, 
IL-4 and IL-10, are produced by CD4+ T cells belonging to the Th2 subset. 
IL-4 inhibits the development of Th1 CD4+ T cells (Swain et al., 1990b), 
whereas IL-10 suppresses the expression of IL-2 and IFN-y (Fiorentino et 
al., 1989). 
The protozoa Trypanosoma cruzi and Toxoplasma gondii invade a 
large number of different cell types. Cell-mediated immunity plays a 
major role in resistance to infection, with IFN-y implicated as a 
protective cytokine against both pathogens (Silva et al., 1991; Suzuki et 
al., '1988). The control of these protozoa by activated macrophages can, 
however, be down-regulated by the cytokines IL-4 and IL-10 (Sher et al., 
1992). Helminth infections induce elevated serum IgE and Th2 
cytokine levels (Bazin, 1974; Scott et al., 1989). This increase is usually 
coincident with a down-regulation in Th1 responses (Sher et al., 1992). 
IL-10 plays a role in the suppression of Th1-type cytokine synthesis, as 
the addition of neutralizing mAb against IL-10 to spleen cultures up-
regulates the suppressed IFN-y responses to parasite antigen in infected 
mice (Sher et al., 1991). Activated macrophages are thought to be 
important effector cells of protective immunity against schistosomes in 
mice (Sher et al., 1992). Thus IL-10, which is produced during 
schistosome infection, and is able to suppress many macrophage 
functions (Fiorentino et al., 1991b), will have a profound effect on the 
immune response to this infection. 
The pattern of mutually exclusive Th1 and Th2 clones, which could be 
isolated from mice, was not apparent among human T -cell clones for 
several years. However, as first described by Romagnani (1991), T-
lymphocyte clones can be isolated from patients with infections, or 
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from immunized individuals which display the Th1 or Th2 cytokine 
profiles. The importance of generation of an appropriate response has 
been demonstrated in the response to Mycobacterium leprae. This 
disease presents either as tuberculoid (resistant) or lepromatous 
(susceptible) lesions. Yamamura et al. (1991) have shown that mRNA 
for IL-2 and IFN-y, ie. Th-1 type cytokines, were expressed in 
tuberculoid lesions, whereas mRNA for IL-4, IL-5 and IL-10 were 
characteristic of lepromatous lesions. 
The production of an appropriate response to infection with the 
human immunodeficiency virus (HIV) may also be regulated by 
cytokines. Individuals infected with HIV have a severe depletion of 
CD 4 + T cells as the infection progresses towards acquired 
immunodeficiency syndrome (AIDS). Loss of T helper function has 
been observed prior to the decrease of CD4 + T cell numbers (Clerici et 
al., 1989). The independence between loss of Th function and CD4+ T 
cell count indicates that factors other than CD4 + depletion contribute to 
T cell dysfunction. These factors might include cytokines, and it has 
been suggested that the Th1- and Th2-type cytokines play a role in the 
progression of HIV infection to AIDS (Sher et al., 1992). The model 
proposed is that HIV-specific T cell responses that result in the 
production of Thl-type cytokines prevents infection, and/ or keeps the 
infection under control. In contrast, HIV seroconversion could be 
correlated with a transition to a Th2-type response, with increased HIV-
specific antibodies. This latter state would be more susceptible to the 
progression to AIDS (Clerici and Shearer, 1993). This model is 
consistent with the hypothesis where any immunological stimulus 
that induced a strong Th2 response would render the individual more 
susceptible to 1-llV infection and/ or progression to AIDS. This is of 
particular relevance to the AIDS epidemic in developing regions of the 
world where helminth infections, which are known to generate Th2 
responses, are common (Actor et al., 1993). 
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7 Scope of this thesis 
As has been discussed, an immune response to an infection involves 
the participation of a large number of distinct cell types. The functions 
of these cells must be co-ordinated to ensure that the response is not 
only appropriate, but also of the right magnitude, to the eliciting 
antigen. The co-ordination is regulated by cytokines secreted by T 
lymphocytes. 
The host response to a vuus infection involves the co-ordinated 
response of macrophages, B cells, NK cells and T cells. Cytokines have 
been shown to be important in this response, not only as regulatory 
molecules, but also as direct antiviral effector molecules. The use of 
recombinant vaccinia virus encoding cytokine genes has revealed that 
cytokines can indeed influence the outcome of a virus infection. In 
order to have some further understanding of the role of cytokines in 
the control of a virus infection, an in vitro model was established to 
analyse cytokine production during the response to restimulation with 
vaccinia virus, with a focus on the antiviral cytokines. 
Chapter 3 establishes the conditions for restimulation of vaccinia virus 
immune cells and their production of antiviral cytokines. Primed 
spleen cells could be restimulated with virus infected syngeneic cells to 
synthesize TNF, IFN-y and IL-6. Production of TNF and IL-6 was very 
rapid, occurring within several hours of restimulation, whereas IFN-y 
production was delayed by 4 h. 
Chapter 4 examines the cells responsible for the cytokine production, 
using cultures depleted of specific cell phenotypes. The majority of the 
TNF and IL-6 was produced by the adherent cell population, probably 
the macrophages. IFN-y production was dependent on the CD4+ T cells. 
An interesting finding was the CD4 + T cells had a negative influence 
on TNF production. TNF and IL-6 production was found to be non-
antigen specific, whereas IFN-y production required restimulation with 
the immunizing antigen. 
Chapter 5 examines the interaction of endogenous cytokines in the 
production of antiviral cytokines by the immune cells. Antibodies, or 
an exogenous source of cytokine, were added to the immune cells 2 h 
prior to restimulation or at the onset of culture. TNF, IL-2 and IL-4 
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have a role in IFN-y production, whereas the production of TNF and 
IL-6 is not significantly influenced by other cytokines. 
The effect of stimulation with recombinant vaccinia v1rus encoding 
cytokine genes is examined in Chapter 6. A virus encoding IFN -y 
stimulated enhanced production of IFN-y by the responder cells, while 
stimulation with a TNF-encoding virus resulted in increased levels of 
both TNF and IFN-y. Viruses encoding IL-2, IL-4 or IL-10 had no effect 
on TNF or IL-6 levels, however, these viruses stimulated enhanced 
IFN-y production. 
37 
T cell TCR 
LFA-1 
VLA-4 
CD2 
T cell 
~ ~ ICAM-1 
ICAM-2 
TCR 
... .. 
Proliferation. 
* No proliferation 
* Induction of 
. 
unresponsiveness 
APC 
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From a review by Liu & Linsley (1992) 
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CHAPTER2 
Materials and Methods 
2.1 Mice 
CBA/H (H-2k) mice raised under specific pathogen free conditions at 
the John Cur tin School of Medical Research were used at 6 to 7 weeks. 
Female mice were used in all experiments unless otherwise stated. 
2.2 Virus 
The neurovirulent, L929 cell-adapted strain of vaccinia virus, VV-WR, 
was used in all experiments (Wokatsch, 1972). Virus stocks were 
prepared from infected CV-1 cells (0.01 pfu/ cell) grown in 2 litre Schott 
acid-washed roller bottles. The stocks were stored in 100 ~1 aliquots at 
-7ooc and titrated on 143B cells. Before use for injection, virus stocks 
were diluted in 1 ml of gelatin saline and sonicated for 5 seconds at 
50 watts using a Branson Sonifier (Branson Sonic Power Company, 
Danbury, CT. USA). The virus was then made up to the desired 
concentration in gelatin saline. 
2.3 Infection of mice 
Mice were infected with 2.5 x 106pfu of VV-WR in a volume of 0.2 ml 
l.V. 
2.4 Culture medium 
The predominant culture medium used was Dulbecco's Modified 
Eagle's with supplements. H16 refers to DMEM (GIBCO BRL, Life 
Technologies, MD, USA) supplemented with L-glutamine (216 mg/1), 
10 mM HEPES buffer, 2-mercaptoethanol (Sx1o-s M), 10°/o heat-
inactivated foetal calf serum (Flow Laboratories North Ryde, Australia), 
penicillin (30 mg/1), streptomycin sulphate (50 mg/1), and neomycin 
sulphate (50 mg/1). 
The enriched medi urn, referred to as Mixed L ym phocyte Medi urn 
(MLC), is H16 supplemented with glucose (4 g/1), folic acid (6 mg/ml), 
L-asparagine (36 mg/1), L-arginine (116 mg/1) and 1 mM sodium 
pyruvate. 
F15 consists of Eagles Minimum Essential Medium (Cytosystems, Castle 
Hill, NSW, Australia) supplemented with sodium bicarbonate (2.2 g/1), 
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L-glutamine (216 mg/1) and 5°lo heat-inactivated foetal calf serum, 
penicillin (30 mg/1), streptomycin sulphate (50 mg/1), and neomycin 
sulphate (50 mg/1) and 2-mercaptoethanol (5x1o-s M). 
2.5 Virus titration 
100 ~1 of the sample to be titrated, in gelatin saline, was incubated with 
an equal volume of trypsin (1 mg/ml) for 30 min at 37oc. The trypsin 
was neutralized by adding 800 ~1 F15 medium containing 10°lo FCS. 
Serial ten-fold dilutions were then made in gelatin-saline-HEPES 
(0.02M HEPES) and the virus was titrated as plaques on 143B cell 
monolayers in 6 well Linbro plates (Flow Laboratories, Virg. USA). The 
virus was adsorbed for one hour before the cell monola yers were 
overlaid with F15 medium. Following incubation for 2 days at 37oc in 
a humidified atmosphere of 5°lo C02, the monolayers were fixed and 
stained with 0.1 °lo crystal violet in 20°lo ethanol for 5 min, dried and the 
plaques counted. 
2.6 Cell lines 
CV-1,. a cell line derived from African green monkey kidney (Jensen et 
al., 1964), 143B, a human osteosarcoma cell line (Rhim et al., 1985) and 
L929, a continuous fibroblast line from C3H mouse (Sanford et al., 1948) 
were maintained in FlS and incubated at 37oc in a humidified 
atmosphere of 5°lo C02. 
The IFN-y sensitive cell line WEHI 279, a B cell lymphoma (Reynolds et 
al., 1987) and the IL-6 dependent cell line, B9, a B-cell hybridoma cell 
line, (Aarden et al., 1987), obtained from L.A. Aarden (University of 
Amsterdam, Amsterdam, The Netherlands) were maintained in MLC. 
The B9 cell medium was supplemented with 10°lo of a Con A 
supernatant source of IL-6. The TNF sensitive cell line, WEHI 164, a 
murine fibrosarcoma line (Espevik and Nissen-Meyer, 1986), was 
maintained in H16 medium. 
The Con A supernatant source of IL-6 was generated by stimulating 
mouse spleen cells with Con A. Single cell suspensions were made 
from spleens aseptically removed from 15 CBA/H mice . After 
washing, these cells were resuspended in 200 ml complete H16 
supplemented with 1 °lo FCS and 5 ~g/ml Con A (Pharmacia, Uppsala, 
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Sweden). The cells were incubated at 37°C in a humidified atmosphere of 
5°/o C02 for 3 days. The supernatant was removed and mixed with 
a-methyl-D-mannoside (2 g/100 ml; Sigma, St Louis, MO, USA) to bind to 
excess Con A. This was collected by centrifugation at 11,000 g for 10 min 
at 4°C. The supernatant was sterilized by filtration through a 0.22 jlm 
membrane and frozen at -7ooc. 
2.7 Pr~paration of responder cells 
Spleens were removed aseptically from mice infected with VV-WR 6 days 
earlier and pooled. Single cell suspensions were obtained by pressing 
through stainless-steel mesh into MLC medium. The resultant cell 
suspension was transferred to a sterile tube and allowed to settle for 5 min 
to remove clumps. The supernatant was transferred to a fresh sterile 
centrifuge tube, centrifuged at 300 g for 5 min and the medium decanted. 
Erythrocytes were lysed by hypotonic shock, in which 4.5 ml sterile water 
was added to the tube and mixed, quickly followed by 0.5 ml10 x Hanks 
buffer and 5 ml medium. The remaining cells were washed and made up 
to a concentration of 2 x 107 /ml in MLC medium. 
2.8 Prepa·ration of stimulator cells 
Single cell suspensions were made from spleens removed from naive 
syngeneic mice. The erythrocytes were removed from suspension by 
hypotonic shock and washed. The cells were infected with VV-WR at 
10 pfu/ cell at a concentration of 5 x 107 cells/ml, at 37oc for 1 h. The cells 
were washed three times in culture medium, made up to 10 ml and placed 
in a 65 cm2 plastic Petri dish and subjected to 5 min UV irradiation at an 
intensity of 600 jlW I cm2 in the 230 - 270 nm range. Virus titrations of a 
sample before and after UV-irradiation are shown in Table 2.1. This level 
of UV-irradiation completely destroyed virus activity. The cells were then 
made up to a concentration of 4 x 106 cells/ml in MLC medium. 
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Table 2.1 Effect of UV-irradiation onvirus activity 
UV -irradiation 
2.9 Cell culture 
None 
5 min 
VV-WR titration 
(pfulml) 
2.2 X 1()6 
< 100 
Cultures were set up in 1 ml volumes in 24-well plates (Linbro, Flow 
Laboratories, Virg, USA). 107 immune responder cells were mixed with 
2 x 106 stimulator cells and incubated at 37°C in a humidified 
atmosphere of 5°/o C02. Sufficient wells of each culture condition were 
set up to allow supernatant from one well to be removed at each of the 
eight time points over the next 48 hours. These were frozen in aliquots 
at -70°C until assayed for cytokine levels. The set up has been presented 
schematically in Figure 2.1. As a positive control, 5 ~glml Con A was 
added to wells containing 107 immune responder cells in the absence of 
stimulator cells. 
2.10 Recombinant cytokine standards 
Recombinant standard murine TNF-a and IFN-y were kindly provided 
by Boehringer Ingelheim, Vienna, Austria; TNF specific activity was 
1.2 x 107 U I mg, IFN-y specific activity was 1 x 107 U I m g. Recombinant 
standard murine IL-6, prepared by F. Lee (DNAX) was provided by 
Dr. P. Hodgkin (John Curtin School of Medical Research). The r-Mu-IL-
6 preparation was calibrated against the International Standard 
reference preparation of recombinant human interleukin-6 (881514), 
(National Institute of Biological Standards and Control, Herts, U.K.) 
and therefore all titres have been given in arbitrary units (AU). 
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2.11 Antibodies 
Polyclonal antisera to recombinant munne TNF-a, or recombinant 
murine IFN-y, were produced for use in cytokine ELISAs. NZ white 
rabbits were immunized with 40 J..Lg r-Mu-TNF-a or r-Mu-IFN-y 
emulsified in Complete Freunds Adjuvant (CFA; DIFCO, Mich. USA) 
supplemented with 4 mg/ml of diced Mycobacterium tuberculosis, 
(H37RA; DIFCO) which was freshly prepared. The emulsion was 
injected subcutaneously over 3 sites on the back of each rabbit and they 
were boosted 5-12 weeks later with a subcutaneous injection of 
recombinant TNF-a or IFN-y in Incomplete-FA (DIFCO). The sera was 
collected between 6 to 8 days after the booster injection and tested by 
ELISA for levels of antibody. The antisera were then IgG precipitated by 
adding 2 volumes of 27°/o sodium sulphate while stirring vigorously, 
followed by an incubation for 2 - 4 h at 37°C. The precipitated 
antibodies were collected by centrifugation at 10,000 g, and resuspended 
in distilled water. The antibodies were extensively dialysed against 
PBS, titrated for use in ELISAs and stored at -20°C. 
The hamster anti-mouse TNF mAb, TN3-19.12 (Sheehan et al., 1989) 
was provided by Or R. Schreiber (Celltech, UK) and the rat anti-mouse 
IFN -y, R4.6A2 hybridoma cell ascites (Spitalny and Havell, 1984; 
American Type Culture Collection, Rockville, MD), protein A purified, 
was provided by Or J. Ruby Gohn Curtin School of Medical Research). 
2.U Cytokine Assays 
2.12.1 TNF Bioassay 
TNF was assayed for its cytotoxic effect on WEHI 164 cells (Espevik and 
Nissen-Meyer, 1986). Assays were prepared in flat bottomed 96 well 
trays (Nunc, Roskilde, Denmark). 50 J..Ll samples of culture supernatant 
were serially diluted in complete H16 medium. All titrations were 
carried out in duplicate. Each well received 50 J..Ll of WEHI 164 
suspension, at a concentration of 4 x 105 /ml in H16 medium containing 
1 J..Lg/ml actinomycin 0 (Sigma). Control cultures consisted of wells 
containing medium and WEHI 164 cells alone. The cultures were 
incubated at 37°C in a humidified atmosphere for 18 to 20 h. 10 J..Ll of 
5 mg/ml MTT in PBS (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
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tetrazolium bromide; Sigma) was added to each well and plates were 
incubated for a further 6 h. The crystals were dissolved by adding 150 J.il 
10°/o SOS in 0.01 M HCl and incubating overnight. Optical density was 
measured using a Dynatech Microplate reader at 570 nm with a 
reference wavelength of 630 nm. TNF titres were determined by 
comparison to r-MuTNF. Figure 2.2 shows a typical dose response 
curve obtained from plotting OD against log1o dilution of a sample 
containing TNF. The resultant curve is sigmoid in shape but 
approximates a straight line over its central region. The titre of the 
sample was defined as the reciprocal of the dilution resulting in 50°/o 
survival of the TNF sensitive cells. This was converted to pg/ ml by 
comparison with a 50°/o survival titre of a standard TNF sample of 
known concentration. 
2.12.2 IL-6 Bioassay 
IL-6 was measured using the IL-6-dependent cell line, B9 (Aarden et al., 
1987). A 50 J.il sample of culture supernatant was serially diluted and 
cultured for 44 h with 1 ()4 washed B9 cells in a total volume of 100 111 in 
MLC medium. Control cultures consisted of wells containing medium 
and B9 cells alone. Proliferation was quantitated using [3H]-thymidine 
incorporation (78 Ci/mmole; ICN Radiochemicals, CA, USA) which 
was estimated with the use of a 96 well automatic harvester and a 
betaplate liquid scintillation counter (Pharmacia). IL-6 titres were 
determined by comparison of the dilution giving half maximal 
proliferation of the B9 cells with that of a concurrently run 
recombinant standard murine IL-6. The method of analysis is similar 
to that described for TNF. 
2.12.3 IFN-y Bioassay 
IFN-y was measured using the IFN-y-sensitive cell line, WEHI 279 
(Reynolds et al., 1987). A 50 111 sample of culture supernatant was 
serially diluted in MLC medium and cultured for 3 days with 104 
washed WEHI 279 cells in a total volume of 100 J.il. Control cultures 
consisted of wells containing medium and WEHI 279 cells alone. 10 111 
of 5 mg/ml MTI was added to each well and cultures were incubated 
for a further 6 h. The crystals were dissolved by adding 150 J.il 10°/o SOS 
in 0.01 M HCl and incubating overnight. Optical density was measured 
using a Dynatech Microplate reader at 570 nm with a reference 
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wavelength of 630 nm. IFN-y titres were determined by comparison to 
r-MuiFN-y as described for the TNF bioassay. 
2.12.4 TNF-a and IFN-y ELISA 
TNF-a and IFN-y in culture supernatants were measured by indirect 
ELISA methods (Sheehan et al., 1989). Briefly, 50 J.!l of 10 J.lglml 
hamster anti-mouse TNF mAb, TN3-19.12 (Sheehan et al., 1989) or 
50 J.!l of 3 J.lglml R4.6A2 hybridoma cell ascites (ATCC), protein A 
purified, diluted in carbonate-bicarbonate coating buffer (pH 9.6) was 
incubated at 4°C overnight in 96 well, flat bottomed ELISA plates 
(Titertek, Flow Laboratories, The Netherlands). The plates were 
washed 6 times in phosphate-buffered saline (PBS)-Tween (0.01 M PBS, 
0.1 °/o Tween (Sigma)). The wells were blocked with 100 J.!l 3°/o BSA 
(Sigma) in PBS-Tween for 2 h at room temperature. After washing 
with PBS-Tween 6 times, 50 J.!l of sample was added to each well. 
Dilutions of r-MuTNF or r-MuiFN-y were used to generate a standard 
curve. The plates were then incubated overnight at 4°C. The plates 
were washed 6 times and 50 J.!l of polyclonal rabbit anti-mouse TNF-a 
antibody diluted 11500, or 50 J.!l of polyclonal rabbit anti-mouse IFN-y 
antibody diluted 11250 in 1 °/o BSA, was added and incubated for 2 h for 
TNF-a and 1 h for IFN-y. After washing, 50 J.!l of sheep anti-rabbit IgG 
alkaline phosphatase conjugate (Silenus, Hawthorn, Australia) at 
111000 dilution was added and incubated for 1 h. The plates were 
washed and then 50 J.!l of the substrate disodium-p nitrophenyl 
phosphate at 1 mgl ml (Sigrna) was added to each well. Optical density 
was measured 30 rnin later using a microplate reader at 405 nrn with 
reference 630 run. A standard curve was generated for each ELISA and 
a curve of best fit applied. The equation was used to determine the 
cytokine levels in supernatant samples. The lower limit of the assays 
was defined as background + 2 SO. This was routinely found to be 
80 pg I rnl TNF and 0.3 ng I ml IFN -y. 
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VV-
WR 
Figure 2.1 Preparation of cell culture 
6 week CBA/H mice were injected with 2.5 x 106 pfu VV-WR i.v. The 
spleens were removed 6 days later, dispersed through a grid and 
erythrocytes removed. These cells are referred to as responder cells. For 
the preparation of stimulator cells, spleens were removed from naive mice 
and pressed through a grid. Erythrocytes were removed and the cells 
were infected with VV-WR for 1 h. The stimulator cells were UV-
irradiated and 2 x 106 cells were put in culture with 107 responder cells. 
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Figure 2.2 Assay for TNF biological activity 
3.0 3.6 
Culture supernatants taken at various times throughout the culture period 
were titrated in the TNF bioassay. This graph represents the OD readings 
for the titration of one sample, having subtracted the background OD 
reading. The thick dashed line represents the mean maximum OD reading 
determined in the absence of TNF. A straight line was drawn over the 
centre part of the graph and the half maximum titration was calculated as 
shown with the dotted line. This was then compared with a similar graph 
drawn for the standard to determine TNF levels in the sample. 
47 
CHAPTER3 
Cytokine production by restimulated vaccinia virus immune 
cells - Establishing an in vitro model 
3.1 INTRODUCTION 
T lymphocytes attracted to the site of virus replication play an essential 
role in recovery from the infection. They can be directly_ cytolytic and 
release cytokines that are involved in the recruitment of other cell 
populations. Inflammatory cells at sites of vaccinia virus infection are 
composed of 77°/o Thyl.2+ cells with over 50°/o Lyt.2+ cells (Hurwitz et 
al., 1983). Many of the recruited cells are capable of producing a variety 
of cytokines, for instance Lyt.2+ cells secrete IL-2, IFN-y and IL-3 (Fong 
and Mosmann, 1990), NK cells produce IFN-y (Anegon et al., 1988) and 
macrophages produce TNF and IL-6 (Beutler and Cerami, 1989; Horii et 
al., 1988). 
An in vitro model was established to exam1ne the production of 
cytokines thought to be involved in the recovery from virus infection, 
specifically the production of TNF, IFN-y and IL-6. TNF is antiviral in 
vitro against several RNA and DNA viruses and acts synergistically 
with IFN-y, both in inducing resistance in uninfected cells and in the 
lysis of virus infected cells (Wong and Goeddel, 1986). IFN-y is also 
essential for virus clearance in vivo, as inhibition with specific mAb 
prevents mice from clearing the virus (Karupiah et al., 1993; Klavinskis 
et al., 1989; Ruby and Ramshaw, 1991). Although IL-6, originally 
described as IFN-~2 (Weissenbach et al., 1980), has limited antiviral 
activity, it has been included in this study as high levels are induced in 
virus infections (Cayphas et al., 1987). As well as having antiviral 
properties these factors also regulate the type of immune response 
depending on the pattern of cytokines expressed (Balkwill and Burke, 
1989). A Th1 cytokine profile, where IL-2 and IFN-y are produced, 
preferentially induces cell-mediated immunity whilst Th2 cytokines, 
such as IL-4, IL-5 and IL-10, selectively stimulate humoral responses. 
This chapter describes the establishment of an in vitro model to 
examine the production of the antiviral cytokines TNF, IFN-y and IL-6. 
Splenocytes from mice infected with vaccinia virus were restimulated 
in vitro with virus-infected UV -irradiated spleen cells from naive 
syngeneic animals. The levels of cytokines produced by the 
restimulated responder cells were then assessed at various time 
intervals over the next 48 h. 
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3.2 MATERIALS AND METHODS 
3.2.1 
Mice 
Virus and infection of mice 
Cell lines 
Culture medium 
As described in Chapter 2.1 
As described in Chapter 2.2 
As described in Chapter 2.6 
As described in Chapter 2.4 
Preparation of responder and stimulator cells for 1 ml cultures 
As described in Chapter 2.7 
and 2.8 
Culture conditions (1 ml) As described in Chapter 2.9 
Antibodies As described in Chapter 2.11 
3.2.2 In vitro generation of CTL 
Responder and stimulator cells were mixed at a ratio of 5:1 with 107 
6 day vaccinia immune responder cells in a 25 cm2 flask (Nunc) in H16 
medium (Andrew et al., 1986). The flasks were incubated at 37oc in a 
humidified atmosphere of 5°/o C02. Cytotoxic activity of the cells was 
determined on the fifth day of incubation. 
3.2.3 Cytotoxicity assays 
2 x 106 L929 target cells were labelled with 50 ~Ci 51Cr for 1 hat 37oc in a 
total volume of 0.5 ml H16 medium, washed three times in medium 
and resuspended at a concentration of 2 x 105 cells/ml. For virus-
infected targets, L929 cells were infected with VV-WR at 10 pfu/ cell 
during the 1 h labelling period. The standard chromium release assay 
was carried out in triplicate, using a range of effector to target ratios 
(E:T). 2 x 104 target cells, in 100 ~1 volumes, were dispensed into wells 
of 96-well, round bottomed micro titre plates (Linbro ). Total releasable 
51Cr (maximal release) was determined by adding 100 ~1 2°/o Triton 
X-100 to wells containing only target cells and spontaneous release 
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determined by adding 100 ~1 medium to targets. The plates were 
incubated for 6 h at 37°C in a humidified atmosphere of 5°/o C02. 
Radioactivity in 100 ~1 supernatant from each well was measured in a 
Packard Auto-Gamma counter and percent specific lysis calculated 
using the formula 
0/o specific lysis = experimental release - spontaneous release x 100 
maximal release - spontaneous release 
3.2.4 Assay of TNF-dependent cytotoxic activity against WEHI 164 
The level of TNF in cell lysates was determined using the TNF 
bioassay, which has been described in Chapter 2.12.1. The bioassay uses 
WEHI 164 cells, a mouse fibrosarcoma line, which is sensitive to the 
action of TNF (Espevik and Nissen-Meyer, 1986). To ensure the 
cytotoxic activity against the WEHI 164 cells was due to TNF, rather 
than a non-specific factor within the lysate, antibodies to TNF were 
added and the cytotoxic activity assessed. 50 ~1 cell lysate was incubated 
with 2 x 104 WEHI 164 cells in H16 medium, in the presence or absence 
of antibodies to TNF, in a total volume of 100 ~1. A control irrelevant 
antibody was also included. The antibodies used are described in 
Chapter 2.11. TN3.19.12, a hamster anti-TNF antibody was used at 0.5 
and 0.1 mg/ml. R4, a rat anti-IFN-y antibody was used at 0.1 mg/ml. 
The TNF bioassay was then carried out as described in Chapter 2.12.1. 
MTT was added at the appropriate time and the percentage of dead 
target cells was determined using the formula 
0/o dead cells = 100 - optical density in wells with TNF x 100 
optical density in control wells 
3.2.5 Preparation of plasma membrane 
Membrane preparations of lymphocytes recovered from the interface of 
a Ficoll density gradient were prepared, based on a method by Whisnat 
et al. (1978). 5 x 107 cells were washed twice in medium, resuspended in 
1 ml cold TE buffer for 10 min on ice (10 mM Tris, 1 mM EDTA, pH 7.4) 
and then disrupted with a glass homogeniser. The cells were 
transferred to an Eppendorf tube and centrifuged at 500 g for 5 min at 
4oc, after which the supernatant was decanted into another tube and 
centrifuged at 9000 g for 60 min at 4oc. The pellet was gently 
resuspended in 0.2 ml cold PBS, made up to 1 ml and centrifuged for 
5 min at 500 g. The supernatant was decanted into another tube and 
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centrifuged for a further 60 min at 9000 g. The pellet, containing the 
crude plasma membrane, was resuspended in 0.5 ml PBS and stored at 
-700C. 
3.2.6 Protein assay 
The protein concentration in the plasma membrane preparations was 
assaye_d using the Pierce Micro BCA protein assay reagent (Pierce, 
Rockford, IL, USA). Protein standards were prepared using BSA in 
PBS, with concentrations ranging from 20 Jlg/ml to 1 Jlg/ml. 1 ml of 
standard preparation or 1 ml of unknown protein sample was mixed 
with 1 ml Pierce Micro BCA Working Reagent. Following incubation 
at 60°C for 1 h, the samples were cooled to room temperature and the 
absorbance read at 562 nm. A standard curve was drawn up and used to 
determine the protein concentration of the unknown samples. 
3.2.7 Dose response analysis and effect of well type 
Serial two-fold dilutions of immune responder cells were made 1n 
100 Jll volumes in MLC in 96 well flat-bottomed plates (Nunc), with 
the first ·well containing 50 x 104 cells. The responder cells were 
incubated with a series of dilutions of stimulator cells added in 100 Jll 
volumes. To determine whether the two populations required mixing 
for optimal response, the cells were mixed by pipetting up and down 
several times. Cells were also added to round-bottomed plates in order 
to determine whether these plates were better suited for culturing the 
restimulated immune cells. Cultures were incubated at 37°C and 
supernatant samples harvested at the determined time of peak 
response for each cytokine, ie. 8 h for TNF and 24 h for IFN-y. 
3.2.8 Antibodies 
Hybridoma supernatants were used as antibody sources for cell 
depletions. The following rat anti-mouse hybridoma lines were grown 
in MLC and the supernatant collected for use in cell depletion 
protocols: Jlld secreted mAb (IgM) which reacted with the heat stable 
antigen on B cells, immature T cells, erythrocytes and neutrophils 
(Bruce et al., 1981). Clone 31M secreted mAb (IgM) which reacted with 
Lyt.2 (anti-CD8+ T cells; Sarmiento et al., 1980), and clone RL172.4 
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secreted an antibody that reacted with L3T4 (anti-CD4+ T cells; Ceredig 
et al., 1985). 
3.2.9 Depletion of cell sub-populations 
Immune responder cells were washed and depleted of B cells, and if 
appropriate CD4+ and/or CD8+ T cells, by resuspending in MLC 
(1 °/o FCS) at 1 x 107 cells/ml. The cells were incubated with J11d (1/5 
dilution), to remove B cells, and anti-CD8+ (31M; 1/10 dilution) or 
anti-CD4+ (RL172.4; 1/10 dilution) for T cell depleted cultures, for 
10 min at 37°C. This was followed by incubation with guinea pig serum 
as a source of C, at a 1/10 dilution, for a further 45 min. Viable cells 
were recovered on a Histopaque density gradient (Sigma). The antibody 
depletion step was repeated and the cells washed twice in MLC 
medium. The J11d treated cells were counted and the volume adjusted 
to give the desired cell concentration. Samples further depleted of 
CD4 + or CD8+ T cells were made up to the same volume as cells treated 
with J11d alone, so that the difference in cell number reflected the loss 
of cells specific for the anti-CD4 + or anti-CD8+ antibody treatment. 
3.2.10 Inactivation of stimulator cells 
In this in vitro model, vaccinia virus-infected stimlator cells were UV-
irradiated, as vaccinia virus is a cytopathic virus. To consider the effect 
of altering the metabolic state of the stimulator cells on antigen 
presentation, they were subjected to various treatments before 
incubation with responder cells. 2 x 107 B cell depleted spleen cells 
were put into each of four 10 ml plastic tubes. The cells were infected 
with VV-WR at 10 pfu/ cell at 37oc for 1 h in a volume of 200 ~1. The 
cells in each tube were washed twice and then treated as follows. One 
sample of cells was UV -irradiated in a petri dish for 5 min, as described 
in Chapter 2.8. A second sample was made up to 10 ml with medium 
and subjected to 2000 rads y-irradiation. The third sample was treated 
with 50 ~g mitomycin C (Sigma) for 30 min at 37°C and then washed 
three times in PBS. The fourth sample was left untreated. For initial 
proliferation studies (see 3.3.9.1), stimulator cells were used at a 
concentration of 5 x 104 cells/well and incubated with 5 x 105 immune 
responder cells. In cultures used for dose-response analysis (see 3.3.9.2), 
the stimulators were used at 5 x 104 cells/well, with serial two-fold 
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dilutions of responder cells. Proliferation was quantitated by adding 
[3H]-thymidine for the last 4 h of a 24 h culture. 
3.2.11 Proliferation assay 
Cultures were pulsed with [3H]-thymidine to assess proliferation. 
Wells were pulsed with 1 J..LCi [3H]-thymidine (78 Ci/mmole, ICN 
Radiochemicals, CA, USA) during the last 4 h of a 24 or 48 h culture at 
37oc. The plates were harvested onto filter mats using a Skatron 
96 well cell harvester (Pharmacia). Scintillation fluid (LKB 
Scintillation Products, Leics, UK) was added and the [3H]-thymidine 
uptake was measured in a Pharmacia liquid scintillation counter. 
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3.3 RESULTS 
3.3.1 An in vitro model of antigen-specific stimulation of virus 
immune spleen cells 
To establish the conditions for an zn vitro model of antigen-specific 
stimulation of virus immune spleen cells, cultures were set up based 
on a protocol designed to generate CTL (Andrew et al., 1986). Spleens 
were taken from mice which had been infected with 2.5 x 106 pfu 
VV-WR i.v. 6 days earlier. These immune responder cells were 
cultured in the presence of syngeneic VV-infected, UV-irradiated 
stimulator cells at a ratio of 5:1, in a total volume of 1 ml. Culture 
wells were also set up containing immune responder cells alone, 
immune responder cells stimulated with 5 Jlg/ml Con A, or naive 
responder cells with VV -infected stimulator cells. 
After 3 days of incubation, the wells containing immune responders 
stimulated by VV -infected stimulators and those stimulated by Con A 
were densely filled with cells, many of which were clumped. In 
contrast, wells of immune responders without stimulation appeared to 
contain fewer cells and these were not clumped. 
3.3.2 Antigen specificity of CTL response 
To confirm that virus-specific CTL were generated in this system, 6 day 
vaccinia immune responder cells were stimulated with syngeneic 
VV-infected, UV-irradiated cells and incubated for 5 days. Figure 3.1 
shows that cells taken from these cultures only lysed VV-infected target 
cells, and not uninfected targets. 
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3.3.3 Cytokine production by restimulated immune responder cells 
3.3.3.1 TNF was produced following restimulation of responder cells 
To determine whether 6 day vaccinia virus immune splenocytes would 
produce cytokines when cultured in vitro, these cells were cultured 
with UV-irradiated virus-infected syngeneic cells or were stimulated 
with Con A. Immune responder cells stimulated with Con A rapidly 
began TNF secretion with levels detectable in the supernatant within 
2 h of culture (Figure 3.2). Maximal levels were reached by 8 h. 
Immune responder cells also secreted TNF when stimulated in an 
antigen-specific manner with virus-infected stimulator cells. This was 
detectable after 4 h and reached peak levels at 12 h of culture. The non-
specific Con A stimulation induced secretion of 3 times the level of 
TNF produced by the virus stimulated immune cells. TNF was not 
detected in supernatant taken from cultures of immune responder cells 
lacking stimulation, nor in naive responder cell cultures stimulated 
with virus-infected cells. 
3.3.3.2 IFN-y was also secreted by immune responder cells 
Con A stimulation of immune responder cells induced rapid 
production of IFN-y with detectable levels within 2 h of culture. The 
levels rose logarithmically to peak at 20 h (Figure 3.3). Stimulation of 
immune responder cells with virus-infected cells induced IFN-y with a 
2 - 4 h delay compared to the Con A stimulated cultures. Once 
production began the levels increased logarithmically for 12 h and 
continued to rise for the rest of the culture period. As seen with the 
TNF results, cultures of immune cells without stimulation, or 
stimulation of naive cells did not induce significant levels of IFN-y 
production. After 48 h the level of IFN-y detected in either of these 
culture conditions was only 1 °/o of that seen in the wells containing 
stimulated immune responder cells. 
3.3.3.3 Restimulated responder cells produced high levels of IL-6 
Stimulation of immune responder cells with Con A or with virus-
infected cells resulted in similar kinetics and levels of IL-6 production 
(Figure 3.4). IL-6 was present in the supernatant within 2 h of culture 
and increased rapidly to peak at 12 - 16 h. Low levels of IL-6 were 
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detectable in cultures without stimulation and in cultures of 
stimulated naive responders . However, these were less than 5°/o of the 
levels in the corresponding cultures of stimulated immune cells . 
3.3.4 TNF was present in cell lysate 
TNF exists in secreted or membrane-bound forms (Kriegler et al., 1988). 
To determine whether cell-associated TNF was a significant component 
of the TNF response to stimulus it was necessary to release the TNF 
from the cells. This was done by collecting the cells after an incubation 
period and subjecting them to a series of freeze/ thaw cycles 
(Lonnemann et al., 1989). Biologically active cell-associated TNF could 
be detected following this treatment, although the amount released 
following one, two or three freeze/thaw cycles was not significantly 
different (Table 3.1 ). 
Table 3.1 TNF released from cell lysate by freeze/thaw cycles 
106 Con A 
stimulated cells 
One cycle 
Biologically active TNF (pg) 
Two cycles Three cycles 
107 immune responder cells were stimulated with Con A for 12 h. 
Supernatant was removed, the cells resuspended in 500 J..Ll fresh medium 
and placed in three tubes which were subjected to 1, 2, or 3 freeze/thaw 
cycles. Following exposure to these cycles, the lysed cells were assayed for 
cell-associated TNF activity in the WEHI 164 biological assay. The TNF 
levels were calculated for 106 cells added to the bioassay wells and are 
expressed as the mean + SD of triplicate wells. 
To ensure that the cytotoxic effect observed was due to TNF, and not to 
another non-specific factor within the cell lysate, antibodies to TNF 
were added to the bioassay. Preincubation of the cell lysate with 
antibody against TNF reduced the cytotoxic activity of the lysate and 
TNF was no longer detectable above background levels (Table 3.2). 
Addition of a control irrelevant antibody had no effect on the TNF 
activity. 
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Table 3.2 Cytotoxicity in TNF bioassay was due to TNF in cell lysate 
Time Antibody added to bioassay 
None a-IFN-y a-TNF a-TNF 
0.1 mg/ml 0.5 mg/ml 0.1 mg/ml 
2h 65 °/o 59 °/o 23 °/o 15 °/o 
12 h 82 °/o 82 °/o 39 °/o 43 °/o 
48 h 84 °/o 82 °/o 40 °/o 31 °/o 
TNF std 90 °/o 
Percentage of dead target cells in TNF biological assay. 107 immune 
responder cells were stimulated with Con A for the time indicated. The 
supernatant was removed for cytokine analysis and cells were 
resuspended in fresh medium. Following exposure to two freeze/thaw 
cycles, celllysates were assayed for cytotoxic activity on the TNF sensitive 
cell line WEHI 164. Celllysates were incubated with 10 Jll of antibodies at 
dilutions indicated, for 90 min prior to addition of TNF sensitive cells. 
The antibodies used were a hamster anti-TNF antibody (TN3-19.12) and a 
rat anti-IFN-y antibody (R4.6A2). 
Cell lysate preparations were prepared from cultures of immune 
responder cells incubated with Con A or virus-infected stimulator cells. 
These were assayed for biologically active TNF. As shown in 
Figure 3.5.1, the amount of cell-associated TNF in cells restimulated 
with Con A was similar to that secreted. Following antigenic 
stimulation of the responder cells, the level of secreted TNF was greater 
than that which remained cell-associated, although this was not 
statistically significant (Figure 3.5.2). The kinetics of production were 
similar in both stimulation conditions, with a rapid increase in TNF 
levels in the first 8 h, followed by a plateau. TNF levels decreased in 
the last 4 h of culture. 
It was uncertain whether the cell-associated TNF detected 1n the 
bioassa y was cytosolic or membrane bound. In order to determine the 
relative contribution of each to the cell-associated TNF pool, crude 
plasma membrane preparations were made from Con A stimulated 
lymphocytes, as described in section 3.2.5. These preparations had 
cytotoxic activity against WEHI 164 cells which was inhibited by 
preincubation with antibodies to TNF (Table 3.3). The level of TNF 
detected in these preparations from 107 cells was less than 5°/o of that 
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found in the culture supernatant or 1n cell-associated preparations 
(Table 3.4). 
Table 3.3 Plasma membrane preparations of Con A stimulated 
lymphocytes contained TNF biological activity 
Assay 1 
Assay 2 
protein ( ng) 
625 
312 
150 
75 
375 
375 
375 
anti-TNF dil. 
1/50 
1/200 
0/o cell death 
68 °/o 
44 °/o 
28 °/o 
17 °/o 
5 x 107 splenocytes were collected from the interface of a Histopaque gradient. 
The cells were stimulated with 5 ~g/ml Con A for 17 hand cell membranes 
prepared as outlined in section 3.2.5. Protein concentration was determined 
using the Pierce Micro BCA protein assay kit. 10 ~l of TNF antibody (5 mg/ml) 
was added to appropriate wells, at the dilutions indicated, 90 min before 
addition of the TNF sensitive cells. 
Table 3.4 Membrane bound TNF was a minor component of TNF in these 
cells 
107 Con A 
stimulated cells 
secreted TNF 
175 pg 
cell-associated membrane bound 
TNF TNF 
175pg 5 pg 
A comparison of the TNF detected in the extracellular, intracellular and 
membrane fractions of a Con A stimulated culture. TNF was assayed using the 
TNF bioassay. 
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3.3.5 Comparison of biologically active and total levels of IFN-y and 
TNF 
Bioassays measure biologically active cytokine only, whereas an ELISA 
may also recognise cytokine molecules which have lost biological 
activity. Samples from immune responder cells cultured with virus 
infected cells were assayed for TNF and IFN-y using these two assay 
methods to determine which would be suitable for future work. The 
results for the IFN-y assays are shown in Figure 3.6.1. The ELISA 
results were less variable and detected at least twice the level of IFN-y as 
the bioassay. The cell-associated IFN-y was assayed using the ELISA 
system, and at 26 h was less than 10 °/o of the levels detected in the 
supernatant. Thus, the major source of IFN-y for detecting production 
by these cells was the supernatant. For future IFN-y assays supernatant 
samples were assayed by ELISA. The two TNF assays detected similar 
levels of TNF in the cell-associated samples, whereas the ELISA results 
for the 7 h supernatant samples showed greater than 4 times the level 
of biologically active TNF detected in the bioassay (Figure 3.6.2). By 26 h 
incubation, the ELISA showed greater than 20 times the level of 
biologically active TNF, indicating that secreted TNF lost biological 
activity over time. The ELISA assay was therefore chosen for future 
TNF assays and thus, TNF levels represent total TNF released by 
cultured cells. 
3.3.6 Modifying the culture conditions to use 96 well plates 
3.3.6.1 Greater cytokine production in flat-bottomed culture wells 
The results from the section 3.3.3 indicated it was possible to take 
spleen cells from mice infected with VV-WR 6 days earlier and 
restimulate them to produce cytokines, in an antigen specific manner. 
These cultures consisted of 1 x 107 immune responder cells stimulated 
with 2 x 106 VV -WR infected syngeneic cells in a total volume of 1 ml. 
For greater efficiency, the culture conditions were modified to use 
96 well plates and smaller cell numbers. These culture conditions 
would allow for greater numbers of individual cultures and enable the 
estimation of cytokine production from multiple wells. The use of 
both round-bottomed and flat-bottomed 96 well plates was compared, 
as well as the necessity to mix the responder and stimulator cell 
populations. 
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Table 3.5 shows the results of incubation of two dilutions of responder 
and stimulator cells. The cells were incubated in either flat or round 
bottomed wells. Half the cultures in the flat bottomed wells had a 
mixing step at the beginning of culture. 
Table 3.5 Effect of well type and mixing on cytokine production 
Cell number 
(x 104) 
50 resp/ 25 stim 
11 
11 
25 resp/25 stim 
11 
Well type 
Flat 
11 
Round 
Flat 
11 
Cells 
mixed 
no 
yes 
no 
no 
yes 
TNF (pg/ml) 
540 ±30 
550 + 30 
520 + 20 
410 +50 
490 +50 
IFN-y 
(ng/ml) 
630 ± 120 
420 ± 250 
140 ±50 
90± 15 
62± 10 
11 Round no 440 +50 50± 5 
Spleen cells from 6 day VV -WR infected mice were depleted of B cells and 
incubated in a volume of 200 J..Ll with syngeneic VV-WR infected, UV-
irradiated spleen cells. The cytokine levels are expressed as mean + SD of 
quadruplicate wells. 
Table 3.5 shows that the levels of TNF in the culture supernatants of 
cells incubated in different well types were not sigificantly different. 
Mixing of the cells also had no effect on the levels of TNF produced. 
The production of IFN-y, however, was influenced by the well type, 
with significantly increased levels in the flat bottomed wells (p < 0.05). 
Mixing of the cells led to decreased IFN-y production, although this was 
statistically significant only in cultures with lower numbers of 
responder cells. From these results it was decided to use 96 well flat 
bottomed plates for further experiments, without mixing the responder 
and stimulator populations. 
3.3.6.2 Dose response curves 
Experiments are described later in this thesis which involve depletion 
of individual subsets of cells to assess their contribution to cytokine 
production (Chapter 4). Therefore, it was important for these 
experiments that the production of cytokines by the responder cells was 
on the linear portion of the response curve. To ensure that the level of 
cytokine was proportional to the cell number, a dose response analysis 
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was carried out. Cultures with varying numbers of both responder and 
stimulator cells were established and supernatant samples taken at the 
time of peak response, ie. 8 h for TNF and 26 h for IFN-y. The results 
from one set of cultures (representative of three) are shown in 
Figure 3.7. A linear IFN-y response was obtained by varying the 
number of responder cells and keeping the number of stimulators 
constant (Figure 3.7.1). Cultures produced significant levels of IFN-y 
when they contained 50 x 104 responder cells. Over the dilutions tested, 
the number of stimulator cells in the wells did not appear to be a 
limiting factor in the IFN-y response. The TNF response remained 
linear until the number of stimulator cells fell below 2.5 x 104 cells or 
less (Figure 3.7.2). From these results, and data not shown, it was 
decided for further experiments to use 50 x 104 responder cells and 
5 x 104 UV-irradiated stimulator cells in a total volume of 200 ~1. At 
each time point, 180 ~1 supernatant was removed from 4 culture wells. 
The 180 ~1 was divided into three aliquots and frozen in 96 well round 
bottomed plates, until assayed in three different cytokine assays. 
3.3.7 B cell depletion did not effect cytokine production 
As it was anticipated that futher studies would entail FACS analysis of 
cultures using antibodies which may bind to B lymphocytes non-
specifically, the effect of B cell depletion on cytokine production was 
examined. 
The B cells were removed from both the responder and stimulator 
populations by incubating the cells with Jlld hybridoma supernatant 
followed by C, as described in section 3.2.9. Viable cells were recovered 
on a Histopaque gradient. The response of immune cells depleted of 
B cells was compared to that of immune cells which had erythrocytes 
removed by hypotonic shock. As shown in Table 3.6, depletion of 
B cells did not affect the level of cytokines produced by the responder 
cell population. The increased cytokine levels obtained in B cell 
depleted cultures would be accounted for by an enrichment of cytokine 
producing cells. 
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Table 3.6 Effect of B cell depletion on cytokine production 
Time IFN-y TNF IL-6 
(h) (ng/ml) (pg/ml) (AU/ml) 
B cell Erythrocytes B cell Erythrocytes B cell Erythrocytes 
de~::leted removed depleted removed depleted removed 
8 5.4 ± 0.6 2.1 + 0.8 100 + 40 60± 10 2.7 ± 0.2 1.2±0 
12 15.7 + 2.4 7.7 ± 1.0 110 ± 30 75± 10 5.4 ± 1.3 3.8 + 2.1 
18 > 20 a 16.7 ± 1.8 240 ± 60 140 ± 40 6.5 ± 0.3 4.8 + 2 
24 > 20 >20 340 ±50 150 ± 20 8.3 ± 1.8 5.5 + 1.1 
Spleen cells from 6 day VV-WR infected mice were either depleted of B cells by incubation with J11d antibody 
followed by complement lysis, or depleted of erythrocytes by hypotonic shock. 5 x 105 responder cells were 
then incubated with 5 x 104 B cell-depleted syngeneic UV-irradiated cells in a 200 J.ll volume, and supernatant 
was harvested at times indicated. Cytokine levels are expressed as mean + SD of quadruplicate wells. 
a IFN-y titres in these samples were greater than the standard and cannot be presented accurately. The 
levels exceed 20 ng/ml. 
3.3.8 Both CD4+ and CD8+ T cells proliferated upon antigenic 
stimulation 
To determine the nature of the cells proliferating in response to 
antigenic stimulation, the CD4+ and/ or CDB+ T cells were depleted 
from the responder population. In the last 4 h of culture with 
stimulator cells [3H]-thymidine was added to each well to assess 
proliferation. The immune responder cells proliferated in response to 
stimulation by VV-WR infected, UV-irradiated syngeneic spleen cells 
(Figure 3.8). Removal of the CDB+ T cells from the responding 
population led to a 40°/o decrease in cell proliferation, while CD4 + T cell 
depletion reduced cell proliferation by 90°/o. Depletion of both CD4+ 
and CDB+ T cells reduced proliferation to levels observed in the absence 
of stimulation. Thus, both the CDB+ and CD4+ T cell populations 
responded to the stimulus provided by the UV-irradiated stimulator 
cells. The observation that wells containing CD4-/CD8+ T cells had 
only 10°/o of the level of proliferation in control wells suggest that 
CDB+ T cells may require the presence of CD4 + T cells for proliferation. 
3.3.9 Effect of subjecting stimulator cell populations to various 
inactivating treatments 
3.3.9.1 Inactivated stimulator cells induced proliferative responses 
from responder populations 
The cultures had been established by basing the conditions on a CTL 
preparation where immune responder cells were stimulated with UV-
irradiated VV-WR infected syngeneic spleen cells. UV-irradiation 
prevented viral replication, as shown in Chapter 2 (Table 2.1), however 
the treatment may have impaired the ability of stimulator cells to 
present antigen (Pamphilon et al., 1991). The stimulatory ability of UV-
irradiated cells was compared to that of cells treated with mitomycin C 
or y-irradiation. These latter treatments block cell division but do not 
affect RNA or protein synthesis (Wagner, 1973). 
All three treatments of stimulator cells led to a significant decrease in 
proliferation, when compared to cultures stimulated with virus-
infected untreated syngeneic cells (Figure 3.9). The viable stimulator 
cells did not contribute to the greater proliferation seen in these control 
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cultures as proliferation of stimulator cells alone was less than 2°/o of 
that seen in cultures containing responder cells . In all stimulation 
conditions both CD4 + and CDB+ T cells proliferated. Among the three 
inactivating treatments there was little difference in the proliferation 
induced. 
3.3.9.2 Dose response analysis of responder cells 
Two-fold dilutions of responder cells were incubated with a constant 
number of stimulator cells which had been subjected to various 
treatments. The proliferative response of the responder cells was 
dependent on the number of reactive cells which were activated while 
in culture, as a result of cellular interaction. Plotting the logarithm of 
the number of cultured responder cells against the logarithm of the 
proliferative response yields a straight line, the slope of which can give 
information about the requirement for interaction among the 
responder cells (Tse et al., 1980). A slope of 1 is consistent with there 
being no effective interaction among the titrated cells in the generation 
of the response, assuming there are no limiting conditions, such as the 
presence of inhibitors. This can be avoided by analysing the response 
early in the culture period. The responding cells may require 
interaction with the cells which are held constant. 
The logarithm of the proliferative responses of B cell depleted 6 day 
VV-WR immune cells stimulated with UV-irradiated virus infected 
cells were plotted against the logarithm of the cell number and are 
shown in Figure 3.10. The results show a linear region in the response 
of the B cell depleted cells, with a slope much greater than 1. This is 
indicative of responder cell co-operation in the generation of the 
proliferative response. A slope much greater than 1 is also seen in 
cultures depleted of either T cell subsets, which suggests that both the 
CD4 + and CDB+ T cells required responder cell interaction to receive the 
appropriate signals to proliferate. 
To investigate the effect of the metabolic state of the stimulator cells on 
the responder cell population, varying numbers of immune cells were 
cultured with virus-infected stimulators treated with UV or 
y-irradiation, mitomycin C or left untreated. These cultures yielded 
markedly different cell number-response lines (Figure 3.11). Cultures 
containing untreated stimulator cells, infected with VV-WR, had a 
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slope of cell number-response close to 1, indicating these stimulator 
cells were able to provide the necessary signals to induce responder cell 
proliferation. Treatment of the stimulator cells with y-irradiation or 
mitomycin C resulted in steeper slopes, between 2 and 3. The slope was 
further increased in those cultures stimulated with UV-irradiated 
stimulator cells. 
No change in slope was observed when T cell subsets were depleted 
from immune responder cells and the remaining cells were incubated 
with untreated, viable VV-WR-infected stimulator cells (Figure 3.12.1). 
The slope was consistently close to 1. Immune cells cultured with 
y-irradiated stimulator cells had a cell number-response line with a 
slope greater than 2, which is greater than the slope in cultures with 
untreated stimulator cells (Figure 3.12.2). 
3.3.9.3 IFN-y production was proportional to number of stimulator 
cells 
The result of measuring the levels of IFN-y produced in cultures where 
the number of responder cells was held constant, and the number of 
stimulator cells was varied in two-fold steps, is shown in Figure 3.13. 
The relationship between the logarithm of IFN-y titre and the 
logarithm of stimulator cell number was linear, with a slope of 1. 
There was a plateau in cytokine production when the number of 
stimulator cells exceeded 5 x 1()4 cells. 
3.3.9.4 Responder cell interactions in the production of IFN-y 
The amount of IFN-y produced by different numbers of 1mmune 
responder cells when the stimulator cell number was kept constant is 
shown in Figure 3.14. The slope of IFN-y titre versus responder cell 
number was approximately 2, which indicated that there was a 
requirement for interaction among the responding population in the 
production of IFN-y. 
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3.4. DISCUSSION 
The pattern of cytokines produced during an immune response to 
virus infection plays a vital role in regulating the outcome of the 
response. Not only do the cytokines influence the cells drawn into the 
focus of infection, they may up-regulate MHC expression leading to a 
more efficient CTL response. These cytokines may also have antiviral 
activity. In order to study the production of these antiviral cytokines in 
the response to vaccinia infection, an in vitro model was established. 
Spleen cells were removed from mice at the time of peak CTL response 
to infection with vaccinia virus. These cells were restimulated in 
culture by incubation with virus infected syngeneic cells. Cytokine 
secretion was assessed by measuring cytokine levels in culture 
supernatant. The restimulated immune cells produced substantial 
levels of the antiviral cytokines TNF, IFN-y and IL-6. 
The production of cytokines occurred in wells containing restimulated 
immune cells but could not be detected in cultures lacking stimulator 
cells, indicating the need for restimulation, as was observed by Kelso et 
al. (1982). Cytokines have such a diverse range of effects that their 
production needs to be tightly regulated (Kelso, 1989). One mechanism 
of regulation is the requirement for the presence of antigen (Paul, 1989), 
with production reverting to low levels following the removal of the 
antigen. Cytokines synthesis is also short-lived, as many cytokines 
have AU-rich sequences in the 3'-untranslated regions of their mRNAs 
(Shaw and Kamen, 1986), which has been shown to correlate to mRNA 
instability (Wreschner and Rechavi, 1988). These mechanisms to 
regulate cytokine synthesis will protect against systemic spread of the 
cytokine, which could result in pathological effects. 
A study of the kinetics of cytokine production after restimulation in 
vitro showed that TNF appeared in the culture supernatant within the 
first 2 h. Peak levels were reached by 8 h in cultures stimulated with 
Con A, whereas responder cells stimulated with virus infected cells 
produced peak levels at 12 h. Under both stimulation conditions, TNF 
levels had decreased by 24 h. These kinetics are similar to those 
observed by Lonneman et al. (1989) where human mononuclear cells 
stimulated with LPS in vitro produced significant levels of TNF, with 
maximal levels at 12 h of incubation, and levels decreasing from 24 to 
48 h. The immune responder cells required a stimulatory signal to 
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undergo TNF production, as cells lacking stimulation did not secrete 
TNF. This result also demonstrated that contamination of the cultures 
by endotoxin, which may be present in the medium, was not 
responsible for the production of TNF. 
Restimulation of immune cells with Con A induced low levels of 
IFN-y within 2 h. The IFN-y titre increased logarithmically to peak at 
20 to 24 h. A similar profile of IFN-y production by Con A stimulated 
mouse spleen cells has been described previously (Ito et al. , 1984; Klein 
et al., 1985). IFN-y production by responder cells stimulated with virus-
infected cells was delayed compared to Con A stimulation, with 
maximal levels reached 4 h later. In the 24 h following maximal 
production the IFN-y titres did not change. These results were similar 
to those of McKimm-Breschkin et al. (1982), who demonstrated that 
antigen specific IFN-y production by T cell lines was first detectable after 
6 h incubation, and reached maxim urn levels by 30 h. The IFN -y levels 
then remained constant for 3 days, indicating the IFN-y was stable 
throughout this period. Morris et al. (1982) demonstrated that IFN-y 
production by antigen-specific CTL required that the T cells "see" the 
viral antigen in the context of cellular antigens. This may account for 
the delay in production by the immune responder cells in the cultures 
described in this chapter, as the cells must first recognise the antigen in 
the context of MHC molecules on the surface of the APC, before IFN-y 
production begins. 
IL-6 was detected in the culture supernatants within 2 h and levels 
increased rapidly to maximal values after 12 h incubation with virus 
infected stimulator cells. The levels of IL-6 induced by the virus-
infected stimulators were of the same magnitude as those produced by 
Con A stimulated immune cells. Virus infection was a potent 
stimulus for IL-6 production, as demonstrated by Sehgal et al. (1988). 
This group has shown that infection of fibroblasts with a variety of 
viruses strongly enhanced secretion of IL-6, and that the addition of 
bacterial LPS did not enhance IL-6 secretion further . These findings 
indicated that virus stimuli were the dominant determinant in IL-6 
secretion. An alternative, but not exclusive suggestion, is that TNF 
may have been an intermediate in the induction of IL-6 production b y 
the responder cells. Levels of mRNA for IL-6 in human fibroblast 
cultures were enhanced by TNF (van Damme et al., 1987; Walther et al., 
1988) and several in vivo studies have implicated TNF as an 
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intermediate in the production of TNF (Engelberts et al., 1991; Fong et 
al., 1989). The kinetics of cytokine production in this study, where peak 
TNF levels occur 4 to 6 h before maximal IL-6 levels, suggest TNF may 
play a role in IL-6 production in this system. This possibility is 
addressed in Chapter 5. 
TNF has been reported to exist as both a secreted and a membrane 
bound form (Kriegler et al., 1988). Similar levels of biologically active 
TNF were found to be cell-associated and secreted in the culture 
conditions described here. This is in contrast to the results of 
Lonnemann et al. (1989) who found less than 10°/o of the TNF 
produced in response to LPS stimulation was cell-associated 
throughout a 48 h culture. Of the cell-associated TNF produced by the 
immune responder cells, less than 5°/o was in the membrane fraction, 
indicating it was predominantly cytosolic. 
A corn pari son of assay methods for IFN -y and TNF indicated that the 
ELISA method detected higher levels of the cytokines in the 
supernatant than the bioassays. This suggested the cytokines may have 
lost some of their biological activity when released into the supernatant 
and/ or bound to soluble cytokine receptors released into the 
supernatant by the responder cells (Seckinger et al., 1988). However, 
the ELISA method was chosen for further studies on TNF and IFN-y 
production because of its higher degree of precision, shorter operation 
period and insensitivity to modulators of cytotoxicity (Meager et al., 
1989). 
Removal of the B cells from the immune responder population 
recovered from mice at the peak of the CTL response did not negatively 
influence cytokine production. B cells produced IL-6 when activated 
with anti-Ig in vitro (Freeman et al., 1989) but did not produce IFN-y or 
TNF. However, culturing B cell depleted immune responder cells 
resulted in increased cytokine levels within a shorter period of culture, 
including increased IL-6. Thus, the removal of B cells from the 
responder population effectively enriched for the cytokine producing 
cells. These results also indicated that the B cells in the immune spleen 
were not producing significant levels of IL-6 when in culture with UV-
irradiated virus infected cells. 
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Vaccinia v1rus 1mmune responder cells proliferated when cultured 
with UV-irradiated, VV-WR-infected stimulator cells. Depletion of 
C D4 + or CDB+ T cells from the responder cell population led to 
decreased levels of proliferation, indicating that both T cell subsets 
proliferated in this culture system. As CD4 + T cells recognise viral 
antigen in association with class IT MHC and CDB+ T cells recognise 
antigen in the context of class I MHC, this indicates that viral antigen 
was presented in association with both class I and 11 MHC, on APCs. 
The CDB+ T cells accounted for 40°/o of responder cell proliferation, as 
demonstrated by a 40°/o decrease in proliferation following the removal 
of these cells. However, cultures containing CDB+ I CD4- cells had a 
level of proliferation that was only 10°/o of the control wells. These 
results indicate that CDB+ T cells may require the presence of CD4 + T 
cells, or perhaps a secreted factor from these cells, for proliferation. The 
possibility that the CD4+ T cells provided a cytokine, such as IL-2 or 
IFN-y, has been addressed in Chapter 6. 
In studies using in vitro stimulation of lymphocyte cells with another 
cell population, it is general practice to inactivate the stimulator cells. 
This inactivation may take the form of gamma irradiation, mitomycin 
C treatment, or UV-irradiation (Adler et al., 1970; Lafferty et al., 1974), 
and ensures that any proliferative response observed is essentially that 
of the responding population. UV-irradiation was used routinely to 
inactivate stimulator cells in the work described here. The UV-
irradiation step also prevents replication of the vaccinia virus, as 
demonstrated in Table 2.1. The UV -irradiated cells provided a signal to 
the immune cells which induced a proliferative response. 
To investigate whether the metabolic state of the stimulatory 
population influenced the response of the immune cells, the 
stimulators were treated to alter this activity. Viable stimulator cells 
infected with VV-WR induced a greater proliferative response from 
vaccinia immune spleen cells than cells which had undergone a form 
of inactivation treatment; a similar response to that seen in the 
generation of CTL during a secondary MLC (Rollinghoff and Wagner, 
1975). The proliferation of these viable stimulator cells was not 
sufficient to account for the greater proliferation in these cultures. 
Treatment of cells with mitomycin C or y-irradiation blocked cell 
division but had no effect on RNA or protein synthesis (Wagner, 1973), 
and UV -irradiated cells have impaired APC ability (Pamphilon et al., 
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1991). From the results shown in Figure 3.3.9, it appeared that 
stimulator cells, inactivated by these three treatments, induced a 
proliferative response of similar magnitude. 
The requirement for cellular interaction in the proliferation response 
was analysed using dose response plots. The slope of log-cell number-
log-response plots can provide information about the need for 
interaction of cells responding to a given stimulus. The slope analysis 
technique first used by Coppleson and Michie (1966) was further 
developed by Tse et al. (1980). They have shown that plotting the 
logarithm of [3H]-thymidine incorporation against the logarithm of 
primed cell number generated a straight line, the slope of which 
represented the number of interacting populations present in limiting 
concentrations. The cell number-response plot of immune spleen cells 
stimulated with UV-irradiated cells yielded a slope with a linear region, 
as shown in Figure 3.10. The slope was much greater than one 
indicating there was a degree of co-operation among the responder cells 
to generate the proliferative response. This was true for both the CD4+ 
and CDB+ T cells. The form of interaction among the responders was 
not determined but could include antigen presentation, cytokine 
production or possibly the provision of costimulatory signals, such as 
that provided by the B7 molecule. 
An interesting result was that the slope of cell number-response plots 
varied markedly with APC treatment (Figure 3.11). The slope was close 
to 1 for cells incubated with viable VV-WR infected cells. The slope 
increased for cells responding to y-irradiated or mitomycin C treated 
stimulators. The steepest slope, indicating the greatest interaction, was 
generated for immune cells responding to UV -irradiated cells. These 
results are consistent with the view that the viable stimulators were 
able to replace the need for responder cell interaction, perhaps by 
providing cytokine, cell contact and correct antigen presentation. The 
slope for both the CD4 +I CDB- and CDB+ I CD4- T cell cultures was also 
close to 1, when cultured with viable stimulator cells. This indicates 
that the coactivation signals required by these cells, which could not be 
provided by the UV-irradiated stimulator cells, were provided by the 
viable stimulator cells (Figure 3.12.1). The y-irradiated and mitomycin 
C treated stimulators were able to replace some need for responder cell 
interaction compared to cultures with UV-irradiated cells, as shown by 
the decreased slope. Gamma-irradiated or mitomycin C treated cells are 
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metabolically active and, therefore, may produce a product, such as a 
cytokine, that was unable to be provided by UV-irradiated cells. An 
alternative explanation is that the virus was not completely inactivated 
in mitomycin C or y-irradiation treated cells, and was able to infect 
some of the responder cell population. 
These results indicate that UV-irradiation of the stimulator population 
allowed antigen presentation, but removed the cell's ability to provide 
costimulatory signals. This phenomenom has been observed in other 
systems. Hapten-coupled lA+ low density cells were able to activate 
hapten-specific CTL. When these APC were exposed to UV irradiation 
their ability to induce CTL was impaired, although the defect could be 
by-passed by the addition of IL-l or IL-2 (Tominaga et al., 1983). In a 
study by Roska et al. (1985) it was shown that freshly primed T cells 
required additional interactions with APC for effective triggering 
beyond that mediated by the T cell antigen receptor. The interaction 
required a metabolical! y intact accessory cell, which could be 
accomplished by IA- cells or by third-party cells, which themselves were 
not bearing antigen. 
The nature of the defect in the UV-irradiated cells is unknown, 
although UV -B irradiation (290 to 320 nm) has been shown to produce 
a dose-dependent decrease in membrane expression of ICAM -1 in 
human monocytes (Krutmann et al., 1990) and of the costimulatory 
ligands B7 /BBl and ICAM-1/CD54 on human dendritic cells (Young et 
al., 1993). The UV-B irradiation of dendritic cells reduced their ability 
to stimulate T cell proliferation and IL-2 production in an MLR, 
presumably due to the low B7 /BBl expression. Addition of low dose 
r-human IL-2 or MLR supernatant reconstituted the proliferative 
response of the T cells (Young et al., 1993). These studies would 
support the concept that responder cell interaction was required for 
proliferation when stimulated with UV-irradiated cells . Viable 
stimulator cells were able to provide the necessary signals for both 
CD4+ and CD8+ T cell proliferation. 
The plot of the IFN-y response against cell number revealed further 
information about requirements for IFN-y production. The slope of 1 
for the relationship between stimulator cell and IFN-y titre (Figure 3.13) 
in the region of responder cell excess, indicated that one antigenic cell 
was sufficient to trigger IFN-y release from one responder cell. Thus, 
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IFN -y titre was directly proportional to the number of UV -irradiated 
stimulators added to the cultures. This result is similar to the cytokine 
response by murine cytomegalovirus (MCMV)-immune lymph node 
cells upon restimulation with MCMV (Sinickas et al., 1985), where the 
slope between stimulator cell number and IL-3 production was also 1. 
The plateau seen with higher numbers of stimulators was in the region 
of target cell excess, where the number of stimulator cells and 
responder cells were comparable (McKinnon and Hodgkin, 1987). 
The slope of the relationship between responder cell and IFN-y titre 
was 2 (Figure 3.14). This indicated that there was some form of 
interaction among the responder cells in the production of IFN-y. This 
may be due to a direct cellular interaction or the release of a soluble 
factor or cytokine, for example IL-2 which is known to enhance the 
production of IFN-y (Yamamoto et al., 1982). This possibility has been 
addressed in Chapter 5. 
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3.5 Summary 
Spleen cells taken from m1ce at the peak of the CTL response to 
vaccinia virus were restimulated in vitro to produce cytokines . 
Stimulation with Con A or with UV-irradiated vaccinia virus infected 
cells induced the secretion of TNF, IL-6 and IFN-y. TNF was first 
detected in the culture supernatant within 2 h, and peaked at 8 to 12 h. 
IL-6 production was also rapid with maximum titres reached 12 h after 
initiation of culture with virus infected stimulators. In comparison, 
IFN-y production was delayed by 4 to 8 h, and peak levels were reached 
by 24 h. The majority of TNF and IFN-y was in the secreted form, 
rather than cell-associated. Removal of the B cells from the responder 
cell population did not reduce cytokine production, rather it resulted in 
an enriched cytokine-producing population. The metabolic state of the 
stimulator cells influenced the proliferative response of the responder 
cell population. Stimulator cells exposed to UV- or y-irradiation or 
treated with mitomycin C had reduced ability to provide the necessary 
signals to induce a proliferative response from the immune cells. 
However, the responder cells were able to compensate for these 
missing signals by cellular co-operation. IFN-y production was 
proportional to the number of stimulator cells, and required 
interaction among the responder population. 
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Figure 3.1 CTL activity of cultured responder cells 
Mice were injected i.v. with 2.5 x 106 pfu of VV-WR and 6 days later the 
spleens were removed. 107 water-lysed spleen cells were cultured with 
2 x 106 UV-irradiated VV-WR infected syngeneic cells in a final 
volume of 15 ml. The cells were incubated for 5 days and then tested 
for their ability to lyse virus infected target cells. Results are shown as 
means of triplicates. 
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Figure 3.2 Time course of TNF production by 6 day W- WR immune 
spleen cells 
Spleens were removed from mice injected with VV-WR 6 days earlier, 
the cells dispersed and erythrocytes removed. 107 immune responder 
cells were incubated with 2 x 106 UV-irradiated vaccinia virus infected 
spleen cells in a total volume of 1 ml. As a positive control 107 
immune responder cells were stimulated with 5 J.lg/ml Con A. 
Cultures of immune responder cells lacking stimulators and cultures of 
naive spleen cells incubated wth UV-irradiated, VV-WR infected cells 
were also set up. TNF levels in supernatant were measured by 
bioassay. Duplicate samples were taken from single culture wells. The 
results are shown as mean+ SD. 
75 
1~ ~------------------------------------------~ 
Q 
s 1000 
........... 
00 ~ ~ '--"" ~ 100 ~ 0 
~ 
Q) 
~ 
~ 
Q) 10 ...... 
~ 
1 
0.1~--~--~--~~~~--~--~--~---r--~--~~ 
0 8 16 24 32 40 48 
Time (h) 
-o-- Immune + stim 
• Immune+ Con A 
~ Immune 
0 Naive+ stim 
Figure 3.3 Time course of IFN-y production from 6 day VV- WR 
immune spleen cells 
107 immune responder cells were incubated with 2 x 106 UV-irradiated 
vaccinia virus infected spleen cells in a total volume of 1 ml. Other 
culture conditions are described in legend 3.2. IFN-y levels were 
measured by ELISA. Duplicate samples were taken from single culture 
wells. Results are shown as the mean + SO. 
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Figure 3.4 Time course of IL-6 production by 6 day VV- WR immune 
spleen cells 
107 immune responder cells were incubated with 2 x 106 UV-irradiated 
vaccinia infected spleen cells in a total volume of 1 ml. Other culture 
conditions are described in legend 3.2. IL-6 levels were measured by 
bioassay. Duplicate samples were taken from single culture wells. 
Results are shown as the mean+ SD. 
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Figure 3.5 Comparison of secreted and cell-associated TNF produced 
by restimulated immune responder cells 
107 water-lysed spleen cells from mice injected with VV-WR 6 days 
earlier w~re stimulated with 5 ~g/ml Con A or UV-irradiated 
vaccinia infected syngeneic cells, in a final volume of 1 ml. 
Supernatant and cells were removed at the times indicated and frozen 
until assayed for TNF levels. Cell-associated TNF was released by two 
freeze-thaw cycles. TNF levels were measured by bioassay. Duplicate 
samples were taken from single culture wells. The results are shown 
as the mean + SD. 
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Figure 3.6 Comparison of the levels of IFN-y and TNF detected by 
bioassay and ELISA 
Spleens were removed from mice injected with VV-WR 6 days earlier, 
the cells dispersed and erythrocytes removed. 107 immune responder 
cells were incubated with 2 x 106 UV-irradiated vaccinia virus infected 
spleen cells in a total volume of 1 ml. Supernatant and cells were 
harvested 7 and 26 h after initiation of culture. Cell-associated 
cytokines were released by two freeze-thaw cycles. IFN-y levels (1) and 
TNF levels (2) were assayed using bioassay and ELISA. Duplicate 
samples were taken from single culture wells. Results are shown as 
the mean + SD. 
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Figure 3.7 The dose response curves for IFN-y (1) and TNF (2) release 
Varying numbers of 6 day VV-WR immune spleen cells were 
incubated with stimulator cells at the concentration indicated in the 
legend (x 104), in a final voluffie of 200 j..il. Supernatants were removed 
at 8 hand 24 hand assayed for TNF and IFN-y, respectively. Cytokine 
levels are expressed as mean+ SD of quadruplicate wells. 
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Figure 3.8 Phenotype of proliferating vaccinia-responsive cells 
stimulated in culture with vaccinia virus-infected spleen cells 
J 
250 
J11d depleted cells from 6 day VV-WR immune mice were further 
depleted of cell subsets as indicated, and cultured with vaccinia-infected 
spleen cells. Incorporation of [3H]-TdR during the final 4 h of a 48 h 
incubation was determined. Results are shown as the mean + SD of 
quadruplicate wells. 
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Figure 3.9 The proliferative response of 6 day W-WR immune spleen 
cells to stimulation with treated W-WR infected syngeneic cells 
6 day VV-WR immune spleen cells were depleted of specific 
subpopulations and incubated with VV-WR infected syngeneic cells 
which had been subjected to various treatments following infection 
with VV-WR for 1 h at 37°C. Incorporation of [3H]-TdR during the 
final 4 h of a 48 h incubation was determined. Results are shown as the 
mean + SD of quadruplicate wells. 
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Figure 3.10 The cell number-proliferative response curve for 6 day 
immune spleen cells stimulated with UV-irradiated cells 
Six day VV-WR immune spleen cells were depleted of B cells and CD4+ 
or CDB+ T cells. Varying numbers of these responder cell preparations 
were incubated with 5 x 104 UV-irradiated virus infected syngeneic cells 
in a final volume of 200 jll. Incorporation of [3H]-TdR during the final 
4 h of a 48 h incubation was determined. Results are shown as the 
(mean - background) + SD of quadruplicate wells. The thin line is 
included as a reference and represents a slope of 1. The dashed line 
represents 3 SD of machine backgr?und counts. 
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Figure 3.11 The cell number-proliferative response lines for 6 day 
immune spleen cells incubated with virus infected syngeneic cells 
following a variety of treatments 
Spleen cells taken from naive animals were infected with VV-WR for 
1 h at 37°C. The cells were then either UV- or y-irradiated, incubated 
with mitomycin C or left untreated and used as stimulator cells. 5 x 
104 stimulator cells were incubated with varying numbers of B cell 
depleted, 6 day vaccinia immune spleen cells in a total volume of 
200 J.ll. Incorporation of [3H]-TdR during the final 4 h of a 48 h 
incubation was determined. Results are shown as the (mean -
background) + SD of quadruplicate wells. The thin lines are included 
as a reference and represent slopes of 1 and 2. The dashed line 
represents 3 SD of ~-counter background. 
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Figure 3.12 The cell number-proliferative response curve for immune 
spleen cells stimulated with untreated (1) and y-irradiated (2) cells 
Six day VV-WR immune spleen cells were depleted of B cells and 
C 04 + or COB+ T cells. Varying numbers of these responder cell 
preparations were incubated with 5 x 104 virus-infected syngeneic cells 
in a final volume of 200 J.ll. Figure 3.12.1 shows the proliferative 
response induced when the stimulators had not received any further 
treatment, whereas the stimulators had been y-irradiated in Figure 
3.12.2. Incorporation of [3H]-TdR during the final 4 h of a 48 h 
incubation was determined. Results are shown as the (mean -
machine background) + SO of quadruplicate wells. The thin lines 
included as a reference represent a slope of 1. The dashed line 
represents 3 SO of the ~-counter machine background counts. 
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Figure 3.13 Stimulator cell-dose response 
Varying numbers of UV-irradiated VV-WR-infected syngeneic spleen 
cells were incubated with 50 x 104 B cell depleted 6 day VV-WR 
immune spleen cells for 24 h in a final volume of 200 ~1. Supernatants 
were assayed by bioassay and IFN-y levels are expressed as the mean + 
SD of quadruplicate wells. The lower limit of this assay is 1 ng/ ml. 
The thin line is included as a reference and represents a slope of 1. 
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Figure 3.14 Responder cell dose response curve 
Varying numbers of B cell-depleted 6 day VV-WR immune spleen cells 
were incubated with 20 x 104 UV-irradiated virus-infected cells for 24 h in 
a final volume of 200 ~1. IFN-y levels in culture supernatant are expressed 
as the mean + SD of quadruplicate wells. The lower limit of this assay is 1 
ng/ml. The thin line is included as a reference and represents a slope of 2. 
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CHAPTER4 
Phenotype of cytokine producing cells 
4.1 INTRODUCTION 
Cytokines are produced by a large array of cell types, including 
macrophages, T cells, mast cells and endothelial cells (Kelso, 1989). 
There is a great deal of overlap in cytokine target range and function, 
which Paul (1989) has described as pleiotropy (multiple functions) and 
redundancy (more than one cytokine may mediate the same or a very 
similar function). This may be a reflection of the levels of control over 
cytokine production, rather than an overwhelming example of 
redundancy. For example, different induction signals will result in the 
production of distinct cytokines with a similar range of actions, while 
in other cases the effect of a cytokine depends not only on the target cell 
phenotype but also on the presence of other stimuli (Balkwill and 
Burke, 1989; Kelso, 1989). The demonstration that cytokine secretion is 
directed towards bound target cells adds another dimension to the level 
of control (Poo et al., 1988). 
The ability of cells to produce cytokines depends in part on the 
inducing stimulus. For example, alloantigens or mitogens stimulate 
both CD4 + and CD8+ T cells to produce IFN-y (Kelso and MacDonald, 
1982), whereas soluble antigens preferentially stimulate CD4 + T cells to 
secrete IFN-y (Biondi et al., 1984). T cell clones have been extensively 
used to study cytokine expression. Two recent papers demonstrated 
that virus specific cytotoxic T lymphocyte clones release IFN-y upon 
contact with target cells presenting viral antigen (Jassoy et al., 1993; 
Kuwano et al., 1993), while Taylor et al. (1989) showed that the 
protective effects of T cell clones against influenza virus was related to 
their ability to produce IFN-y. Other cell types, such as NK cells, also 
secrete IFN-y both in in vitro and in vivo situations in response to a 
variety of bacterial and viral infections (Guo et al., 1992; Welsh, 1978). 
TNF and IL-6 are also produced by a wide variety of cells . Activated 
macrophages are a major source of TNF. Macrophages can be activated 
to produce TNF by stimulation with cytokines, cross-linking of FeR and 
undigested particles (reviewed by Vassalli, 1992). CD4 + T cells, both Th1 
and Th2, and CD8+ T cells also produce TNF, as can NK cells, mast cells, 
keratinocytes and astrocytes (Vassalli, 1992). The major source of IL-6 is 
the monocyte/macrophage (Aarden et al., 1987), although it is also 
produced by T cells, B cells, endothelial cells, fibroblasts, keratinocytes 
and mast cells (Van Snick, 1990). 
88 
This chapter sets out to identify the cells in the vuus Immune 
responder population which are producing the antiviral cytokines, 
TNF, IFN-y and IL-6. 
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4.2 METHODS 
4.2.1 
Mice As described in Chapter 2.1 
Vaccinia virus and infection of mice 
As described in Chapter 2.2 and 2.3 
Cell lines As described in Chapter 2.6 
Culture medium As described in Chapter 2.4 
Depletion ofT cell populations As described in Chapter 3.2.9 
4.2.2 Virus 
Herpes simplex virus type 1 strain SC16 (HSV-1, SC16) (Field et al., 
1979) was provided by Dr. A. Simmons of the Institute of Medical and 
Veterinary Science, Adelaide, South Australia. Stocks of the virus were 
propagated in Vero cells infected at 0.1 pfu/cell for 48 h. After this 
period the infected Vero cells were washed/scraped into the culture 
media and sonicated for 5 seconds at 50 watts using a Branson sonifier. 
The stocks were titrated on Vero cells and stored at -70°C. Stocks were 
provided by Or. B. Lid bury. 
4.2.3 Cell lines 
Vero cells, a cell line derived from African green monkey kidney 
(ATCC, CCL 81), were maintained in F15, while a6310 cells 
(Karasuyama and Melchers, 1988) were maintained in MLC medium. 
The components of these media have been described in Chapter 2.4. 
The cells were incubated at 37oc in a humidified atmosphere of 
5°/o C02. 
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4.2.4 Antibodies 
The following antibodies were used for cell surface analysis by 
cytofluorimetry, to assess the efficacy of cell depletion protocols: anti-
COB, clone S3.6.7 (Ledbetter and Herzenberg, 1979) and anti-CD4, clone 
GK-l.S (Dialynas et al., 1983) hybridoma supernatants were used 
undiluted; biotinylated anti-Thyl.2, clone 30-H12 (Ledbetter and 
Herz~nberg, 1979; Becton Dickinson, Mountain View, CA, USA) was 
used at 1/2S; FITC-conjugated sheep anti-rat IgG (Silenus Laboratories, 
Hawthorn, Victoria, Australia) was used at 1/30 as a secondary 
antibody; Streptavidin fluorescein (Amersham Australia, North Ryde, 
NSW, Australia) was used at 1/40. 
4.2.5 Depletion of cell sub-populations 
Immune responder cells were washed and depleted of B cells and, if 
appropriate, CD4+ or CDB+ T cells, as described in Chapter 3.2.9. The 
efficacy of these T cell depletions was confirmed by flow cytometry, by 
demonstrating that the treatment with antibody against CD4 +or CDB+ 
and C resulted in less than S0lo of the respective CD4 + or CDB+ T cell 
subset remaining. 
Adherent cells were removed following one B cell depletion step by 
incubating S x 107 cells in a 60 x 1S mm petri dish inS ml medium for 
1 h at 37°C. The non-adherent cells were washed off with warm 
medium and were incubated in a second petri dish for a further 30 min 
at 37°C. Non-adherent cells were collected and resuspended in the 
same volume as the J11d depleted cells. 
4.2.6 Restimulation of immune spleen cells in vitro 
J11d depleted responder cells were made up to a concentration of S x 106 
cells/ml. Those responder cells depleted of additional subsets were 
then made up to this volume. Stimulator cells were prepared as 
described in Chapter 2.8 and, following UV-irradiation, were made up 
to S x 105 cells/ml. Cultures consisted of 100 ~1 of the stimulator cell 
preparation added to 100 ~1 of a responder cell preparation in a well of 
a 96 well flat bottomed plastic plate (Nunc). Cultures were incubated at 
37°C in a humidified atmosphere of S0lo C02. At the time of harvest, 
the plates were centrifuged at 200 g for 3 min and 180 ~1 of supernatant 
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was removed from each well. This was divided into three and frozen 
in wells of a 96 well round bottom plate. Thus, the supernatant from 
each culture was assayed for the cytokines TNF, IL-6 and IFN-y. 
4.2. 7 I mm unofl uorescent staining 
The efficacy of the cell depletion protocols was confirmed by flow 
cytometry, following staining the cells for the possible contaminating 
cell type. 1 x 106 B cell depleted spleen cells in MLC were pelleted by 
centrifugation at 200 g for 5 min. Medium was aspirated and the cells 
resuspended in 100 J..Ll hybridoma supernatant or 50 J..Ll of mAb diluted 
in MLC and incubated for 20 min on ice. Samples were centrifuged 
through 0.5 ml heat-inactivated FCS (Flow Laboratories, North Ryde, 
Australia) and resuspended in 50 J..Ll of the appropriate secondary 
antibody and incubated for a further 20 min on ice. The cells were 
centrifuged through FCS and resuspended in 0.5 ml cold PBS for flow 
cytometry. When flow cytometry was performed the day after staining, 
the cells were fixed in phosphate-buffered 1 °/o paraformaldehyde, pH 7.4 
(10 g/1 paraformald-ehyde, 16.83 g/1 NaH2P04.2H20, 3.85 g/1 NaOH, 
5.4 g/1 glucose). 
4.2.8 Flow cytometry 
Fluorescent labelled samples were analyzed on a FACScan (Becton 
Dickenson) using 100mW of 488 nm laser light to excite FITC. 
Fluorescence emissions of FITC were detected through a 530 nm band 
pass filter. 10,000 events were collected for each sample and gating was 
performed using forward vs 900 light scatter. Data analysis was 
performed using a Hewlett Packard workstation with the the Becton 
Dickinson Lysis II program. The percentage of positively stained cells 
was calculated relative to control cells stained with the fluorochrome-
conjugated reagents. 
92 
,....... 
4.3 RESULTS 
4.3.1 Phenotype of the cytokine-producing cells 
4.3.1.1 Adherent cells were major IL-6 producers 
To identify the cell population responsible for the production of the 
high levels of IL-6, immune responder cells were depleted of either 
C 04 + or COS+ T cells, or adherent cells. IL-6 was detected in the 
supernatant of the control cell population within 4 h and levels 
increased steadily throughout the . culture period (Figure 4.1.1). 
Depletion of either CD4+ or COS+ T cells from the responder cell 
population had little effect on the level of IL-6 produced. Removal of 
adherent cells, however, caused a large (70°/o) reduction of IL-6 
produced (p<O.OS), eg. from 7.5 AU/ml to 2.2 AU/ml at 18 h 
(Figure 4.1.2). The cellular origin of the remaining IL-6 was not 
determined. This suggests that the major source of IL-6 production was 
the adherent cell population and this production was not dependent on 
either CD4+ or COS+ T cells. 
4.3.1.2 Adherent cells were also the major producers of TNF 
With the new culture conditions, (see 4.2.6 ie. reduced number of cells), 
the profile of TNF production was different to that described in 
Chapter 3.3.3. TNF levels were still increasing at 24 h of culture, 
whereas in cultures with a greater concentration of cells a plateau was 
reached by 12 h. Depletion of CD4 + T cells from the responder 
population resulted in a significant increase (50 - 100°/o) in TNF 
production (p<O.OS in 3 out of 4 experiments) within the first 18 h of 
culture (Figure 4.2.1 and Table 4.1). In contrast, removal of COS+ cells 
had no effect on levels of TNF produced. Figure 4.2.2 shows that 
removal of adherent cells resulted in a drama tic decrease in TNF 
production, from 400 pg to 150 pg 24 h after initiation of the culture 
(p<O.OS). The TNF that was produced by the adherent cell depleted 
population occurred approximately 6 h later than in non-depleted 
cultures. 
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4.3.1.3 IFN-y production was dependent on CD4+ T cells and adherent 
cells 
Levels of IFN-y produced by the immune responder cells were not 
detectable until after 4 h of culture. The delay of several hours, 
compared to the IFN-y response in the 1 ml cultures described in 
Chapter 3, probably results from the culture conditions in which fewer 
cells were added per well. The production of IFN-y increased 
logarithmically and began to plateau at 12 h, in similar kinetics to that 
seen with the culture conditions described in Chapter 3. Depletion of 
the CD4 + T cell population resulted both in a delay and decrease in the 
production of IFN-y (Figure 4.3.1). Little or no IFN-y was produced in 
the first 8 h of culture and by 24 h the level of IFN-y was still only 14°/o 
that of the non-depleted population. Depletion of CDB+ T cells, 
however, resulted in little change in the IFN-y profile. Removal of 
adherent cells also resulted in a significant decrease in IFN-y 
production late in the culture period, eg from 36 ng/ml to 22 ng/ml at 
24 h (p<O.OOS) (Figure 4.3.2). 
4.3.1.4 The adherent population contained a small number of T cells 
Adherent cells were isolated from the immune responder cell 
population by two incubations on plastic with non-adherent cells 
removed by vigorous washing. To investigate the possibility that 
activated T cells were present in the adherent population, the cells were 
scraped off the plastic and incubated with anti-Thyl.2 antibody and 
analysed by flow cytometry. The adherent cells, which made up only 
1 °/o of the original responder cells, contained 11 °/o Thyl.2 positive 
T cells. Thus the majority of the cells removed by the adherence step 
were not T cells, and are believed to be macrophages and monocytes. 
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4.3.2 IL-6 and TNF production were not dependent on T cells 
Depletion of both CD4+ and CD8+ T cells did not significantly reduce 
levels of TNF or IL-6 produced by the immune responder cells . 
However, the IFN-y titres reached only 4°/o that of the non-depleted 
population at 20 h (Table 4.1). This indicated that IFN-y production was 
totally dependent on the presence of T cells, whereas TNF and IL-6 
production was T cell independent. 
Table 4.1 Effect ofT cell depletion on cytokine levels 
Antibody treatment of IL-6 (AU /ml) IFN-y (ng/ml) TNF (pg/ml) 
responders 
J11d + c 
J11d + anti-CD4 + C 
J11d + anti-CD8 + C 
J11d + anti-CD4 +anti-
CD8+C 
7.8 ± 1.1 
ND 
9.6 ± 1.7 
12.4 ± 1.7 
37.7 ± 3.1 210 ± 80 
13.9 ± 1.3 450 ± 70 
31.9 ± 2.5 220 ± 60 
1.6 ± 0.4 250 ± 40 
Spleen cells from mice immunized 6 days earlier were treated as shown and 
cultured for 20 h with VV-WR infected UV-irradiated syngeneic cells . The 
IL-6 content of the SN was determined by B9 assay while the TNF and IFN-y 
levels were determined by ELISA. The cytokine levels are expressed as the 
mean + SD of quadruplicate wells. 
4.3.3 IL-6 and TNF production were not antigen specific 
The antigen-specificity of an immune response is due to the 
recognition, by specific T cells, of antigen in association with MHC on 
antigen presenting cells . The T cell independence of IL-6 and TNF 
production suggested that the production of these cytokines may not be 
antigen specific. Cells infected with HSV were used as stimulator cells 
in culture with vaccinia virus immune responder cells . The 
VV-immune responder cells produced levels of IL-6 and TNF in 
response to HSV similar to those produced when the immunizing 
virus was used (Table 4.2). In contrast, IFN-y was not detected in 
cultures stimulated with HSV. With HSV-infected stimulator cells, 
non-immune cells were able to produce low levels of TNF and IL-6. 
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Table 4.2 Production of cytokines by non-immune or vaccinia virus 
immune spleen cells stimulated with W or HSV 
Spleen cells 
Non-immune 
VV-immune 
Non-immune 
VV-immune 
Stim.virus 
vv-WR 
vv-WR 
HSV 
HSV 
IFN-y 
(ng/ml) 
<0.3 
25 ±3.5 
<0.3 
<0.3 
Cytokine 
IL-6 
(AU/ml) 
0.13 ± 0.01 
6.76 ± 0.72 
1.49 ± 0.22 
4.5 ±0.9 
TNF 
(pg/ml) 
<50 
350 + 80 
110 + 10 
300 + 20 
Spleen cells from non-immune mice or mice immunized 6 days earlier with 
VV -WR were depleted of B cells and cultured for 24 h with syngeneic spleen 
cells which had been infected with VV or HSV for 1 h and then UV-
irradiated. The cytokine levels of the SN are expressed as the mean + SD of 
quadruplicate wells. 
4.3.4 Memory cells and IFN-y production 
To determine whether memory cells could be induced to produce 
cytokines, mice were injected with vaccinia virus i.v. and spleens were 
removed three weeks later for use in cultures. These 3 week vaccinia 
immune spleen cells did not produce significant levels of TNF when 
cultured with vaccinia virus infected UV-irradiated stimulator cells 
(Table 4.3). The IL-6 titre was also low and by 48 h was less than 5°/o of 
that observed in cultures containing responder cells from mice at the 
peak of the CTL response to VV-WR. However, IFN-y was produced by 
immune responder cells, although significant levels did not appear 
until 48 h of culture. 
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Table 4.3 TNF and IL-6 production was not associated with memory 
cells 
Time IFN-y (ng/ ml) TNF (pg/ml) IL-6 (AU /ml) 
(h) 
6 day a 3 week b 6 day a 3 week b 6 day a 3 week b 
12 13.2 ± 1.9 < 0.3 170 + 35 < 100 5.8 ± 1.2 0.2 ± 0.1 
24 28.6 ± 6.8 < 0.3 260 + 45 110 ± 70 19.3 ± 4.7 0.4 ± 0.1 
48 49.3 ± 4.1 2.8± 0.7 510 ± 150 < 100 22.0 ± 5.0 0.8 ± 0.1 
Spleens were removed from male mice which had been injected with 
VV -WR i.v. either 6 days or 3 weeks earlier. 50 x 104 B-cell depleted 
responder cells were incubated with 5 x 104 UV -irradiated, vaccinia virus 
infected stimulator cells. Supernatant was harvested at the times indicated. 
Cytokine levels are expressed as mean + SD of quadruplicate wells. 
a Mice injected with VV-WR 6 days earlier. 
b Mice injected with VV -WR 21 days earlier. 
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4.4 DISCUSSION 
The immune response to a virus infection involves a variety of cell 
types. The peak of the CTL response to vaccinia infection occurs 6 days 
post infection (Koszinowski and Thomssen, 1975). At this time in the 
response the relative numbers of CD4+ and COB+ T cells are equal and 
account for 70°/o of the non-B cells in the spleen (Ruby et al., 1993), 
whereas the NK cytotoxic activity has declined and is barely detectable 
(Karupiah, 1990). The results in Chapter 3 showed that spleen cells 
taken from mice at the peak of the CTL response to vaccinia virus 
secreted TNF, IFN-y and IL-6 after restimulation in vitro. 
IL-6 is known to be produced by a variety of cell types, including 
macrophages /monocytes and T cells (Horii et al., 1988; Tosato et al., 
1988). In cultures stimulated with UV-irradiated virus infected cells, 
removal of either the CD4+ or CDB+ T cells from the responder cell 
population had little effect on the production of IL-6 (Figure 4.1). 
Depletion of the adherent cell population decreased the level of IL-6 
produced by as much as 70°/o, indicating that these cells were the major 
source of IL-6. This result is in agreement with Aarden et .al. (1987) 
who have reported that monocytes were the major source of IL-6 in 
freshly isolated cell preparations. 
The adherent cells were also the major producers of TNF in this 
culture system (Figure 4.2). This has also been seen in a study of PBMC 
cultured with Sendai virus (Aderka et al., 1986). Removal of the 
C 04 + T cells significantly enhanced levels of TNF in the culture 
supernatant. In contrast, CDB+ T cell depletion did not alter TNF levels. 
Finally, cultures in which both CD4+ and CDB+ T cells were removed 
had levels of TNF which were similar to control cultures. A possible 
explanation for these results is that the CDB+ cells are a major source of 
TNF, but in the presence of CD4+ T cells their production is down-
regulated. CDB+ T cells have been shown to produce TNF (Fong and 
Mosmann, 1990) and there are examples of virus specific CTL clones 
releasing TNF upon exposure to their target antigen (Jassoy et al., 1993; 
Kuwano et al., 1993). 
It would appear that the IL-6 and TNF production by adherent cells was 
not T cell dependent in this system, as depletion of both CD4 + and 
CDB+ T cells had no effect on production of these cytokines (Table 4.1). 
98 
It has been shown that some viruses are able to trigger cytokine release 
from monocytes, in vitro (Aderka et al., 1986; Houde and Arora, 1990). 
Culturing human monocytes with coxsackievirus 3B induced IL-l, IL-6 
and TNF expression by the cells, and IL-l and IL-6 were still produced 
when infectivity of the virus was destroyed by UV-irradiation (Henke 
et al., 1992). Also, UV-irradiated human herpes virus was able to 
stimulate IL-6 and TNF production by PBMC cultures, suggesting that 
virus particle-cell contact is sufficient to enhance monokine release 
(Gosselin et al., 1992). A recent study of a murine model of influenza 
showed an increase in IL-la, IL-lp, IL-6 and TNF production by lung 
resident cells, suggesting the alveolar macrophages participate actively 
in the early response against the virus (Hennet et al., 1992). It is 
interesting to note that vaccinia immune responder cells cultured with 
HSV-infected UV-irradiated cells produced three times the amount of 
TNF and IL-6 as non-immune cells (Table 4.2). The vaccinia virus 
immune responder cells contain a population of activated 
macrophages (Blanden, 1982), which may have been primed in vivo by 
T cell-dependent lymphokines such as IFN-y (Stein and Gordon, 1991), 
and these appear to be triggered to release higher levels of monokines 
on contact with viral antigen. The macrophages seem to lose their 
primed status over time, as cells taken from mice immunized three 
weeks before restimulation in vitro did not produce significant levels 
of TNF and IL-6. This may reflect a mechanism of regulation over 
cytokine production. Both TNF and IL-6 have been shown to bring 
about a cascade of events, eg. TNF activates several different cell types, 
including macrophages, T cells, NK cells and endothelial cells (Vassalli, 
1992), while IL-6 acts on T and B cells and induces acute phase response 
and fever (Van Snick, 1990). During a period of acute infection, it 
would be advantageous to the host to have macrophages moving 
throughout the body able to respond rapidly to virus antigen which 
may have escaped the T cell response. Thus, a co-ordinated response by 
T cells at the focus of infection and surveillance by mobile macrophages 
would ensure the antigen was not able to escape detection and thus, 
would not persist. However, upon clearance of the antigen, the 
possible detrimental effects of inappropriate TNF and IL-6 production 
would necessitate a down-regulation of the cells responsible for their 
production. This may be achieved through immunosuppressive 
cytokines, such as IL-10 or TGF-p, which suppress macrophage effector 
activity and appear late in the immune response (Sher et al., 1992; 
Tsunawaki et al., 1988). 
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Several groups have suggested recently that the CD8+ T cells control 
virus infections by an IFN-y-dependent mechanism (Klavinskis et al., 
1989; Ruby and Ramshaw, 1991). However, in this in vitro model the 
CD8+ T cells were not the major producers of IFN-y, as their removal 
had little effect on the level of IFN-y produced. Removal of CD4 + T 
cells, on the other hand, delayed production by 8 hand only low levels 
were detected by 24 h. These low levels are believed to be produced by 
CD8+ T cells as depletion of both CD4+ and CD8+ T cells resulted in less 
than 5°/o the level of IFN-y detected in complete cultures. Thus, 
production of the majority of IFN-y in this system was dependent on 
the CD4+ T cells. The ability of CD4+ T cells to produce IFN-y may 
explain why P2 microglobulin disrupted mice, although lacking 
CD 8 + cells, are able to resolve vaccinia virus infection via a 
CD4+ mediated mechanism (Spriggs et al., 1992). However, care must 
be taken in interpreting these in vitro results as it has been shown 
recently, using single cell analysis, that the majority of the cells 
producing IFN-y during a vaccinia virus infection were CD8+ T cells 
(Ruby et al., 1993). In contrast, the in vitro restimulation of spleen cells 
taken from mice during a vaccinia virus infection induced production 
of IFN-y'which was dependent on CD4+ T cells. Production of IFN-y by 
CD4+ T cells in a secondary culture has been reported (Budd et al., 1987; 
Kelso and Glasebrook, 1984). Spleen cells taken from mice immunized 
three weeks earlier also produced IFN-y in an antigen-specific manner 
suggesting that IFN-y producing cells are able to persist beyond the 
period of virus infection. 
The results from this in vitro study indicate that T cells removed from 
mice at the peak of the CTL response to vaccinia virus infection can be 
restimulated to produce high levels of IFN-y. Using flow 
cytofluorimetric analysis to simultaneously detect cytokine production 
and T cell phenotype, Ruby et al. (1993) demonstrated that of 
splenocytes removed from mice at this stage of infection, 25.6°/o were 
CD8+ /IFN-y+ and 13.4°/o were CD4+ /IFN-y+. The increases in IFN-y 
production described are beyond what can be expected as a specific 
response to the virus. For example, the frequency of influenza specific 
CTL was estimated to be only 1/2500 following virus clearance (Owen et 
al., 1988). This would indicate that a large proportion of the cells 
increasing cytokine expression in these restimulated cultures must be 
responding to non-antigen-specific factors . Similarly, of the 
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bronchoalveolar lavage cells obtained from mice during a secondary 
infection to influenza A, at least 20°/o showed increased expression of 
IFN-y mRNA (Carding et al., 1993). Yang et al. (1989) observed that 
spleen cells taken from mice infected with a variety of viruses, 
including vaccinia virus, generated allospecific CTL coincidental with 
the generation of virus-specific CTL. This generation of CTL was 
dependent on CD4+ secretory factors, which suggested that 
lymphokines produced as a consequence of virus infection may act to 
stimulate the proliferation and activation of CTL not specific to the 
challenging virus. These cells may have direct cytotoxic activity in 
vivo, or secrete cytokines which will amplify other clearance 
mechanisms, and possibly enhance the proliferation of CD8+ T cells 
(Nahill and Welsh, 1993). Thus, the increase in IFN-y production by 
T cells upon incubation with vaccinia virus-infected stimulator cells 
may be a result of polyclonal stimulation during the normal response 
to virus infection, as described by Yang et al. (1989). 
The removal of adherent cells also led to a decrease in IFN-y 
production (40°/o). Two interpretations of this result are that the 
adherent cells themselves produce IFN-y after 12 h in culture, or that 
the adherent cells are required to stimulate another population to 
produce IFN-y, perhaps via another cytokine. These results do not 
distinguish between these two possibilities. Others have reported that 
depletion of adherent cells from human tonsil cultures resulted in a 
50°/o reduction in IFN-y-producing cells (Czerkinsky et al., 1991), while 
lymph node cells produced greater IFN-y levels when stimulated in the 
presence of adherent cells (Hoiden and Moller, 1991), again suggesting a 
requirement for an adherent cell population. It is not known whether 
the adherent cell induction of IFN-y production is through secretion of 
soluble molecules, such as IL-6 or IL-l, that affect T cells, or by direct 
accessory cell-T cell interaction via surface molecules. 
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4.5 SUMMARY 
Depletion of individual cell populations from the vacCinia 1mmune 
responder cells enabled the identification of the cells producing the 
antiviral cytokines. The adherent population was the major producer 
of TNF and IL-6. The secretion of these cytokines was not antigen-
specific and did not require the presence of T cells. This may be a 
demonstration of first order defence mechanisms, which would come 
into play in the host defence to virus infection, before the antigen-
specific T cell response. IFN-y production was T cell dependent, with 
the majority dependent on CD4+ T cells. Adherent cells were also 
shown to play a role in production of maximal levels of this cytokine. 
IFN-y production was antigen-specific and the producing cells were able 
to persist beyond the period of virus infection. 
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Figure 4.1 Effect of cell depletion on the kinetics of IL-6 production 
B cell depleted vaccinia immune spleen cells were stimulated with 
vaccinia virus-infected cells in a 200 ~1 volume. The responder cells 
were also depleted of CD4 + or CDB+ T cells ( 4.1.1) or the adherent cells 
were removed (4.1.2). IL-6 levels are expressed as the mean + SD of 
quadruplicate wells. 
100 
0.1 
100 
1 
0.1 
0 
0 
8 
J11d depl 
Adherent depl 
8 
16 
16 
Time (h) 
4.1.1 
• J11d depl 
~ &CD4depl 
A: & CD8 depl 
24 
4.1.2 
103 
Figure 4.2 Effect of cell depletion on the kinetics of TNF production 
B cell depleted vaccinia immune spleen cells stimulated with vaccinia 
virus-infected cells in a 200 ~1 volume. The responder cells were also 
depleted of CD4 + or CDB+ T cells ( 4.2.1) or the adherent cells have been 
removed ( 4.2.2). TNF levels are expressed as the mean + SD of 
quadruplicate wells. 
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Figure 4.3 Effect of cell depletion on the kinetics of IFN-y production 
B cell depleted vaccinia immune spleen cells stimulated with vaccinia 
virus-infected cells in a 200 J.ll volume. The responder cells were also 
depleted of CD4+ or CDB+ T cells (4.3.1) or the adherent cells have been 
removed (4.3.2). IFN-y levels are expressed as the mean + SD of 
quadruplicate wells. 
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CHAPTERS 
Analysis of cytokine interactions during the immune response 
to vaccinia virus 
5.1 INTRODUCTION 
A wealth of evidence has revealed that cytokines interact in a complex 
network in vivo (Balkwill and Burke, 1989; Paul, 1992). CD4+ T cells 
play a major role in the regulation of cytokines produced during an 
immune response with two types having been clearly defined 
(Mosmann et al., 1986). Cells belonging to the Th1 phenotype 
synthesize IL-2, IFN-y and LT, while Th2-type cells produce IL-4, IL-5, 
IL-6 and IL-10 (Mosmann and Coffman, 1989b). CD8+ T cells express a 
pattern of cytokines that corresponds to the Th1 pattern (Fong and 
Mosmann, 1990). The Th1 and Th2 cells are able to cross-regulate the 
growth and activities of each other. For example, IL-10, a Th2 product, 
inhibits the synthesis of cytokines by Th1 cells, whereas IFN-y inhibits 
the proliferation of Th2 cells (Fiorentino et al., 1989; Gajewski and 
Fitch, 1988). 
Cytokines often work in an autocrine or paracrine, rather than 
endocrine, manner (Balkwill and Burke, 1989), being both produced 
and consumed at the site of immune reaction. Autocrine induction 
has been reported for a number of cytokines. This has been 
demons.trated for TNF and IFN-y in vitro by the addition of 
recombinant cytokine material to cell cultures (Cockfield et al., 1993; 
Descoteaux and Matlashewski, 1990). TNF has also been shown to act 
on the production of other cytokines. For example, the administration 
of TNF to humans rapidly induced production of IL-6 (Jablons et al., 
1989). Cytokines have also been shown to inhibit the production of 
each other, as demonstrated by Aderka et al. (1989). Interleukin 6, itself 
induced by TNF, is able to inhibit TNF production by LPS stimulated 
human monocytes and in mice in vivo. 
It is highly probable that in the in vitro model described in this thesis, 
various cytokine interactions govern the overall cytokine response 
observed. These interactions may have relevance to the in vivo 
situation. Other in vitro studies have demonstrated that TNF activates 
macrophages and is a potent inducer of IL-6 in cultured fibroblasts 
(Kohase et al., 1986). IL-6 was shown to play a role in the induction of 
CTL (Renauld et al., 1989), cells which are able to produce IFN-y upon 
appropriate stimulation (Klein et al., 1982; Morris et al., 1982). IL-2 also 
acts on a variety of cells, including monocytes and T cells (Holter et al., 
1987; Morgan et al., 1976) and has stimulatory activity on IFN-y 
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secretion by NK cells and CTL (Farrar et al., 1981; Handa et al., 1983) . 
IL-4 and IL-10, Th2 cytokines, as well as being able to suppress 
production of Th1 cytokines, such as IFN-y (Mosmann et al., 1986) have 
an inhibitory effect on LPS-ind uced cytokine production by 
macrophages, in both human (Hart et al., 1989) and mouse (Fiorentino 
et al., 1991b ). 
In order to examine cytokine interactions in more detail, individual 
cytokines were neutralized using specific antibodies or exogenous 
cytokines were added to the culture system. 
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5.2 METHODS 
5.2.1 
Vaccinia virus As described in Chapter 2.2 
Infection of mice As described in Chapter 2.3 
Culture medium As described in Chapter 2.4 
5.2.2 Mice 
Male CBA/H m1ce were used at 7 weeks of age. A preliminary 
experiment demonstrated that the proliferative and cytokine response 
of cells from vaccinia immune male mice was of the same magnitude 
as cells taken from female mice (data not shown). 
5.2.3.1 Antibodies 
Table 5.1 describes the anti-cytokine monoclonal antibodies added to 
the cultures. The neutralizing abilities of the antibodies are described 
in.Table 5.2. The antibodies S4B6, 11B11, 20F3 and 2A5 were provided 
by Dr P. Hodgkin (John Curtin School of Medical Research). TN3.19.12 
antibody has been described in Chapter 2.11. The antibodies were 
diluted in medium and added in a 20 Jll volume either at the initiation 
of culture, or the immune responder cells were incubated with the 
antibody for two hours at 37°C before addition of the stimulator cells. 
The SXCl, SXC4 and BVD6 antibodies were also provided by Dr. P. 
Hodgkin. Biotinylated BVD6 and SXCl antibodies were provided by 
K. Doherty (John Curtin School of Medical Research). 
Rabbit anti-gangliotetraosylceramide (anti-asialo-GM1) (Wako Pure 
Chemicals Industries, Osaka, Japan) was used at a final dilution of 1/50. 
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Table 5.1 Antibodies used in cell culture 
Antibody 
S4B6 rat-a-mu-IL2 
11B11 rat-a-mu-IL4 
20F3 rat-a-mu-IL6 
2A5 rat-a-mu-IL-10 
TN3.19.12 hamster-a-mu-
TNF 
I so type 
IgG2a 
IgG1 
lgG1 
IgG 
Protein Preparation 
Cone. 
1 mg/ml Serum free 
culture 
supernatant 
1 mg/ml Serum free 
culture 
supernatant 
10 mg/ml Ascites 
12 mg/ ml Ascites 
5 mg/ml Culture 
superna tant 
Purification 
IgG precipitated 
Ion exchange 
column 
IgG precipitated 
IgG precipitated 
Protein A-
agarose 
Reference 
(Mosmann,1986) 
(Ohara and Paul, 
1985) 
(Starnes et al., 1990) 
(Ishida et al., 1992) 
(Sheehan et al., 1989) 
Table 5.2 Neutralizing ability of antibodies 
Antibody Protein Neutralization activity Assayed on: 
conc.a 
S4B6 20 Jlglml 10 Jlgl ml : 0.2 U I ml IL-2 HT -2 cell line 
11B11 20 Jlglml 3 Jlglml: 70 U lml IL-4 HT-2 cell line 
20F3 200 Jlglml 4.8 ngl ml : 0.03 AU I ml IL-6 B9 cell line 
TN3.19.12 100 Jlglml 2.5 Jlglml : 83 pglml TNF WEHI 164 
cell line 
2A5 250 Jlglml ND 
a Concentration of antibody in first well of subsequent cultures (115 
dilution). 
5.2.3.2 Determination of cytokine contamination in ascites-derived 
antibodies 
Antibody preparations active against several murine cytokines were 
available. A number of these have been prepared from ascites fluid, 
which may contain inflammatory cytokines. To determine whether 
such contaminants were present, the antibodies were added to wells 
containing naive responder cells and UV-irradiated stimulator cells. 
This incubation would also allow the detection of endotoxin 
contaminants, as low levels of endotoxin would stimulate TNF 
production from the naive cells. In the absence of antibody the cultures 
did not produce detectable levels of any of the cytokines assayed 
(Table 5.3, medium alone). 
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Table 5.3 Determination of presence of cytokines in antibody 
preparations 
Antibody a Activity Naive Responders, stimulated b 
TNF IFN-y IL-6 
(pg/ml) (ng/ml) (AU/ml) 
_medium <50 < 0.3 < 0.2 
S4B6 IL-2 <50 < 0.3 ND 
11811 IL-4 <50 < 0.3 ND 
20F3 IL6 <50 < 0.3 < 0.2 
2A5 IL-10 <50 < 0.3 0.2 + .01 
TN3.19.12 TNF c < 0.3 0.6 ± 0.2 
a Antibody was added at the first of the four dilutions used 1n 
subsequent cultures. 
b 50 x 104 B cell depleted naive spleen cells were cultured with 5 x 104 
UV-irradiated virus infected cells. Antibodies were added at initiation 
of culture to give a final volume of 220 J-.Ll. Supernatants were 
harvested after 20 h incubation. Cytokine levels are expressed as mean 
+ SD of triplicate wells. 
c Supernatants were not able to be assayed for this cytokine as the 
antibody interfered with the detection of TNF. 
TNF was not detected in any of the cultures, indicating endotoxin 
contaminants were not present. Low levels of IL-6 were present in the 
2A5 and TN3.19.12 preparations. 
5.2.3.3 Cytokine contaminants in antibody preparations may stimulate 
immune cell cytokine production 
To determine whether the antibody preparations were able to stimulate 
the responder cells to produce cytokines, they were added to wells 
containing immune responder cells, in the absence of stimulator cells . 
The presence of antibodies did not influence the background 
proliferation of the responder cells (Table 5.4). 
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Several antibodies induced some cytokine secretion by these cells . The 
IL-6 antibody, 20F3, stimulated production of IFN-y to levels 
approximately 10°/o of that produced by restimulated immune cells. 
The hamster antibody specific for TNF, TN3.19 .12, stimulated low 
levels of IL-6, less than 10°/o that secreted by the immune cells upon 
antigenic restimulation. 
Table 5.4 Determination of the stimulatory effects of antibody 
preparations on immune responder cells 
Antibody a TNF IFN-y IL-6 Proliferation 
(t:~/ml) (n~/ml) (AU/ml) (x 103) 
medium <50 < 0.3 < 0.2 22 + 5 
S4B6 IL-2 <50 < 0.3 ND 18 + 2 
11B11 IL-4 <50 < 0.3 ND 18±3 
20F3 IL6 <50 2.1 ± 0.8 0.6 + 0.2 23 + 3 
2A5 IL-10 <50 < 0.3 1.2 + 0.1 13 + 2 
TN3.19.12 TNF b < 0.3 1.8 ± 0.3 15 + 2 
VV-WR stim c 290 ± 30 28.2 ±3.9 24.3 + 2.4 ND 
50 x 104 B cell depleted spleen cells from mice injected with VV-WR 6 days 
earlier were cultured in wells lacking stimulator cells. Antibodies were added 
at the initiation of culture to give a final volume of 220 J..Ll. Supematant was 
harvested after 20 h incubation. Cytokine levels and proliferation are 
expressed as mean + SD of quadruplicate wells. 
a Antibodies added at first of four dilutions used in subsequent experiments. 
b Supematants were not able to be assayed for TNF as the antibody interfered 
with the assay. 
c Immune cells restimulated with 5 x 104 UV -irradiated virus infected cells. 
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5.2.4 Cell lines 
HT-2 cells (Watson, 1979) were maintained in MLC medium, described 
in Chapter 2. a6310 supernatant was added as a source of IL-2 at 
50 U /ml. The a6310 cells (Karasuyama and Melchers, 1988) were 
maintained in MLC medium also. YAC-1 (H-2a) cells, a cell line 
derived from Moloney leukemia virus-induced lymphoma of A/Sn 
mouse (Kiessling et al., 1975), were maintained in F15 medium, 
described in Chapter 2.4. YAC-1 cells are sensitive to the cytotoxic 
activity of NK cells and were used as targets in NK cell cytotoxicity 
assays. 
a6310 cell supernatant was used as a source of recombinant IL-2. The 
cells were incubated in MLC medium for two days at 37oc 1n a 
humidified atmosphere of 5°/o C02. The cells were removed by 
centrifugation and the supernatant sterilized by filtration through a 
0.22 ~m membrane and frozen at -70°C. The IL-2 content of the 
supernatant was assayed on the HT-2 cell line (Watson, 1979) and 
found to be approximately 5000 U /ml. 
5.2.5 Cytokines 
Recombinant munne TNF was provided by Boehringer Ingelheim, 
Vienna, Austria, and was diluted in MLC medium for use in cultures. 
Recombinant standard murine IL-2, prepared by N. Arai (DNAX) and 
recombinant murine IL-4, prepared by R. Kastelein (DNAX), were 
provided by Dr. P. Hodgkin (John Curtin School of Medical Research). 
Recombinant murine IL-10 was purchased from Genzyme. These 
standards were used in cytokine assays. 
5.2.6 Cui tu res 
Spleens were taken from mice which had been injected with VV-WR 
i.v. 6 days earlier. Single cell suspensions from pooled spleens were 
obtained and B cells depleted by incubation with J11d antibody and C, as 
described in Chapter 3.2.9. For these experiments the complement 
source was low toxicity rabbit complement (Cedarlane Laboratories, Ltd, 
Canada). This was used at a final dilution of 1/15. Cultures were set up 
as described in Chapter 4.2.6, with 50 x 104 immune responder cells 
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incubated with 5 x 104 UV -irradiated vaccinia infected cells, in 96 well 
plates in MLC medium. Immune cells were depleted of various cell 
sub-populations as described in Chapter 3.2.9. 
5.2. 7 Cytokine Assays 
IL-2 Bioassay 
The HT-2 cell line (Watson, 1979) was used to determine the presence 
or absence of IL-2 in the culture supernatants. The supernatant 
samples and standard were titrated across a 96 well flat-bottomed plate 
(Nunc) in a final volume of 50 ~1. After washing several times in 
medium, the HT -2 cells were added to the wells in a 50 ~1 volume, at a 
concentration of 2000 cells/well. The cultures were incubated at 37oc in 
a humidified atmosphere of 5°/o C02 for 24 h. Proliferation was 
quantitated using [3H]-thymidine incorporation during the last 4 h of 
culture, as described in section 3.2.11. This cell line proliferates in 
response to IL-2 and IL-4, therefore antibodies were used to determine 
the relative concentration of each cytokine. However, the HT -2 cells 
did not proliferate in the presence of culture supernatant, indicating 
that neither IL-2 nor IL-4 were present. 
IL-4 and IL-10 ELISA 
IL-4 and IL-10 in culture supernatants were measured by ELISA. The 
coating antibody was bound to 96 well, flat bottomed ELISA plates 
(Dynatech Laboratories, Inc.) by incubation overnight at 4°C, in 50 J..Ll 
volumes. The antibodies used were the anti-IL 4 antibody, 11B11 (Ohara 
and Paul, 1985), at a concentration of 5 ~g/ml or the anti-IL-10 antibody, 
SXC4 (Mosmann et al., 1990), at a concentration of 1.25 J..Lg/ml, diluted 
in carbonate, bicarbonate coating buffer (pH 9.6). The plates were 
washed three times in phosphate-buffered saline (PBS)-Tween (0.01 M 
PBS, 0.1 °/o Tween) and then excess protein binding sites were blocked by 
the addition of 100 J..Ll 3°/o BSA PBS-Tween for 1 h at 37°C. After 
washing three times in PB5-Tween, 50 J..Ll of sample was added to each 
well and the plates were incubated for 2 h at room temperature. 
Dilutions of recombinant murine IL-4 or IL-10 were used to generate a 
standard curve. The plates were washed again and 50 ~1 of biotinylated 
antibody was added to each well for 1 h at room temperature. 
Biotinylated BVD6 (DNAX), anti-IL-4, was used at 625 ng/ml and 
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biotinylated SXC1 (Mosmann et al., 1990), anti-IL-10, was used at 
1.25 J.tg/ml. After washing, 50 Jll of streptavidin-alkaline phosphatase 
conjugate (Amersham Life Science) at 1/1000 dilution was added to 
each well and incubated for 1 h at room temperature. The plates were 
washed and then 50 Jll of the substrate disodium-p nitrophenyl 
phosphate at 1 ng/ml (Sigma) was added to each well. Optical density 
was measured 30 min later using a microplate reader at 405 nm with a 
reference of 630 nm. A standard curve was generated for each ELISA 
and a curve of best fit applied. The equation was used to determine the 
cytokine levels in supernatant samples. 
5.2.8 NK cell depletion 
Immune responder cells were depleted of B cells as described in section 
3.2.9. The cells were then incubated with anti-asialo-GM1 for 10 min at 
37oc, followed by a 45 min incubation with rabbit C at 37°C. Viable cells 
were recovered on an Histopaque gradient, washed in cold MLC and 
made up to the same volume as control cells, ie. J11d depleted only, 
which had a concentration of 5 x 106 cells/ml. The efficiency of the 
depletion was assessed with the NK cytotoxicity assay. The specific lysis 
decreased from· 29°lo to 5°lo, at the effector:target ratio of 20:1, following 
treatment of the immune cells with anti-asialo-GM1 and C. 
5.2.9 NK cytotoxicity assay 
The standard chromium release assay was performed, as described in 
section 3.2.3. 2 x 106 YAC-1 cells were labelled with 50 Jll 51Cr in a 
volume of 200 Jll for 90 min at 37oc. The cells were washed three times 
in complete medium and resuspended at a concentration of 2 x 105 
cells/ml for use as targets. The assay was carried out in triplicate in 
round-bottom 96 well plates (2 x 104 target cells plus the appropriate 
number of effector cells) for 4 h at 37°C in a humidified atmosphere of 
5°lo C02 in air. 
0lo specific lysis = experimental release - spontaneous release x 100 
maximal release - spontaneous release 
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5.3 RESULTS 
5.3.1 Endogenous TNF had a role in IFN-y production 
To determine whether TNF influenced the production of IFN-y or IL-6, 
the cytokine was neutralized in the cultures using the hamster TNF 
antibody. This neutralization led to a significant decrease in IFN-y 
production by the restimulated immune responder cells (Table 5.5). 
The decreased response was more evident at earlier time points. 
Preincubation of the responder cells with the antibody led to a further 
reduction in IFN-y levels, throughout the culture period. Despite this 
antibody inducing low levels of IL-6 from unstimulated immune cells 
(Table 5.4), it had no significant effect on the levels of IL-6 produced by 
restimulated cells, in a 20 h culture (Table 5.5). 
To determine whether the addition of TNF to the cultures would have 
a reverse and stimulatory effect on IFN-y production, recombinant TNF 
was added to the cultures. However, the presence of the recombinant 
TNF had little or no effect on IFN-y or IL-6 produced by the 
restimulated immune cells. Four dilutions of TNF were added, with 
the first dilution containing 200 pg recombinant murine TNF. This 
amount of TNF was similar to that produced by stimulator cells 
infected with a vaccinia virus encoding TNF, which is discussed in the 
next chapter. Following a 24 h incubation, cytokine levels in the 
supernatant were assayed. The TNF levels in cultures with 200 pg TNF 
added were less than expected when compared to cultures with 
medium alone (Table 5.6). The difference between the TNF level 
expected and TNF detected, approximately 60 pg, may indicate that TNF 
was bound to receptors on the restimulated responder cells. At the 
lower TNF concentrations, the TNF detected was similar to control 
wells. 
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Table 5.5 Effect of neutralizing TNF on IFN-y and IL-6 levels produced by restimulated vaccinia immune cells 
Antibody IFN-y (n~/ml) IFN-y (n~/ml) IL-6 (AU /ml) 
dilution 8 h culture 20 h culture 20 h culture 
No preincub. a Preincub. b No preincub. a Preincub. b No preincub. a Preincub. b 
None 5.5 + 0.6 28.2 + 3.9 13.6 ± 2.3 13.6 ± 2.3 
1/5 3.8 + 0.2 ** 2.1 + 0.7 ** 22.6 + 3.1 20.2 + 2.2 ** 10.0 + 1.8 12.3 + 0.6 
1/10 4.3 ± 0.4 * 2.7 + 0.2 ** 24.8 + 2.5 17.6 ± 1.8 ** 13.0 + 7.0 15.2 + 3.1 
1/20 4.5 + 0.8 2.2 + 0.7 ** 26.2 + 1.3 22.3 + 1.8 ** 8.7 + 2.8 13±2 
6 day vaccinia immune spleen cells were depleted of B cells. 50 x 104 of these responder cells were incubated with 5 x 104 UV-
irradiated virus infected cells in a total volume of 200 )ll. The TNF antibody, was added in a 20 Jll volume and supernatant was 
harvested at times indicated. Cytokine levels are expressed as the mean + SD of quadruplicate wells. 
a Antibody added to responder cells in culture wells two hours before addition of stimulator cells. 
b Antibody added to responder cells in culture wells at time of addition of stimulator cells. 
* significant < 0.05, Students t-test. 
** significant < 0.005, Students t-test. 
Table 5.6 Exogenous TNF did not alter IFN-y or IL-6 levels produced 
by immune responder cells 
r-TNF added TNF IFN-y IL-6 
(pg) a (pg/well) (ng/ml) (AU/ml) 
Medium 150 ± 10 35.8 ± 4.7 13.6 + 2.3 
200 290 + 20 31.5 ± 3.7 16.6 + 1.7 
100 240 + 20 34.7 ± 3.0 22.0 + 3.7 
50 210 + 20 41.0 ± 3.1 18.2 + 4.9 
25 200 + 10 39.7 ± 3.4 18.4 + 4.4 
Spleen cells were removed from mice infected with VV-WR 6 days earlier. 
The immune cells were depleted of B cells and made up to a concentration of 
50 x 10S /ml in medium. 5 x 104 UV -irradiated stimulator cells were added 
to 100 ~l immune cells, with a final volume of 220 ~l. Supernatant was 
harvested 24 h after initiation of culture. Cytokine levels are expressed as 
mean + SD of quadruplicate wells. 
a Recombinant murine TNF-a was diluted in medium and added to the 
culture wells in a 20 ~l volume. 
5.3.2 IL-6 antibody enhanced IFN-y levels 
Preincubation of the immune responder cells with the IL-6 antibody 
preparation led to a significant increase in IFN-y production in the first 
12 h of restimulation (Table 5.7). This level of IFN-y was twice that 
seen in cultures lacking antibody. Although the antibody preparation 
was able to directly induce IFN-y production from immune responder 
cells (2.1 ng/ml, Table 5.4), the increase shown here in restimulated 
wells was 8 times the level of IFN-y produced in the unstimulated 
wells. A decrease in TNF levels was observed in the cultures incubated 
with a 1/5 dilution of the IL-6 antibody preparation after 12 h of culture, 
however, by 24 h there was no difference in TNF levels (Table 5.7). 
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Table 5.7 Effect of neutralizing IL6 on IFN-y and TNF levels 
12 h 24 h 
Antibody dil. IFN-y (ng/ml) TNF (pg/ml) TNF (pg/ml) 
Medium 19.3 + 1.4 160 + 30 220 + 30 
1/5 37.0 ±3.8 ** 90 + 10 ** 180 + 30 
1/10 28.6 ± 6.9 * 130 ± 20 250 + 60 
1/20 24.2 ± 9.4 130 +50 430 + 10 ** 
1/40 22.1 + 1.8 150 +50 290 +50 
Antibody to IL-6 was added in 20 J!l volumes to wells containing 50 x 10 4 
immune responder cells. Two hours later 5 x 104 stimulator cells were added 
to each well, with a final volume of 220 J!l. Cytokine levels are expressed as 
mean + SD of quadruplicate wells. No IL-6 was detected in the supernatants 
of cultures treated with the IL-6 antibody, using the B9 assay. 
Cultures incubated with the IL-10 antibody, 2AS, had no significant difference 
in IFN-y of TNF levels at 12 h incubation. 
* significant < 0.05, Students t-test. 
** significant < 0.005, Students t-test. 
5.3.3 IFN-y production was dependent on IL-2 
The presence of an antibody against IL-2 in cultures of restimulated 
immune cells led to a significant reduction in the production of IFN-y 
(Table 5.8), with levels less than 40°/o of those seen in control wells. 
After 12 h of culture, TNF levels were increased in the presence of anti-
IL-2, however, by 24 h the TNF levels were similar to wells lacking 
antibody. 
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Table 5.8 Effect of neutralizing IL2 on IFN-y and TNF levels 
12 h 24 h 
Antibody dil. IFN-y (ng/ml) TNF (pg/ml) TNF (pg/ml) 
Medium 19.3 ± 2.2 160 + 30 220 ± 30 
1/5 6.7 ± 1.3 ** 250 ± 40 ** 300 ± 60 
1/10 8.4 + 2.7 ** 220 + 30 ** 210 ± 70 
1/20 10.0 + 1.1 ** 250 ±50 * 160 ± 40 
1/40 8.0 + 1.4 ** 220 + 60 * 200 ± 75 
Antibody to IL-2 was added in 20 IJ.l volumes to wells containing 50 x 10 4 
immune responder cells. Two hours later 5 x 104 stimulator cells were 
added to each well, with a final volume of 220 IJ.l. Cytokine levels are 
expressed as mean + SD of quadruplicate wells. 
* significant < 0.05, Students t-test. 
** significant < 0.005, Students t-test. 
The .supernatant of the a6310 cell line contains IL-2, and was used as a 
source of exogenous IL-2 for these cultures. IFN-y was not detected in 
the a6310 supernatant when assayed by ELISA, nor in supernatant 
harvested from wells containing stimulated naive responder cells 
cultured in the presence of the a6310 supernatant. Responder cells 
lacking restimulation did not produce IFN-y (Table 5.4), however, the 
addition of 100 U /ml IL-2 induced the production of significant levels 
of IFN-y (Table 5.9). These results indicate that the IL-2 source was not 
contaminated with IFN-y, and that only activated cells responded with 
IFN-y production. 
The IFN-y titre 1n cultures of non-stimulated responder cells 
supplemented with the IL-2-containing supernatant was 10°/o of that 
produced by restimulated immune cells. However, it was only 5°/o of 
that produced by restimulated cells in the presence of an exogenous 
source of IL-2 (Table 5.9). Depletion of both the CD4 + and CD8+ T cells 
abrogated the IFN-y response, indicating the IFN-y production was 
dependent on the presence of T cells. The addition of 100 U I ml IL-2 to 
the cultures led to a significant increase in the production of IFN-y by 
restimulated immune cells, with increased IFN-y titres of about 
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30 ng/ml. Cultures containing CD4-/CD8+ T cells also had marginally 
increased levels of IFN-y when incubated with the IL-2 source 
(5 ng/ml). The CD8- /CD4+ T cell cultures, however, did not respond by 
increased IFN-y production to the IL-2 added. These results indicate 
that both CD4+ and CD8+ T cells were required for the optimal inducing 
effect of the exogenous IL-2. 
Table 5.9 Effect of an exogenous source of IL-2 on IFN-y production by 
immune cells 
Responder cells No stim. a With stimulators With stimulators 
+ a6310 sup b + a6310 sup b 
B cell depl. 2.5 ± 0.7 27.3 ± 5.6 61.6 + 12.6 ** 
& CD4 depl. 1.3 ± 0.6 4.4 ± 1.1 9.3 ± 2.2 * 
& CD8 depl. 0.4 ± 0.1 16.2 ± 1.5 14.0 ± 3.6 
& CD4/8 depl. 0.4 ± 0.2 1.8 ± 0.6 5.9 + 1.8 * 
Naive c < 0.3 < 0.3 < 0.3 
Spleens were removed from 6 day vaccinia immune mice and depleted of B 
cells and T cell subsets. The B cell depleted cells were made up to a 
concentration of 5 x 106 cells/ml and the other cells were made up to the 
same volume. 100 J..Ll of responder cells was cultured with 5 x 104 UV-
irradiated stimulator cells in a total volume of 200 J..Ll. Supernatant was 
harvested after 24 h culture. Levels of IFN-y are expressed in ng/ml as 
mean + SD of triplicate wells. 
a Cultures received 100 J..Ll medium instead of stimulator cells. 
b 20 J..Ll of a6310 supematant, with a concentration of approximately 
1000 U /ml IL-2, was added to each well at the initiation of culture. 
c Responder cells were B cell depleted spleen cells taken from uninfected 
mice. 
* significant, p < 0.05, Students t-test. 
** significant < 0.005, Students t-test. 
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Although 100 U /ml IL-2 resulted in a marginal increase in IFN-y levels 
in CD4-/COB+ cultures, the addition of 500 U /ml increased the response 
significant! y such that levels were restored to non-depleted levels of 
IFN-y (Table 5.10). The increased TNF levels following removal of the 
CD4 + T cells remained unchanged. Depletion of asialo-GM+ cells from 
the immune responder cells led to a significant decrease in IFN-y 
levels. Supplementing the cultures with 500 U /ml IL-2 restored the 
IFN-y production, indicating the IFN-y produced in response to the IL-2 
was not derived from the asialo-GMt +cells 
Table 5.10 High levels of endogenous IL-2 restored IFN-y 
production by CD4-ICDB+ immune T cells 
Responder cells 
B-cell depleted 
& CD4 depleted 
& CD4 depleted 
& asialo-GM 1 
depleted 
& asialo-GMt 
depleted 
a 6310 sup a 
absent 
absent 
present 
absent 
present 
IFN-y TNF 
(ng/ml) (pg/ml) 
37.7 ± 3.1 170±3 
13.9 + 1.3 450 + 70 
34.9 + 1.2 430 ± 60 
27.3 + 5.0 NO 
50.6 ± 7.9 NO 
Spleen cells were removed from mice infected with VV -WR 6 days earlier, 
depleted of B cells and made up to a concentration of 5 x 106 /ml in medium. 
CD4 + T cells were also depleted from immune cells and made up to the same 
volume as the B cell depleted cells. 100 Jll of responder cells was cultured 
with 5 x 104 UV -irradiated stimulator cells in a total volume of 200 Jll. 
Supematant was harvested 20 h after initiation of culture. Cytokine levels 
are expressed as mean + SD of quadruplicate wells. 
a 20 Jll of a6310 supernatant, at a concentration of approximately 5000 U /ml 
was added to each well at initiation of culture. 
Interestingly, it was not possible to detect significant levels of IL-2 in the 
supernatant of restimulated responder cells during the first 12 h of 
culture, using the HT -2 cell line to assay IL-2 (Table 5.13). 
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5.3.4 Endogenous IL-4 influenced IFN-y and TNF production 
IL-4 was not able to be detected in the supernatant harvested from 
restimulated vaccinia immune cultures, over a 3 day period 
(Table 5.13). Despite this, the addition of antibodies to IL-4 led to a 
decrease in TNF production by the restimulated immune cells 
(Table 5.11). This was observed whether the responder cells were 
preincubated with the antibody, or not. In contrast, the presence of an 
antibody specific for IL-10 had no effect on TNF levels. Neutralization 
of IL-4 also led to decreased levels of IFN -y, although this effect was 
seen later in the culture period, after 20 h incubation of the 
restirnulated responder cells (Table 5.12). 
Table 5.11 Effect of neutralizing IL-4 or IL-10 on TNF levels 
Ex:eerirnent 1 (20 h)a Exp. 2 (24 h)b 
Antibody anti-IL-10 anti-IL-4 anti-IL-4 
dil. 
Medium 300 ± 40 300 + 40 220 + 25 
1/5 340 ±30 160 ± 20 * 150 ± 40 
1/10 360 ±50 230 ± 20 140 ± 20 * 
1/20 370 ± 60 210 ± 40 150 + 10 * 
6 day vaccinia immune responder cells were incubated with UV -irradiated 
virus infected cells. Antibody to IL-4 or IL-10 was added in 20 111 volume to 
give a final volume of 220 jll. Supernatant was harvested at the times 
indicated. TNF levels are expressed as mean + SD of triplicate wells. 
a Antibody added to the wells at the same time as stimulator cells. 
b Antibody added to responder cells two hours prior to addition of stimulator 
cells. 
* significant < 0.05, Students t-test. 
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Table 5.12 Effect of neutralizing IL-4 on IFN-y levels produced by 
restimulated vaccinia virus immune cells 
Antibody Experiment 1 a Experiment 2 (20 h) 
dil. (12 h) No preincub. b Preincub. a 
Medium 16.9 + 1.5 28.2 ±3.9 
1/5 16.1 ± 0.6 20.6 ± 1.4 * 10.7 ± 1.4 * 
1/10 18.2 + 1.5 22.6 ± 2.5 25.2 ± 1.7 
1/20 16.7 + 2.8 23.8 ± 2.6 24.7 ± 3.1 
6 day vaccinia immune spleen cells were depleted of B cells. 50 x 104 of these 
responder cells were incubated with 5 x 104 UV -irradiated virus infected cells 
in a total volume of 200 J..Ll. Antibody was added in a 20 J..Ll volume and 
supernatant was harvested at times indicated. IFN-y levels are expressed as 
ng/ml and are mean + SD of quadruplicate wells. 
The presence of antibody to IL-10, 2AS, in the cultures had no significant effect 
on IFN -y levels. 
a Antibody added to responder cells in culture wells two hours before 
addition of stimulator cells. 
b Antibody added to responder cells in culture wells at time of addition of 
stimulator cells. 
* significant < 0.005, Students t-test. 
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5.3.5 IL-10 was produced later in culture period 
IL-10 was detected in the culture supernatant of the restimulated 
immune cells, but not until after 24 h of culture (Table 5.13). The 
addition of antibodies to this cytokine had no effect on TNF levels, 
within the first 20 h of culture, by which time the TNF levels had 
begun to plateau (Table 5.10). 
Table 5.13 Culture supernatant did not contain significant levels of IL-2 
or IL-4 
Time IL-2 IL-4 IL-10 
(h) (U/ml) (U/ml) (pg/ml) 
4 < 10 < 0.2 ND 
12 < 10 < 0.2 1.5 ± 0.6 
24 ND < 0.2 11 + 1 
48 ND < 0.2 30 + 3 
72 ND < 0.2 21 + 5 
50 x 104 B cell depleted vaccinia immune responder cells were 
incubated with 5 x 104 UV -irradiated virus infected spleen cells in a 
total volume of 200 ~1. Supernatants were harvested at the times 
indicated and frozen until assayed for cytokine levels. IL-2 was assayed 
on the HT -2 cell line, whereas IL-4 and IL-10 were assayed using ELISAs. 
IL-2 was not detected above the limit of the assay (10 U /ml), nor was 
IL-4 (0.2 U /ml). IL-10 levels are given as pg/ml and are the mean + SD 
of quadruplicate wells. 
A summary table of the results presented in this chapter can be found 
in Chapter 7, the general discussion (Table 7.2). 
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5.4 DISCUSSION 
Vaccinia immune spleen cells produced the cytokines TNF, IL-6 and 
IFN-y upon restimulation with virus infected cells. There have been 
numerous reports demonstrating that the production of these three 
cytokines is closely interrelated. TNF induced the production of IL-6 
in cell culture (Kohase et al., 1986) and in vivo (Fong et al., 1989; 
Jablo~s et al., 1989), whereas IL-6 may have served to down-regulate 
TNF production (Aderka et al., 1989). TNF has been shown to be 
necessary for production of IFN-y from NK cells (Wherry et al., 1991) 
while IFN-y may be involved in the negative feedback control of TNF 
(Doherty et al., 1992). On the other hand, there are also examples 
where the induction of cytokine production occurs through 
independent pathways (Havell and Sehgal, 1991). In order to 
investigate whether the production of the cytokines IL-6, TNF and 
IFN -y by vaccinia immune cells involved cytokine interaction, 
antibodies specific for several cytokines were added to the cultures of 
restimulated cells. 
Treatment of the vaccinia immune cells with the TNF antibody did 
not significantly affect IL-6 levels produced by the cells upon 
restimulation (Table 5.5), indicating the production of IL-6 occurred 
through a TNF-independent mechanism. This is in agreement with 
the work presented in Chapter 3 which indicated that the responder 
cells contained a population of activated macrophages which could be 
triggered to produce IL-6 directly by the UV-irradiated virus-infected 
stimulator cells, as was shown by Gosselin et al. (1992) in a study using 
EBV and HSV. In contrast to these results, there have been several 
reports of TNF acting as an intermediate in IL-6 production. 
Pretreatment with anti-TNF antibodies significantly lowered IL-6 
serum levels after E. coli challenge in baboons and mice (Fong et al ., 
1989; Starnes et al., 1990), whereas treatment of fibroblasts with 
recombinant TNF induced IL-6 mRNA (Kohase et al., 1986). The 
TN3.19.12 TNF antibody preparation was used by Engelberts et al. 
(1991) and was shown to be more effective at reducing IL-6 levels in 
vivo than in cultures of LPS stimulated macrophages. 
Treatment of vaccinia immune responder cells with anti-TNF did, 
however, affect their ability to produce IFN-y, with a 30°/o decrease 
observed in IFN-y titre (Table 5.5). This result suggests that at least a 
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portion of IFN-y production was dependent on TNF. A similar result 
was seen in vivo, with mice treated with LPS and anti-TNF having 
lower IFN-y levels in their serum (Doherty et al., 1992). In addition, 
the production of IFN-y by NK cells isolated from scid mice, cultured 
with macrophage conditioned medium was reduced in the presence of 
antibodies to TNF (Wherry et al., 1991). The responder cells in the 
studies described here were taken from mice injected with VV-WR 
6 days earlier. It has been shown that the NK cell activity (lysis of 
YAC-1 cells) increased following VV-WR infection of normal mice, 
with peak activity at 3 days. By 6 days, however, the NK cytolytic 
activity had decreased to below the levels of unimmunized controls 
(Karupiah et al., 1990a). Thus, NK cells are not believed to be major 
contributors to IFN-y production in the system described here. The 
observation that there was no more than a 30°/o decrease in IFN-y titres 
may suggest the antibody was acting on one IFN-y producing cell 
population, with another population producing IFN-y in a TNF-
independent manner. This suggestion is supported by the kinetics of 
IFN-y production following depletion of adherent cells, as described in 
Chapter 4. The decrease in IFN-y titres following removal of adherent 
cells was not evident until after 12 h incubation, indicating the initial 
IFN-y production was independent of the adherent cells. 
Preincubation of the responder cells with TNF antibodies augmented 
the suppressive effect on IFN-y production by the cells. The 
preincubation may have allowed for binding of antibody to the 
immune responder cells expressing membrane bound TNF before 
secretion of soluble TNF (Sheehan et al., 1989), and thus interfered 
with subsequent TNF release or interaction with a target cell. 
The addition of recombinant TNF to cultures of restimulated vaccinia 
immune cells led to only a marginal increase in the levels of IL-6 
(Table 5.6). Similarly, IFN-y levels were not influenced by this level of 
exogenous TNF. This lack of response suggests several possibilities. 
Firstly, the TNF may not be active in this form; membrane bound 
TNF may be more active. Secondly, TNF may not be involved in the 
generation of IL-6 and IFN -y and, finally, the cells producing these 
cytokines were optimally stimulated and could not respond further . 
In contrast, treatment of the responder cells with antibody to TNF 
indicated that TNF was involved in production of IFN-y by a subset of 
the immune responder cells, but that IL-6 production was not 
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influenced by TNF. These results indicate that IL-6 production was 
TNF independent, and that the level of exogenous TNF added was not 
able to stimulate increased IFN-y production. 
Responder cells produced greater levels of IFN-y when antibody to IL-6 
was present in cultures, compared to cells cultured without antibody 
(Table 5.7). No IL-6 was demonstrable in the supernatants from the 
IL-6 antibody treated cultures, suggesting that IL-6 produced by the 
responder cells following restimulation was neutralized by the 
antibody. This may indicate that IL-6 was able to down-regulate IFN-y 
production. Another possibility is that the antibody interfered with 
binding of IL-6 to the B9 IL-6 receptor, while the IL-6 retained activity 
on IFN-y producing cells. As shown in the previous chapter, removal 
of the adherent cells, the major IL-6 producers, resulted in a decrease 
in IFN-y levels. This argues against the possibility that IL-6 is able to 
down-regulate IFN-y production. 
Decreased levels of TNF were observed in cultures of responder cells 
restimulated in the presence of the IL-6 antibody. However, this effect 
on TNF was only seen at high concentrations of the antibody, despite 
its potent neutralizing activity against IL-6. Twelve hours later the 
decreased TNF response was no longer apparent. This is in contrast to 
the increased levels of TNF observed following anti-IL-6 treatment of 
E. coli induced TNF in vivo in mice (Starnes et al., 1990). This in vivo 
result, and the decreased levels of TNF in IL-6 treated cultured cells 
(Aderka et al., 1989), has led to the conclusion that IL-6 may be part of a 
feedback loop that blocks TNF production. Such a loop was not 
consistent with the observations made of the culture conditions 
described here. A recent study examined the regulation of IFN-y 
receptor expression by a monocytic cell line. The results indicated that 
TNF and IL-6 up-regulated the IFN-yR gene via different mechanisms 
(Sanceau et al., 1992). Perhaps removal of IL-6 from these cultures led 
to decreased IFN-yR expression by the macrophages such that they 
were less able to be activated, and in consequence led to a decrease in 
TNF and IL-6 production. 
The addition of antibodies to IL-2 to cultures of restimulated vaccinia 
virus immune spleen cells led to a significant decrease in IFN-y titres 
(Table 5.8). A study of IFN-y producing tonsillar cells has similarly 
shown a decrease in IFN-y production following treatment with 
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anti-IL-2 (Quiding et al., 1993). In contrast, TNF levels were enhanced 
after 12 h culture in the presence of this antibody. Enhanced TNF 
levels have been described in Chapter 4, in cultures lacking CD4 + T 
cells. Recombinant IL-2 added to cultures depleted of CD4 + T cells did 
not alter the enhanced levels of TNF (Table 5.10), indicating that the 
negative influence CD4+ T cells have over TNF production was not 
mediated through IL-2. 
Addition of a6310 supernatant, as a source of r-IL-2, to cultures of 
unstimulated vaccinia immune spleen cells led to a production of 
low, but significant levels of IFN-y (Table 5.9), as seen by Yamamoto et 
aZ.. (1982). IL-2 is known to be involved in the production of IFN-y 
(Farrar et al., 1981) and was required for maximum synthesis of IFN-y 
in vitro (Reem and Yeh, 1984). In the absence of restimulation, 
CD4- /CD8+ responder cells produced 50°/o of the level of IFN-y upon 
incubation with IL-2, as compared to B cell depleted cells. The 
CD8-/CD4+ immune cells did not respond to the exogenous IL-2, 
suggesting the IFN-y inducing effect of IL-2 is acting on the CD8+ T cell 
population. This is in agreement with the work of Torres et al. (1982) 
in which Lyt.2+ cells were the IFN-y producers in cultures of unprimed 
lymphocytes incubated with IL-2. Vaccinia immune spleen cells 
produced higher levels of IFN-y upon restimulation. The addition of 
100 U /ml IL-2, in the form of a6310 supernatant, enhanced the 
secretion two-fold (Table 5.9). This level of IL-2 was in the same order 
of magnitude as other in vitro studies (Reem and Yeh, 1984; Torres et 
al., 1982). A similar two-fold enhancement was observed in cultures 
of CD4-/CD8+ responder cells, although the level of IFN-y production 
was still only 15 °/o of that seen in non-T cell depleted cultures. Those 
cultures containing CD8-/CD4+ cells were the only ones not to respond 
to the IL-2 with increased IFN-y production. Similarly, Kelso et al. 
(1984) reported that IL-2 was found to enhance the precursor frequency 
of MAF secreting Lyt.2+ cells while not affecting the Lyt.2- cells. The 
addition of 500 U /ml IL-2, in the form of a6310 supernatant, 
completely restored levels of IFN-y produced by CD4-/CD8+ T cell 
responders to that produced by non-T cell depleted cultures 
(Table 5.10). The fact that depletion of CD4+ T cells dramatically 
reduced IFN-y titres which could only be restored with excessive levels 
of IL-2 suggested that cells other than CD4 + T cells responded to the 
high levels of IL-2 with IFN-y production. These may have been 
CD8+ T cells or NK cells. NK cells are able to produce IFN-y (Cuturi et 
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al., 19S9) and IL-2 is known to augment NK cell activity, in the absence 
of IFN-y (Henney et al., 19S1; Sayers et al., 19S6). Removal of the NK 
cells from responder cells with anti-asialo GM1 and C resulted in 
decreased IFN-y production. The addition of 500 U /ml IL-2 to the 
culture restored IFN-y levels, indicating that the IFN-y production in 
response to IL-2 was not dependent on NK cells, but was dependent on 
IL-2. The IL-2 was acting on COS+ T cells to increase IFN-y expression, 
however, C04+ T cells must also be present for this increase to occur. 
This suggests the C04+ T cells are providing another signal, perhaps 
another cytokine, to the COS+ T cells. This may account for the 
interaction observed among the responder cells in Chapter 3. 
IL-4 was not detected in the supernatant of restimulated vacc1n1a 
immune spleen cells at any time throughout the 4S h culture. IL-4 may 
be secreted by these cells, but if so, the levels were below the detection 
limit of the assay, or the cytokine was bound to receptors on responder 
cells. Similarly, IL-2 was not detected in culture supernatant. 
Cytokines are released in a localized space in the vicinity of interacting 
cells (Kupfer et al., 1991), and thus, lack of detection in the supernatant 
of these cells does not necessarily indicate the cytokine was not being 
prod.uced. IL-4· has been shown to be a macrophage activating factor, 
increasing their tumoricidal activity and expression of class I and II 
MHC antigens (Crawford et al., 19S7; Stuart et al., 19SS). A recent report, 
however, has demonstrated that IL-4 inhibited the expression of TNF 
mRNA in murine peritoneal macrophages following stimulation with 
IFN-y or IL-2, whereas LPS-induced TNF mRNA remained unaffected 
(Gautam et al., 1992). Antibodies to IL-4 in the cultures of restimulated 
vaccinia immune cells led to a decrease in TNF levels (Table 5.11 ). As 
TNF appeared to be produced upon contact with virus antigen in these 
cultures, the role of IL-4 was likely to be minor, although IL-4 may have 
enhanced macrophage activation. 
The IFN-y levels also decreased upon incubation of the responder cells 
with the IL-4 antibody (Table 5.12). It was shown in the previous 
chapter that the majority of IFN-y produced was dependent on the 
C04+ T cells. Although the C04+ T cells may be regulating IFN-y 
production by another cell type through the production of cytokines, a 
significant level of IFN-y was produced by these cells, as seen by the lack 
of IFN-y response in cultures lacking these cells supplemented with 
100 U /ml IL-2. C04+ T cells which produce IFN-y belong to the Th1 
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phenotype (Mosmann et al., 1986). IL-4, a Th2-type cytokine, has been 
shown to suppress a Th1 response, through down-regulation of IL-2 
production (Schwarz et al., 1993). Neutralization of IL-4 in the cultures 
might be expected to lead to increased IFN-y levels, if the IL-4 was 
involved in such an inhibitory activity. The results presented using 
the IL-4 antibody treatment do not readily fit with the Th1/Th2 model. 
The decrease in IFN-y levels following neutralization of IL-4 was 
observed later in the culture period (20h). A similar, late, decrease in 
IFN -y levels was observed following removal of the adherent cells 
(Chapter 4.3.1.3). Neutralization of IL-4 also resulted in decreased TNF 
levels, as discussed above. This may suggest that the decreased IFN-y 
levels following neutralization of IL-4 were a consequence of the 
reduced TNF levels. Interestingly, as will be discussed in the following 
chapter, stimulation of responder cells with a recombinant vaccinia 
virus encoding IL-4 enhanced IFN-y levels two-fold. Alternatively, the 
IL-4 may act on the vaccinia immune CD8+ T cells. IL-4 has been 
associated with secondary responses, as a high proportion of primed 
cells were able to produce IL-4 following restimulation whereas it was 
not readily produced by 1 ym phoid cells freshly isolated from mice 
(Powers et al., 1988). IL-4 was demonstrated to be able to drive 
CD4-/CD8+ CTL-precursors to maturation (Quentmeier et al., 1992), and 
was involved in the induction of allo-CTL induction in a secondary 
response. In both these studies IL-4 was provided by primed CD4 + T 
cells (Suzuki et al., 1992). 
The addition of antibodies to IL-10 to the culture system described here 
had no effect on TNF production by restimulated immune responder 
cells. The supernatants were harvested after 12 h of culture. 
Significant levels of IL-10 were not detected in the culture until 24 h of 
culture. This later stage production has been observed with anti-CD3 
stimulated T cell clones and peripheral blood T cells (Yssel et al., 1992). 
TNF levels had begun to plateau by the time IL-10 was detected in the 
culture supernatant. The kinetics of production could suggest the IL-10 
had a regulatory effect on TNF production. IL-10 was first described as a 
cytokine produced by Th2 cells which inhibited macrophage APe-
dependent cytokine synthesis by Th1 cells (Fiorentino et al., 1989). IL-10 
has been found to have a number of effects on other cells, including an 
inhibitory effect on TNF and IL-6 production by activated macrophages 
(Fiorentino et al., 1991b). The lack of effect in cultures treated with 
antibody to IL-10 did not necessarily imply that the cytokine is not 
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involved. Cytokines are released into a localized space in the vicinity 
of the interacting cells (Kupfer et al., 1991), possibly beyond reach of 
antibodies. The lack of effect with antibodies was alluded to in a recent 
review: "it is our personal experience that neutralizing the effects of an 
autocrine cytokine is not always easy" (De Maeyer and De Maeyer-
Guignard, 1992). 
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5.5 SUMMARY 
It was highly probable that cytokines produced by restimulated vaccinia 
immune cells interacted in a network, and induced the production of 
each other. Individual cytokines were neutralized by the addition of 
specific antibodies in order to examine this more closely. Neutralizing 
TNF reduced IFN-y production by 30°/o, indicating at least a portion of 
IFN-y production was dependent on TNF. In contrast, IL-6 production 
was TNF independent. IFN-y production was also dependent on IL-2. 
Neutralization of IL-2 reduced IFN-y production, while the addition of 
IL-2 led to an increase in IFN-y levels. The induction of IFN-y by IL-2 
was dependent on the presence of both CD4+ and CDB+ T cells. 
Neutralization of IL-4 led to a decrease in levels of TNF and IFN-y; a 
result which does not fit with the Thl/Th2 model. IL-4 was not 
detected in culture supernatant, although antibody to IL-4 reduced both 
TNF and IFN-y levels. 
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CHAPTER6 
Effect of restimulation of vaccinia virus immune cells with 
recombinant vaccinia virus encoding cytokine genes 
6.1 INTRODUCTION 
An immune response to virus infection involves a number of distinct 
cell types, whose functions must be co-ordinated to ensure an 
appropriate response. The co-ordination of these functions is regulated 
through the production of cytokines. The previous chapter examined 
the influence of several cytokines on the generation of antiviral 
cytokines by vaccinia virus immune spleen cells. The approach taken 
was to inhibit cytokine activity by the addition of antibody, or to add 
exogenous cytokine. However, this approach has its limitations. 
Cytokine release by T cells is polarized towards the interactive cells 
(Kupfer et al., 1991; Poo et al., 1988) which leads to very high local 
concentrations of the cytokine. Thus, antibodies against the cytokines 
may be unable to reach the localized area of cytokine production. 
Likewise, the addition of exogenous cytokine to cultures is unlikely to 
mimic the localized concentrated effect of natural cytokine activity on a 
responsive cell. 
An alternative method of presenting cytokines in a virus infection is 
readily available through the use of recombinant vaccinia viruses 
which encode cytokine genes (Ramshaw et al., 1987). The foreign gene 
encoded by the recombinant vaccinia virus is expressed independent of 
the type of cell infected. Thus, although IL-2 is normally secreted only 
by T cells, any cell infected with a recombinant IL-2 virus will produce 
the cytokine (Ramshaw et al., 1992). Therefore, infection of cells with 
recombinant vaccinia viruses ensures the cytokine of interest is 
produced at the site of antigen presentation. 
A number of recombinant vaccinia viruses which encode cytokine 
genes have been constructed. These recombinant viruses can be 
regarded as belonging to two groups. The first group includes those 
viruses that encode cytokines which act as antiviral effector molecules, 
ie. the viruses which encode IL-2, IFN-y and TNF. Several important 
observations have been made following replication of these viruses in 
vivo. To summarise these observations: 
(1) vector-encoded IL-2 enhanced host antiviral responses mediated 
by NK cells; 
(2) IL-2 was critically dependent on host-derived IFN-y for antiviral 
activity; 
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(3) vector-encoded IFN-y and TNF, unlike IL-2, mediated direct 
antiviral activity (reviewed by Ramshaw et al., 1992). 
The second group of recombinant vaccinia viruses contains those 
which encode cytokines that act at the level of antigen presentation and 
regulation of immune response. Vaccinia virus encoding IL-4 was 
lethal in normal mice, but the toxicity was overcome by coexpression of 
IFN -y, indicating the IL-4 abrogated the IFN-y response to virus 
infection (Andrew and Coupar, 1992). In contrast, IL-10 encoded by a 
recombinant vaccinia virus had no significant effect on immune 
response in vivo (Milbourne et al., submitted). 
This chapter sets out to examine the effect of virus-encoded cytokine 
production, at the site of antigenic stimulation, on the production of 
the antiviral cytokines by vaccinia virus immune cells. Viruses 
encoding Th-1 type cytokines were found to enhance production of 
IFN-y by responder cells. Viruses encoding the Th-2 type cytokines, IL-4 
and IL-10 were also used to examine whether the presence of these 
cytokines at the site of restimulation would skew the response by the 
immune cells towards a Th-2 cytokine response. 
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6.2 METHODS 
6.2.1 
Mice As described in Chapter 2.1 
Culture medium As described in Chapter 2.4 
6.2.2 Viruses 
The viruses have been constructed using the neurovirulent, L929 cell-
adapted WR strain of vaccinia virus (Wokatsch, 1972), which is 
designated VV-WR. VV-HA-IL-2 (Ramshaw et al., 1987) and 
VV-HA-TNF (Sambhi et al., 1991), VV-HA-IL-4 and VV-HA-IL-10 were 
constructed using the recombinant VV-PR8-HA6 (Andrew et al., 1986), 
which encodes the haemagglutinin (HA) of influenza A/PR/8/34. 
VV-IFN-y was constructed without the HA gene (Kohonen-Corish et 
al., 1990). Virus stocks were prepared from infected CV-1 cells grown in 
2 litre Schott acid-washed roller bottles. VV-HA-TNF, VV-IFN-y and 
VV-HA-IL-2 stocks were provided by Mrs Jill Medveczky; VV-HA-IL-4 
stocks were provided by Or D. Sharma; and VV-HA-IL-10 stocks were 
provided by Or E. Milbourne Gohn Curtin School of Medical Research) . 
6.2.3 Preparation of stimulator cells 
To analyse the ability of cytokine-encoding recombinant vuuses to 
synthesize cytokines following UV -irradiation, spleen cells were 
infected with the VV-HA-TNF or VV-IFN-y virus at 10 pfu/cell for 1 h 
at 37°C. After washing twice in medium the cells were made up to a 
concentration of 106 cells/ml and subjected to increasing periods of UV-
irradiation. 106 cells were placed in a well of a plastic 24-well plate 
(Linbro) and subjected to 1 min UV-irradiation at an intensity of 
600-JlW I cm2 in the 230- 270 run range. 106 cells were added to a second 
well and the plate further exposed to 1 min UV -irradiation. This was 
continued until the first well had been subjected to 5 min irradiation. 
The 30 second irradiation was performed separately, then a final 1 ml 
containing 106 cells was added to a further well, as a non-UV-irradiated 
control. The cells were incubated at 37°C in a humidified atmosphere 
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of 5°/o C02 for 48 h. Supernatant was harvested and frozen until 
assayed for cytokine levels. 
As shown in Table 6.1, subjecting the cells to up to 5 m1n UV-
irradiation reduced the level of cytokine produced by up to 25°/o. 
However, levels were still sufficiently high that it was possible to use 
these recombinant viruses to infect stimulators and set up cultures 
using the same protocols as described in Chapter 4. 
Table 6.1 Effect of UV-irradiation on cytokine production by spleen 
cells infected with recombinant vaccinia viruses encoding cytokine 
genes 
UV- VV-IFN-y VV-HA-TNF 
irradiation IFN-y (n~/ml) TNF (n~/ml) 
(min) Sh 19 h Sh 19 h 
0 2.6 ± 0.0 2.2 ± 0.0 1.45 + 0.08 2.35 ± 0.05 
0.5 3.0 + 0.1 2.6± 0.1 1.22 + 0.03 2.34 ± 0.05 
1 2.4 ± 0.1 2.1 ± 0.0 1.25 + 0.1 2.22 ± 0.05 
2 2.5 ± 0.2 2.0 ± 0.2 1.31 + 0.03 2.07 ± 0.1 
5 2.3 ± 0.6 1.6 ± 0.1 1.01 + 0.09 1.91 ± 0.01 
6.2.4 Culture conditions 
The culture conditions were the same as described in Chapter 4.2.6. 
Spleens were removed from mice injected with VV-WR 6 days earlier, 
dispersed through a grid, and depleted of B cells and other cell 
populations, if appropriate. The B cell depleted cells were made up to a 
concentration of 5 x 106 cells/ml. Responder cells depleted of other 
populations were made up to the same volume, as described in 
Chapter 3.2.9. The immune cells were incubated with 5 x 104 
stimulator cells in a 96 well plate, in a total volume of 200 111. The 
stimulator cells were prepared as previously described, with the 
exception that these cells had been infected with either VV-WR or one 
of the recombinant vaccinia viruses. 
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6.2.5 Immunofluorescent staining of cells 
Following three days incubation of vaccinia Immune cells with 
recombinant virus infected stimulators, the cells were stained for cell 
surface phenotype for analysis by flow cytometry. The previous 
protocol for surface staining, described in Chapter 4.2.7, was scaled 
down, as only 5 x 105 cells were to be stained, rather than the usual 
106 cells. Cells from the culture wells were transferred to wells of a 
V-bottomed 96 well (Linbro/ Titertek) plate. The plate was centrifuged 
at 200 g for 3 min and the supernatant flicked off. The cells were 
resuspended in 25 ~1 of the biotinylated anti-Lyt.2 (clone 53-6.7; Becton 
Dickinson) or the PE-conjugated anti-L3T4 (clone GK1.5; Becton 
Dickinson) diluted in medium, 1/25. After 20 min incubation at 4oc, 
200 ~1 of cold PBS was added to each well and the plate centrifuged 
again. The supernatant was flicked off and those cells stained with the 
biotinylated antibody were incubated for a further 20 min at 4oc with 
streptavidin-phycoerythrin, at a dilution of 1/30. The cells were 
washed with PBS, and then resuspended in 200 ~1 PBS for analysis on 
the FACScan. 
6.2.6 Proliferation assay As described in Chapter 3.2.9 
138 
6.3 RESULTS 
6.3.1 Virus-encoded cytokine production was rapid 
Spleen cells infected with the TNF-encoding or IFN-y-encoding vuus 
were UV-irradiated and then incubated at 37°C for up to 48 h. Cells 
infected with VV-WR did not produce TNF or IFN-y upon incubation, 
as shown in Chapter 3. High levels of TNF and IFN-y were detected in 
the supernatant of cells which had been infected with VV-HA-TNF and 
VV-IFN-y, respectively, and incubated at 37°C. The cytokines were 
detected in the supernatant within 4 h of culture (Figure 6.1), with peak 
levels reached at 24 h. To put these cytokine levels in the context of 
cytokine production by immune responder cells, levels of IFN-y 
produced by these VV-IFN-y infected stimulator cells was less than 5°/o 
of the IFN-y produced in restimulated cultures. In contrast, the TNF 
levels were 50 - 100°/o of that detected in previous cultures of 
restimulated responder cells. 
6.3.2 Virus encoded TNF dramatically enhanced TNF levels in cultures 
Incubation of the responder cells with VV -HA-TNF infected stimulator 
cells led to a dramatic increase in TNF levels in the culture supernatant 
(Figure 6.2). The TNF levels were 5 to 8 times the levels seen in 
cultures with VV-WR infected stimulator cells. The initial increase 
can be ascribed to TNF production by the TNF-encoding virus. 
However, the increase during the later period may be from responder 
cells, as the kinetic study of virus-encoded cytokine production showed 
that the majority of the virus-encoded TNF was produced within the 
first 8 h (Figure 6.1). 
Significant levels of TNF were secreted into the supernatant by 
stimulator cells infected with VV-HA-TNF, in the absence of responder 
cells (Table 6.2). TNF was not detected in supernatant of stimulator 
cells infected with wild type or the IFN-y- or IL-2-encoding viruses 
when cultured alone. The TNF produced by the TNF-encoding virus 
augmented the TNF produced by the responder cells to levels three 
times that in cultures stimulated with wild type virus. Stimulation 
with an IFN-y- or an IL-2-encoding virus had no effect on the level of 
TNF produced by the responding cells. 
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Table 6.2 Production of TNF by vaccinia virus primed spleen cells stimulated with recombinant vaccinia virus 
Antibody treatment of 
responders 
No responders 
J11d + c 
J11d + anti-CD4 + C 
J11d +anti-COB+ C 
J11d + anti-CD4 + anti-
CD8+C 
J11d + anti-asialo-GMt 
+C 
vv-WR 
< 100 
210 ± 80 
450 + 70 
220 ± 60 
250 ±40 
160 + 10 
STIMULATING VIRUS 
vv-IFN-y vv-HA-TNF VV-HA-IL-2 
<100 170±40 < 100 
260 ± 40 630 + 80 ** 180 ±SO 
430 ± 130 970 +50** 350 + 80 
170 ±50 630 + 130 ** 120 ±SO 
240 ± 60 1030 + 100 ** 310 + 40 
330 + 30 ** 740 + 150 ** 
Spleen cells from mice immunized 6 days earlier were treated as shown and cultured for 20 h with syngeneic spleen 
cells infected with viruses indicated. The TNF level (pg/ml) of the supernatant was determined using ELISA and 
expressed as the mean + SD of quadruplicate wells. 
* levels of TNF were significantly different to those in similar cultures stimulated by VV -WR, p < 0.05, Student's t-test. 
** levels of TNF were significantly different to those in similar cultures stimulated by VV -WR, p < 0.005, Student's t-test. 
To determine the spleen cell subpopulations which responded to the 
TNF-encoding virus with increased TNF production, responder cells 
were depleted of cell subsets prior to incubation with stimulator cells. 
Cultures containing CD4- /CDB+ T cells had increased TNF levels, as 
seen following stimulation with wild type virus. This suggests that the 
CD4+ T cells were negatively influencing the TNF production of 
another cell type. Cultures containing CDB-I CD4 + T cells had similar 
levels of TNF as non-T cell depleted cultures stimulated with this 
virus. Responder cells lacking both T cell subsets produced similar 
levels of TNF as seen in cultures lacking CD4 + T cells. These results 
would suggest a cell type other than CD4 + or CDB+ T cells produced 
TNF in response to the virus-encoded TNF. Responder cells lacking 
asialo-GM1 + cells also produced increased levels of TNF, indicating the 
NK cells were not the cells responding to the virus-encoded TNF. TNF 
levels were also increased following removal of the asialo-GM1 + cells 
in cultures stimulated with VV-IFN-y (p < 0.025). 
6.3.3 IFN-y production by responder cells was enhanced by virus 
encoded cytokines 
Incubation of responder cells with stimulator cells infected with the 
TNF-, IFN-y- or IL-2-encoding virus led to enhanced levels of IFN-y in 
the culture supernatant. This was observed throughout the period of 
the 24 h incubation in cultures stimulated with VV-IFN-y and 
VV-HA-TNF (Figure 6.3). The IFN-y levels in the VV-IFN-y stimulated 
cultures were almost twice the level detected in cultures stimulated 
with VV-WR infected cells, eg. 53 ng/ml compared to 30 ng/ml at 24 h 
culture. The VV-HA-TNF infected cells stimulated three times the 
levels of IFN-y, eg. 22 ng/ ml compared to 8 ng/ ml at 15 h. 
Low levels of IFN-y were secreted by cultured stimulator cells infected 
with recombinant vaccinia virus encoding this factor, whereas IFN-y 
was not detected in supernatant harvested from cultured stimulator 
cells infected with VV-WR or viruses encoding TNF or IL-2 (Table 6.3). 
The augmented levels of IFN-y in cultures of B cell depleted responder 
cells incubated with VV-IFN-y-infected stimulators could not be 
accounted for by the IFN-y produced by stimulator cells alone. 
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Table 6.3 Production of IFN-y by vaccinia virus i~mune spleen cells stimulated with recombinant vaccinia vints 
Antibody treatment of 
responders 
No responders 
J11d + c 
J11d + anti-CD4 + C 
J11d + anti-CD8 + C 
J11d + anti-CD4 +anti-
CD8+C 
J11 d + anti -asialo-GM 1 
+C 
VV-WR 
< 0.3 
37.7 ± 3.1 
13.9 ± 1.3 
31.9±2.5 
1.6+0.4 
27.3 ± 5.0 
STIMULATING VIRUS 
VV-IFN-y VV-HA-TNF VV-HA-IL-2 
1.3 + 0.4 < 0.3 < 0.3 
52.3 + 4.5 ** 60.7 + 6.0 ** 48.1 ± 2.0 ** 
22.2 + 4.1 * 20.7 + 1.4 ** 17.2 ± 3.7 
36.2 + 8.1 42.5 + 7.5 * 42.3 + 2.8 ** 
2.8 + 0.8 2.4 ± 0.5 1.7 ± 0.0 
53.5 + 15.6 * 35.0 + 0.03 * 24.1 ± 3.6 
Spleen cells from mice immunized with VV -WR 6 days earlier were treated as shown and cultured for 20 h with 
syngeneic spleen cells infected with viruses indicated. The supernatant was harvested and frozen until assayed for 
levels of IFN-y. Results shown are expressed as ng/ml and are the mean + SD of quadruplicate wells. 
* levels of IFN-y were significantly different to those in similar cultures stimulated by VV -WR, p < 0.05, Student's t-test. 
** levels of IFN-y were significantly different to those in similar cultures stimulated by VV -WR, p < 0.005, Student's t-test. 
To determine the cells producing the enhanced levels of IFN-y in 
response to the virus encoded cytokines, responder cells were depleted 
of cell subsets before culture with the virus infected stimulator cells. 
Removal of the C04 + T cells from the responder cell population 
dramatically reduced the level of IFN-y produced in all cultures 
(Table 6.3). The levels of IFN-y in the C04-/COS+ T cell cultures were 
significantly greater in the cultures stimulated with recombinant 
viruses encoding TNF or IFN-y, compared to restimulation with wild 
type virus. Stimulation of these CD4- /COS+ T cell cultures with the 
IL-2 -encoding virus, on the other hand, did not increase levels of IFN -y 
compared to cultures stimulated with control virus. 
Cultures containing cos-/CD4+ T cell responders did not respond with 
enhanced production of IFN-y when stimulated with the IFN-y-
encoding virus, when compared to cultures stimulated with VV-WR. 
In contrast, stimulation of these cos-/C04+ cells with VV-HA-IL-2 or 
the TNF-encoding virus produced increased levels of IFNy compared to 
stimulation with the wild type virus. Cultures lacking both C04 + and 
COS+ T cells produced less than 5°/o of the IFN-y found in non-depleted 
cultures, irrespective of the stimulating virus. These results suggested 
that the increased levels of IFN-y observed following stimulation with 
the IFN-y-encoding virus was largely derived from the COS+ T cells, 
although some may be produced by the C04+ T cells. 
Removal of the asialo-GM1 + cells led to decreased IFN-y titres in 
cultures stimulated with either wild type virus (p <0.05) or the TNF- or 
IL-2-encoding viruses (p <0.005) compared to non-depleted cultures. 
Cultures stimulated with VV-IFN-y had no change in IFN-y levels, 
following removal of the asialo-GM1 +cells. 
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6.3.4 Effect of virus-encoded cytokines on proliferative response of 
responder cells 
The proliferative response of responders to stimulation by cells infected 
with the recombinant viruses was examined in order to determine 
whether this could account for the increased IFN-y production 
(Figure 6.4). The proliferation of responder cells depleted of B cells was 
greater in cultures stimulated with recombinant vaccinia viruses than 
control virus-stimulated cells (p <0.05). In cultures containing 
CD4- /CDB+ T cells, the IFN-y encoding virus stimulated enhanced 
proliferation at a low, but significant level. Both the TNF and IFN-y-
encoding viruses stimulated significantly greater proliferation of 
CDB-I CD4 + responders, compared to stimulation with the wild type 
virus. The proliferative response of responders depleted of both CD4 + 
and CDB+ T cells was barely above background levels, irrespective of the 
stimulating virus. Asialo-GM1- responder cells also had increased 
proliferation following stimulation with recombinant vaccinia viruses, 
compared to stimulation with wild type virus, indicating the 
asialo-GM1 + cells were not responsible for the increased proliferation in 
non-depleted cultures. 
6.3.5 Prolonged incubation with recombinant stimulators did not alter 
frequency of CD4+ and CDS+ Tcells 
The proliferation data presented above suggested the recombinant 
viruses may induce enhanced proliferation of specific populations of 
cells. This was further examined by analysing the frequency of CD4+ 
and CDB+ T cells in cultures after 84 h (3.5 days) incubation with 
recombinant virus infected stimulator cells. Table 6.4 shows the results 
of flow cytometric analysis of cells from two experiments. The 
percentage of CD4 + and CDB+ T cells did not vary beyond 7°/o. 
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Table 6.4 Effect of virus-encoded cytokines on CD4+ and CDB+ T cell 
frequency 
Virus 
VV-WR 
VV-HA-IL-2 
VV-HA-TNF 
VV-IFN-y 
(range) 
0lo C04 + T cells 
Exp 1. Exp.2 
30 26 
29 29 
29 22 
31 2S 
(2°lo) (7°lo) 
0lo COS+ T cells 
Exp.1 Exp.2 
27 22 
31 24 
29 22 
33 20 
( 6°lo) ( 4°lo) 
50 x 104 B-cell depleted vaccinia immune splenocytes were incubated with 
5 x 104 UV-irradiated syngeneic spleen cells infected with VV-WR or a 
recombinant virus encoding a cytokine in a total volume of 200 ~l. After 
84 h incubation, cells were transferred to a V -bottomed 96 well plate for 
antibody staining and were analysed by flow cytometry. The results given 
are frequencies of CD4 + and CD8+ T cells in all cells in the re stimulated 
cultures. 
The frequency of T cells within the cultured C04- I COS+ and cos- I C04 + 
responder populations was also examined. The responder cells were 
depleted of C04 + or COS+ T cells by incubation with antibody and C. 
This procedure was not 100°lo efficient, and contaminating cells of up to 
5°lo were considered acceptable, ie. cultures described as C04 +depleted 
(C04- I COS+) may have up to 5°lo C04+ T cells present. The cytokines 
encoded by the recombinant viruses may have stimulated the few 
contaminating cells (C04 + T cells if continuing with the above 
example), in the cultures and induced their proliferation to numbers 
which may then have been able to influence cytokine titres . Table 6.5 
shows the frequency of contaminating COS+ or C04 + T cells in cultures 
containing responder cells which had been depleted of CDS+ or CD4+ T 
cells, respectively . Following three days incubation with recombinant 
or wild type virus-infected stimulators, the difference in frequency of 
contaminating cells was within a 2°lo range . 
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Table 6.5 Recombinant vaccinia viruses did not influence T cell 
regeneration 
Virus 0/o CD4 + cells 0/o CD8+ cells 
CD4 depl. res£onders CD8 depl. responders 
before restim. 3.4 0.1 
VV-WR 3.8 0.6 
VV-HA-IL-2 5.2 1.8 
VV-HA-TNF 3.9 2.1 
VV-IFN-y 3.3 1.6 
range (restim. cells) 1.9°/o 1.5°/o 
Vaccinia immune spleen cells were depleted of B cells and CD4 + or CD8 + T 
cells, as described in 3.2.9. These responder cells were incubated with 
UV-irradiated, syngeneic spleen cells which had been infected with VV-WR 
or recombinant vaccinia viruses encoding cytokines for 1 h at 370C. 
Following an 84 h incubation at 37°C, the cells were transferred to a 96 well 
V -bottomed plate for antibody staining, resuspended in 200 J..Ll PBS and 
analysed by flow cytometry. The results given are the frequency of CD4 + or 
CDB+ T cells in all cells. 
146 
6.3.6 Restimulation with recombinant viruses encoding Th2- type 
cytokines did not down-regulate IFN-y production 
Vaccinia immune spleen cells were incubated with cells infected with 
viruses encoding IL-4 or IL-10, to examine whether the production of 
either of these factors would alter the cytokines produced by the 
responder cells. IL-4 was not detected by the IL-4 ELISA throughout the 
incubation period in any of the cultures, including wells with the 
VV-HA-IL-4 infected stimulators. IL-10 levels in culture supernatant 
were very low also, with maximal titres of 30 pg/ml in cultures 
restimulated with VV-WR, and 55 pg/ml following restimulation with 
the IL-4- or IL-10-encoding virus for 3 days (Figure 6.5). Low levels of 
these cytokines were detected in supernatant harvested from 
stimulator cells infected with the IL-4 or IL-10-encoding virus and 
cultured alone, at 5 x 1()4 cells/ml. After 40 h incubation, supernatant 
taken from UV-irradiated, VV-HA-IL-4 infected spleen cells contained 
2.6 U /ml IL-4. Supernatant harvested from UV-irradiated 
VV-HA-IL-10-infected spleen cells contained 900 pg/ml IL-10. 
Restimulation of the immune cells with the IL-10-encoding virus led 
to increased production of IFN-y (Table 6.6). The VV-HA-IL-10 had no 
effect on TNF levels compared to restimulation with wild type virus. 
The effect on IL-6 production was inconclusive, and the results are not 
shown. The proliferative response was enhanced in cultures 
stimulated with VV-HA-IL-10. 
Restimulation of the vaccinia Immune responder cells with cells 
infected with the IL-4-encoding virus resulted in enhanced secretion of 
IFN-y (Table 6.6), compared to levels stimulated by the wild type virus. 
This effect was observed in two similar experiments. Stimulation with 
VV-HA-IL-4 also led to enhanced proliferation of the responder cells 
compared to cultures stimulated with the wild type virus (Table 6.6). 
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Table 6.6 Effect of restimulation with recombinant viruses encoding IL-4 or IL-10 on cytokine production by 
vaccinia virus immune cells 
Virus Time TNF IFN-y IL-6 Proliferation 
(h) (pg/rnl) (ng/rnl) (AU /rnl) (cprn x 103) 
VV-WR 12 170 + 40 13.2 + 1.9 5.8 + 1.2 
24 260 ±50 28.6 + 6.8 18.9 + 4.6 33.9 ± 7.9 
48 510 + 160 49.3 + 4.1 21.4 + 4.9 
VV-HA-IL-10 12 200 + 10 19.4 + 2.7 * 
24 300 + 40 53+ 6 ** ND 65.0 + 11.9 * 
48 550 + 90 120 + 15 ** 
VV-HA-IL-4 12 19.4 + 3.2 * 
24 ND 60 + 10 ** ND 51.5 + 6.7 * 
48 80 + 14 ** 
Spleen cells from 6 day vaccinia immune mice were depleted of B cells and cultured with syngeneic spleen cells infected 
with the VV -WR or the IL-4- or IL-10-encoding viruses. Supernatant was harvested at the times indicated and frozen 
until assayed for cytokine titres. Results are expressed as mean+ SD of quadruplicate wells. 
* significantly different to levels in similar cultures stimulated with VV-WR, p < 0.05, Student's t-test. 
** significantly different to levels in similar cultures stimulated with VV -WR, p < 0.005, Student's t-test. 
6.4 DISCUSSION 
Recombinant vaccinia viruses which encode cytokine genes were used 
to infect naive spleen cells which were then used as the stimulatory 
population in culture with vaccinia virus immune spleen cells. The 
advantage of using this approach was that the cytokines encoded by the 
recombinant virus were produced at the site of virus presentation and 
thus, were in the immediate vicinity of the cells responding to the 
presentation of antigen. 
The cytokine gene in the vaccinia recombinants was under the control 
of the P7.5 vaccinia promotor, leading to gene expression early and late 
in the vaccinia virus replicative cycle. Genes under the control of this 
promotor were able to be expressed in the absence of DNA replication 
(Coupar et al., 1986). UV-irradiation of cells infected with recombinant 
vaccinia virus prevented replication of the virus, yet did not inhibit 
production of the virus-encoded cytokine (Table 6.1). Cytokine 
production by UV-irradiated cells infected with VV-HA-TNF or 
VV-IFN-y was rapid, with levels detected within 4 to 8 h incubation 
and reaching maximum between 16 and 24 h culture. A similar profile 
was observed following the infection of human 143B cells with 
VV -HA-IL-2 virus. Secretion of a significant amount of IL-2 was 
detected within 4 h, with maximum activity about 12 h after infection 
(Ramshaw et al., 1987). 
Stimulation of vaccinia immune cells with a TNF-encoding virus led 
to a threefold increase in TNF production by the responder cells, 
compared to cultures stimulated with either the wild type or IFN-y-
encoding virus (Table 6.2). The increase was 2.5 times that which could 
be attributed to the TNF produced by the recombinant virus, indicating 
that the viral-encoded TNF was stimulating the production of 
enhanced levels of TNF. A u toind uction of cytokine expression has 
been reported for several monokines and growth factors, including 
TNF. Recombinant TNF added to cultures of human monocytes 
increased their cytotoxic activity on the TNF sensitive cell-line 
WEHI-164 (Philip and Epstein, 1986), while recombinant TNF added to 
murine bone marrow-derived macrophages induced the production of 
TNF mRNA (Descoteaux and Matlashewski, 1990). 
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Removal of the CDB+ T cells did not affect the increased TNF levels 
stimulated by the TNF-encoding virus, indicating the majority of TNF 
was not produced by these cells types in agreement with the results in 
Chapter 4. The asialo-GM1 +cells were not responsible for the enhanced 
TNF production either, as removal of these cells did not affect the TNF 
levels. A further increase in TNF levels was observed in cultures 
lacking CD4 + T cells, suggesting that that these cells had a negative 
regulatory activity on TNF production. However, in cultures 
stimulated with the TNF-encoding virus, the regulatory activity of the 
CD4 + T cells was not directed against the CDB+ T cell TNF production, 
as was observed in Chapter 4. This was demonstrated by the continued 
high levels of TNF in cultures lacking both CD4+ and CDB+ T cells, 
which was not seen following restimulation with the wild type 
vacc1rua vuus. Thus, the source of enhanced TNF induced by the 
virus-encoded TNF was neither a CD4+, CDB+ or asialo-GM1 +cell. 
These results and the studies by Philip and Epstein (1986) and 
Descoteaux and Matlashewski (1990) point to the 
macrophage/monocyte cells in the responder cell population as the 
source of the enhanced TNF. However, these experiments do not rule 
out the possibility that another population of CD4- I CDB- T cells, 
possibly y I 8 T cells, may be induced to produce this factor. In mice 
infected with influenza virus, cells expressing TCR-y I 8 mRNA were 
prevalent at the site of inflammation late in the course of infection 
(Carding et al., 1990). Using in situ hybridization, Carding et al. (1993) 
also demonstrated that y I 8 T cells isolated from influenza virus-
infected mouse lung expressed mRNA for a number of cytokines . 
49°/o of the y I 8 T cells expressed mRNA for IFN-y and 27°/o expressed LT 
(TNF-P) mRNA. The numbers of y/8-TCR+ T cells were also shown to 
be elevated in the spleen of mice during infection with Ectromelia 
virus (Karupiah et al., 1993). There is also another population of CD3+ 
CD4- /CDB- T cells present in the spleens of mice infected with vaccinia 
virus. In contrast to the influenza system, these cells express message 
for the a/ P TCR chain, with no evidence for the y I 8 TCR chain. These 
cells have antiviral activity in vivo, as the transfer of CD4-/CDB- T 
cells to scid mice allows the mice to resolve virus infection (J. Ruby, 
personal communication). The contribution of these cells to the 
antiviral response is unclear, however, they are a potential source of 
cytokines in this in vitro model. 
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Stimulation with VV-HA-TNF also led to increased levels of IFN-y 
compared to stimulation with wild type virus (Table 6.3) in all cultures 
except those lacking T cells. The virus-encoded TNF required the 
presence of both CD4 + and CD8+ cells to stimulate increased IFN-y 
production. Whether the CD4+ or CD8+ T cells were producing the 
IFN-y, or were required for another population to produce the cytokine, 
is unclear. Treatment of the responder population with asialo-GM1 
antibody substantially reduced the IFN-y response, indicating that these 
cells were a major source of the IFN-y induced by the TNF virus. 
Bancroft et al. (1989) demonstrated that the production of IFN-y by NK 
cells isolated from scid mice was dependent on TNF. However, 
recombinant TNF alone was not sufficient to stimulate NK cell 
production of IFN-y (Wherry et al., 1991) and IL-2 induced maximum 
production of IFN-y in response to TNF or IL-12 (Tripp et al., 1993). 
This would explain the lack of IFN-y in the T cell depleted cultures, 
where NK cells may require a T -cell derived stimulus as well as TNF to 
produce IFN -y. 
Stimulation of the immune responder cells with the IFN-y- or IL-2-
encoding virus did not significantly alter TNF levels compared to those 
seen in cultures stimulated with wild type virus, with one exception. 
Responders depleted of the asialo-GM1 +cells cultured with VV-IFN-y 
secreted increased levels of TNF. Anti-asialo-GM1 was used to deplete 
NK cells from the vaccinia immune spleen cells (Kasai et al., 1980), 
although this antibody may have activity against other cell types, 
including T cells (Stein et al., 1978). The increase in TNF levels 
observed following the removal of these cells may indicate that IFN-y 
may negatively regulate TNF production by NK cells. IFN-y has been 
implicated in the negative feedback control of TNF in an in vivo study 
which demonstrated that serum TNF levels in LPS treated mice were 
higher in animals pretreated with antibody to IFN-y (Doherty et al., 
1992). 
IFN-y did not appear to be the mediator of the negative regulatory effect 
of the CD4 + T cells on TNF production. Cultures lacking CD4 + T cells 
and stimulated with wild type virus-infected cells had increased levels 
of TNF The increase in TNF was also observed in CD4- T cell cultures 
stimulated with the IL-2- or IFN-y-encoding virus (Table 6.2) . In 
addition, in results presented in Chapter 5, high levels of IL-2 added to 
CD4- T cell cultures restored the production of IFN-y. However, levels 
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of TNF remained unchanged (Table 5.10) . The results from the 
recombinant virus studies and work presented in Chapter 5 indicate 
that neither IL-2 nor IFN-y mediated the CD4+ T cell negative 
regulation of TNF production. 
The production of low levels of IFN-y by the stimulator cells infected 
with the IFN-y encoding virus augmented the production of IFN-y by 
the responder cells (Figure 6.3 and Table 6.3). This finding is in 
agreement with studies where the addition of recombinant IFN-y to 
murine splenocyte cultures led to increased expression of IFN-y mRNA 
within 2 h, with maximal induction requiring 8 to 12 h culture 
(Cockfield et al., 1993). A similar result was observed with human 
peripheral blood lymphocytes (Hardy and Sawada, 1989). Cultures 
lacking CD8+ T cells did not respond to the VV-IFN-y stimulation with 
enhanced IFN-y production (Table 6.3), thus the enhanced levels of 
IFN-y following stimulation with the virus encoding this factor, were 
largely derived from CD8+ T cells. The increased IFN-y in cultures 
stimulated with the IFN-y encoding viruses did not appear to be 
derived from NK cells as the removal of asialo-GM1 + cells did not 
reduce IFN-y titres. 
The use of VV-HA-IL-2 as a stimulating v1rus also significantly 
enhanced IFN-y production from the vaccinia immune responder cells. 
IFN -y secretion by these cells has been shown to be enhanced upon the 
addition of an exogenous source of IL-2, as described in the previous 
chapter. IL-2 has an important role in augmenting IFN-y synthesis by 
activated T cells (Reem and Yeh, 1984). IL-2 is also a potent stimulator 
of murine NK cells (Henney et al., 1981) and enhances NK cell 
production of IFN-y (Tripp et al., 1993). Studies examining the growth 
of the recombinant vaccinia virus encoding IL-2 have shown the IL-2 
acts on NK cells to enhance their antiviral response (Karupiah et al., 
1991). This is mediated through host-derived IFN-y, as demonstrated 
by administration of mAb against this cytokine (Karupiah et al., 1990b ). 
The work presented in the in vitro study described here would suggest 
the virus-encoded IL-2 enhanced secretion of IFN-y from both the 
C D4 + T cells and the asialo-GM1 + cells (NK cells), as enhanced 
production of IFN-y was not seen in cultures depleted of these cells . 
However, the previous chapter demonstrated that high levels of 
exogenous IL-2 could restore the IFN-y producing ability of responder 
cells depleted of CD4+ or asialo-GM1 + cells. This may indicate that 
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virus-encoded IL-2 produced at the site of antigenic stimulation acted 
upon a different population(s) of cells compared to the exogenous IL-2 
source. 
It may be argued that the augmented cytokine production in cultures 
stimulated with recombinant viruses is due to an increased level of cell 
proliferation caused by the virus-encoded cytokine. Indeed, 
proliferation was significantly increased in cultures of responder cells 
stimulated with most recombinant viruses (Figure 6.4 and Table 6.6). 
However, there was not always a direct correlation between increased 
proliferation and increased cytokine levels. For example, COB+ T cell 
depleted responders had a higher level of proliferation when 
stimulated with VV-IFN-y, compared to the same cells stimulated with 
the wild type virus (Figure 6.4). The IFN-y levels following stimulation 
with these viruses, however, were not significantly different (36 ng/ml 
vs 32 ng/ml, Table 6.3). In another example, these same cells 
stimulated with VV-HA-IL-2 did not have increased proliferation but 
did secrete significantly enhanced levels of IFN-y. Therefore, increased 
proliferation may account in part for the augmented cytokine levels, 
however, this was not the only factor involved. Furthermore, 
increased cytokine levels were observed in some recombinant 
stimulated cultures within B h of culture, eg. IFN-y levels following 
restimulation with VV-HA-TNF (Figure 6.3). This increase occurred 
before substantial cell division would have taken place. Removal of 
the COB+ T cells led to a decrease in proliferation in cultures stimulated 
with all viruses, while a more dramatic decrease in proliferation was 
observed in cultures lacking C04+ T cells. This indicates that both these 
cell types proliferated in response to restimulation with virus infected 
cells. However, the poor proliferative response of COB+ T cells in the 
absence of C04 + T cells suggests that some interaction is occuring 
between these cell populations. The only significant increase in 
proliferation among the COB+ I C04- cells was among those cells 
stimulated with the IFN-y-encoding virus . Novelli et al. (1991) 
demonstrated that the activation of human T cells was inhibited by 
antibodies to IFN-y, indicating that IFN-y is a critical signal in the early 
phases of T cell proliferative responses. Thus, a possible candidate for 
the molecule required by the COB+ cells is IFN-y, which was also 
decreased in those cultures lacking C04 + T cells . The increased 
proliferation in VV-IFN-y stimulated cultures was low, which may 
reflect the low level of IFN-y produced by the VV -IFN-y infected 
153 
stimulators, ie. less than 5°/o of the IFN-y levels in cultures of non-
depleted responder cells stimulated with wild type virus. The 
expression of different cytokines did not selectively stimulate the 
proliferation of sub-types of T cells as the ratio of CD4 + to cos+ T cells 
within the cells in culture did not change after 3 days incubation 
(Table 6.4). 
The analysis of CD4 + and COS+ frequencies among the responder 
population accounted for only 60°/o of the cells (Table 6.4). The 
responder cells had been depleted of B cells by incubation with Jlld 
hybridoma supernatant and C. The phenotype of the remaining 40°/o of 
cells, the non-CD4+ /COS+ cells, was not determined. However, these 
cells made a significant contribution to cytokine levels. IL-6 and TNF 
were produced by non T cells which were plastic adherent. These cells 
are believed to be macrophages and monocytes. NK cells and 
CD4-;cos-T cells (a/~ TCR+, as discussed earlier) would make up a 
proportion of these non-defined cells. The TNF production of these 
cells was potently stimulated by the TNF-encoding virus. 
It has been suggested that the cytokines present at the initiation of an 
immune response will determine the subsequent production of either 
a Thl- or Th2-type of response (Romagnani, 1992). There is clear 
evidence of the importance of certain cytokines in the regulation of the 
response to infection with L. major in mice. Treatment of resistant 
mice with an anti-IFN-y antibody led to increased susceptibility (Scott, 
1991), whereas treatment of BALB/ c susceptible mice with anti-IL-4 
antibody allowed them to develop a healing Th1-type response 
(Chatelain et al., 1992). To examine whether the presence of Th2 type 
cytokines at the initiation of the response would alter the cytokine 
production of the restimulated vaccinia immune cells towards a Th2 
profile, the responders were cultured with cells infected with either the 
IL-4- or IL-10-encoding virus. Supernatant harvested from cultures of 
UV-irradiated VV-HA-IL-4 or VV-HA-IL-10 infected stimulator cells 
contained barely detectable levels of the encoded factors . This contrasts 
with high levels of cytokine produced by 143B cells infected with these 
viruses (D. Sharma, personal communication) . The reason for this is 
unknown, but may be a reflection of utilization of the cytokine by the 
responder cells, or the effect of UV-irradiation treatment of the virus 
infected cells . However, these recombinant viruses did have an effect 
when used as the stimulatory virus in culture with immune responder 
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cells. The results suggest that stimulation with the recombinant 
viruses encoding these Th2-type cytokines was not able to redirect the 
response of the immune cells (Table 6.6). In fact, restimulation of the 
immune cells with these recombinant viruses induced the production 
of 2 to 3 times the level of IFN-y, compared to levels stimulated by 
VV-WR infected cells. The effect of these Th2 virus-encoded cytokines 
on the production of TNF and IL-6 was not so clear. Proliferation of the 
immune cells was also increased when cultured with the IL-4- or IL-10-
encoding viruses. 
IL-4 and IL-10 are produced by Th2-type cells which are able to down-
regulate production of Th1-type cytokines (Fiorentino et al., 1989; 
Mosmann et al., 1986). However, stimulation of the vaccinia immune 
spleen cells with these viruses actually led to an increase in IFN-y titres. 
IL-4 was not able to be detected in the culture supernatant throughout 
the incubation period. IL-10 was detected, but significant levels were 
not reached until 24 h of culture, by which time IFN-y levels were close 
to maximal. The responder cells had been taken from mice primed 
with vaccinia virus, a type of infection that induces specific immune 
responses of the Th1-type. This is achieved through direct stimulation 
of NK cells to produce IFN-y (Romagnani, 1992), or through induction 
of macrophage derived-IFN-a and IL-12, which in turn stimulate NK 
cell IFN-y production (Tripp et al., 1993). The responder cells also 
contain a significant number of activated COB+ T cells which may have 
been producing IFN-y, as the spleens were removed at the height of the 
CTL response to the vaccinia infection (Ruby et al., 1993). This priming 
towards a Th1 response may have prevented the virus-encoded IL-4 
and IL-10 altering the cytokines produced by the vaccinia immune cells. 
The reason for the increased IFN-y levels in the presence of the IL-4- or 
IL-10-encoding virus is unknown, although it has been demonstrated 
that IL-4 plays a role in the generation of secondary allo-CTL (Suzuki et 
al., 1992). 
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6.5 SUMMARY 
This chapter examined the effect of virus-encoded cytokine production, 
at the site of antigenic stimulation, on the production of TNF and 
IFN-y. UV-irradiation of the recombinant virus-infected stimulator 
cells did not inhibit the rapid production and release of virus-encoded 
cytokines into culture supernatant. Restimulation of vaccinia virus 
immune cells with the TNF-encoding virus induced enhanced 
production of TNF and IFN-y, compared to cells restimulated with the 
wild type virus. The virus-encoded TNF stimulated increased 
production of TNF by a non-CD4+ /CDB+ cell, whereas the increased 
IFN -y production was T cell dependent. CDB+ T cells among the 
responder cells were stimulated to produce enhanced levels of IFN-y 
when incubated with stimulators infected with the IFN-y-encoding 
virus. Virus-encoded IL-2 acted on the CD4 + and asialo-GM1 + cells to 
enhance their production of IFN-y. Restimulation of vaccinia virus 
immune cells with recombinant viruses encoding IL-l 0 or IL-4 did not 
influence the cytokine response towards production of Th2 cytokines, 
rather, increased levels of IFN-y were observed. 
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Figure 6.1 Time course of cytokine production by stimulator cells 
infected with vaccinia virus encoding cytokine genes 
48 
B cell depleted spleen cells taken from naive mice were infected with 
VV-HA-TNF or VV-IFN-y at 10 pfu/ml for 1 h at 37°C. After two 
washes and 5 min UV-irradiation, the cells were made up to a 
concentration of 5 x 10s cells/ml. 200 Jll volumes were placed in the 
wells of 96 well plates and these were incubated at 37°C. Supernatant 
from four wells was harvested at each time point and frozen until 
assayed for cytokine levels. The data is presented as mean ±. SD of 
quadruplicate wells . 
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Figure 6.2 Time course of TNF production by virus immune spleen 
cells cultured with recombinant vaccinia virus infected cells. 
Stimulator cells were prepared by infecting naive B-cell depleted spleen 
cells with either wild type vaccinia virus (VV-WR) or a recombinant 
vaccinia virus encoding a cytokine gene. Following 1 h incubation at 
37°C, these cells were UV-irradiated and then incubated, at 37oc in a 
humidified atmosphere in 200 J.ll volumes, with B cell depleted spleen 
cells from 6 day vaccinia virus immune mice. Supernatant was 
harvested at the times indicated. The data is presented as pg/ml, on a 
log scale, and is expressed as mean + SD of quadruplicate wells. 
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Figure 6.3 Time course of IFN-y production by virus immune spleen 
cells cultured with recombinant vaccinia virus infected cells. 
Stimulator cells were prepared by infecting naive B cell depleted spleen 
cells with either wild type vaccinia virus (VV-WR) or a recombinant 
vaccinia virus encoding a cytokine gene. Following 1 h incubation at 
37°C, these cells were UV-irradiated and then incubated, at 37oc in a 
humidified atmosphere in 200 j..tl volumes, with B cell depleted spleen 
cells from 6 day vaccinia virus immune mice. Supernatant was 
harvested at the times indicated. The data is presented as ng/ml, on a 
log scale, and is expressed as mean+ SD of quadruplicate wells. 
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Figure 6.4 Proliferative response of virus immune cells stimulated 
with recombinant vaccinia virus infected spleen cells 
Responder cells were prepared by taking spleens from 6 day VV -WR 
immune mice and depleting of specific cell subsets by incubating with 
antibody and complement. These cells were incubated with virus 
infected stimulator cells for 48 hat 37oc. The viruses used to infect the 
stimulators are shown in the figure. Incorporation of [3H]-TdR during 
the final 4 h of culture was determined. The data is shown as the mean 
+ SD of quadruplicate wells. 
* significant, p< 0.05, Student's t-test 
** significant, p<O.OOS, Student's t-test 
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Figure 6.5 Time course of IL-10 production by restimulated vaccinia 
virus immune spleen cells 
B cell depleted spleen cells from m1ce injected with VV-WR 6 days 
earlier were incubated with syngeneic spleen cells infected with VV-
WR or an IL-4- or IL-10-encoding recombinant virus. Supernatant was 
harvested from individual wells throughout the 72 h incubation 
period and assayed for IL-10 by an ELISA. The data is presented on a log 
scale as pg/ml and is expressed as mean+ SD of quadruplicate wells. 
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CHAPTER7 
Discussion and future directions 
T lymphocytes attracted to the site of virus replication play a crucial 
role in the control and recovery from the infection (Blanden, 1974). 
These cells can be direct! y cytolytic and release cytokines that are 
involved in the recruitment of other cell populations. Many of the 
recruited cells in turn are able to secrete cytokines, including IFN-y and 
TNF, both of which have antiviral activity. Recovery from a pox virus 
infection is dependent on the development of virus-specific class-I-
restricted CTLs. The mechanism of action of these CD8+ cytotoxic T 
cells in virus elimination has always been assumed to be direct cytolytic 
destruction of the virus infected cells, as can be demonstrated in in 
vitro studies. On the other hand, there are reports that demonstrated 
that soluble factors may be important in antiviral protection 
(Lehmann-Grube et al., 1988). The antiviral activity of a number of 
cytokines has been clearly demonstrated in in vitro studies. IFN-y, a 
product of activated lymphocytes, was first defined by its antiviral effect 
in vitro (Wheelock and Toy, 1973). TNF exhibits potent antiviral 
activity in vitro, which may be mediated in part by IFN-~ (Mestan et al., 
1986). The antiviral activity of TNF is dramatically enhanced in 
synergy with both IFN-~ and IFN-y (Wong and Goeddel, 1986). TNF is 
able to enhance the induction of an antiviral state in uninfected cells 
~nd selectively kill virus-infected cells (Wong and Goeddel, 1986). 
IFN-y has been demonstrated to be essential for virus clearance in vivo 
as treatment with specific mAb against IFN-y prevents mice from 
clearing the virus (Karupiah et al., 1993; Klavinskis et al., 1989; Ruby 
and Ramshaw, 1991). IFN-y also activates NK cells and macrophages 
which are themselves able to produce the antiviral cytokines IFN-y and 
TNF. Thus, cytokines may play an important direct role in antiviral 
immunity as well as having immunoregulatory functions . 
Chapter 3 of this thesis described the establishment of an zn vitro 
model to examine the production of antiviral cytokines during an 
immune response. Using this model, the cells in the vaccinia virus 
immune responder population which produced the antiviral cytokines 
TNF, IL-6 and IFN-y were identified. The following table summarises 
these results. 
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Table 7.1 Phenotype of cytokine producing cells 
Cytokine Cell producing 
cytokine 
TNF Adherent cells 
Some by CDB+ T cells 
IL-6 Adherent cells 
IFN-y T cell 
Further observations 
Negative regulation by CD4+ T 
cells 
Majority dependent on CD4+ T 
cells 
Adherent cells may play a role 
The adherent cells among the splenocytes isolated from mice at the 
peak of the CTL response rapidly produced TNF and IL-6 upon contact 
with virus antigen. This indicates that the splenocytes contained a 
population of activated macrophages which may have an important 
function in restricting viral growth in vivo. The macrophages went 
through a process of de-activation prior to three weeks post infection. 
Macrophages play a major role in maintaining homeostasis. These 
cells can recognise, phagocytose and ultimately dispose of dead cells, 
cellular debris and invading organisms (Fidler and Schroit, 1988). 
Those functions which macrophages perform continuously, such as 
removal of dead cells, do not require regulation by other cells . 
However, functions which occur infrequently, such as participation in 
host defense against virus infection, require a process of recruitment 
and activation. Once the viral infection is resolved however, the cells 
revert to the non-activated state. Viral infections are known to elicit 
an inflammatory response, including an accumulation of 
mononuclear phagocytic cells (Allison, 1974). The accumulation of 
these cells at the site of a virus infection is enhanced by release of both 
immunologically specific and non-specific chemotactic factors (Allison, 
1974). The immunologically specific factors include cytokines released 
by T cells, which have also been drawn in to the site of infection 
(Blanden, 1982). Upon interaction with antigen, T cells produce IFN-y 
which is an important priming cytokine of macrophages for activation 
of killing microorganisms (Morris et al., 1982; Russell, 1986). Although 
IFN-y alone cannot activate the macrophages, it is likely that the T cells 
also provide the activating signal, which can be fulfilled by TNF (Stout, 
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1993). Activated macrophages are able to secrete a number of factors 
with antiviral activities, including TNF (Wong and Goeddel, 19S6) and 
nitric oxide (Karupiah et al., 1993). An advantage of these molecules as 
antiviral agents is that their action is independent of immune 
recognition of the infected cell, as demonstrated by the production of 
TNF in response to HSV infected cells. Thus, a rapid antiviral 
response is ensured. 
An important finding of the work presented is that C04+ T cells 
isolated from vaccinia virus immune spleen cells were the major 
producers of IFN-y upon restimulation. That IFN-y is essential for 
clearance of some viruses, including vaccinia virus, has recently been 
demonstrated using mice lacking the IFN-y receptor gene (Huang et al., 
1993). Although these mice appeared to develop a normal immune 
system with normal cytotoxic and T helper cell responses, they had 
increased susceptibility to vaccinia virus infection. There are a number 
of reports demonstrating the control of virus infection by C04 + T cells, 
in the absence of COS+ T cells. For example, the transfer of measles 
virus-specific C04 + T cells is sufficient to control an intracerebral 
measles virus infection (Reich et al., 1992). These cells secreted IFN-y 
and IL-2 in vitro following antigen restimulation, typical of a Th1 
response. Influenza virus is cleared from the lungs of mice depleted of 
COS+ T cells, and also from ~2 microglobulin (~2-m) gene disrupted 
mice which do not develop COS+, a~ T cells (Eichelberger et al., 1991). 
These ~2-m (-I-) mice are also capable of resolving infection with 
vaccinia virus and Sendai virus (Hou et al., 1992; Spriggs et al., 1992). 
The mechanism by which the C04+ cells mediate their antiviral 
effectivity is unknown, although the ability of the vaccinia virus 
immune C04 + T cells to produce IFN-y clearly points to this being a 
possible factor. The specific recruitment and activation of macrophages 
by C04+ T cells may also be an important factor in the elimination of 
VlrUS. 
In order to study the network of cytokines interacting in -the generation 
of antiviral cytokines, endogenous cytokines were neutralized using 
specific antibodies. The results are summarised in the following table. 
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Table 7.2 Summary of cytokine interactions using monoclonal 
antibodies to neutralize specific endogenous cytokines 
Cytokine TNF 
neutralized levels 
IL-2 Increase 
(40°/o) 
TNF ND 
IL-6 Decrease 
(40°/o) 
IL-4 Decrease 
(30°/o) 
IL-10 no change 
IFN-y 
levels 
Decrease 
(60°/o) 
Decrease 
(30- 60°/o) 
Increase 
(100°/o) 
Decrease 
(25°/o) 
no change 
IL-6 
levels 
ND 
no change 
ND 
ND 
ND 
Neutralization of endogenous IL-2 led to a dramatic decrease in IFN-y 
production by the vaccinia virus immune cells, indicating the 
important role that IL-2 plays in the production of IFN-y. IL-2 is 
thought to have a key role in immune responses as it is a major T cell 
growth factor (Smith, 19SS). It was further demonstrated that IL-2 was a 
limiting factor in IFN-y production in this model, by the increase in 
IFN-y levels following the addition of recombinant IL-2 or stimulation 
with the IL-2 encoding virus. These results are presented in Table 7.3, 
which summarises the effects of adding recombinant cytokine to 
immune cells cultures or stimulating the immune cells with 
recombinant vaccinia viruses which encode cytokine genes. IL-2 has 
been demonstrated to induce or enhance IFN-y production in both 
primary and secondary cultures (Farrar et al., 19S1; Kelso et al., 19S4; 
Yamamoto et al., 19S2). The COS+ T cells among the virus immune 
cells responded to the recombinant IL-2 with increased IFN-y 
production. COS+ T cells have been shown to be the major producers 
of IFN-y in a vaccinia virus infection, in vivo (Ruby et al., 1993) . 
However, IL-2 may not be a limiting factor in primary virus infections. 
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Table 7.3 Summary of cytokine interactions using recombinant 
cytokine material or vaccinia virus encoding cytokine genes to expose 
virus immune cells to an exogenous source of cytokines 
Cytokine TNF Cells 
affected 
Recombinant TNF no change 
Virus-encoded Increase CD4-/CD8-
TNF (100°/o) 
Recombinant IL-2 no change 
Virus-encoded IL-2 no change 
Virus-encoded no change 
IFN-y 
Virus-encoded IL-4 NO 
Virus-encoded IL-
10 
no change 
IFN-y 
no change 
Increase 
(60°/o) 
Increase 
(100°/o) 
Increase 
(25°/o) 
Increase 
(40°/o) 
Increase 
( 60°/o) 
Increase 
(100°/o) 
Cells 
affected 
CD4+, 
CD8+ 
CD8+T 
CD4+ I 
asialo-
GMl+ 
CD8+ 
NO 
NO 
The action of the IL-2 encoding virus can be regarded as an example of 
paracrine activity, a common phenomena of cytokine interactions 
(Balkwill and Burke, 1989). The virus-encoded IL-2 acted on CD4 + T 
cells and asialo-GM1 +cells to enhance their production of IFN-y. T cell 
cytokines function mainly as paracrine hormones, being both produced 
and consumed at the site of immune reaction (Kelso, 1989). Such a 
mechanism ensures the response generated by the cytokine acts in the 
region where it is required, and minimizes the amount of cytokine 
needed. Resting T cells neither produce, nor respond to, IL-2. Upon 
receiving the signal from the T cell antigen-receptor complex, the 
T cells begin transcription of both the IL-2 and the IL-2R genes. IL-2 
produced by the T cell can then bind directly to IL-2R present on the 
cell. The cell will enter a phase of DNA replication only when a critical 
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threshold of triggered IL-2 receptors has accumulated (reviewed by 
Smith, 1988). Therefore, the IL-2 produced by T cells, or the IL-2 
encoding virus, acts in an autocrine manner to enhance proliferation 
and cytokine secretion of T cells, particularly of CD4+ T cells. These 
cells secrete a panel of cytokines which act to recruit more cells to the 
site and dictate the type of response elicited eg. a cell-mediated or 
humoral response. The NK cell production of IFN-y, which is able to 
induce an antiviral state in uninfected cells (Staeheli, 1990), is 
upregulated by the IL-2 secreted by T cells. 
The in vitro model of immune cell restimulation demonstrated other 
examples of the paracrine and autocrine action of cytokines. TNF was 
shown to play a role in the production of IFN-y as neutralization of 
TNF led to a decrease in IFN-y levels, whereas stimulation with a TNF-
encoding virus enhanced IFN-y production. The ability of TNF to 
induce production of IFN-y allows for a more aggressive response to 
virus infection. As shown earlier, TNF was released by activated 
macrophages upon contact with antigen. The production of both IFN-y 
and TNF at one site will also act to further increase the numbers of 
activated macrophages. IFN-y acts on macrophages to increase the 
expression of receptors for TNF (Ruggiero et al., 1986; Tsujimoto et al., 
1986). TNF produced by the macrophages in response to viral antigen 
can then act in an autocrine fashion, amplifying cytokine secretion and 
beginning the signal cascade leading to antimicrobial effector functions, 
such as nitric oxide production (Langermans et al., 1992; Stout, 1993). 
The co-ordinated TNF /IFN-y production by the immune cells would be 
particularly effective in a response to virus infection. Not only do 
these cytokines have antiviral activity individually (Mestan et al., 1986; 
Wheelock and Toy, 1973), these cytokines also have demonstrated 
synergistic antiviral activity (Wong and Goeddel, 1986). 
The TNF- and the IFN-y-encoding recombinant vaccinia viruses were 
able to stimulate enhanced levels of TNF and IFN-y production, 
respectively. Auto-induction has been described for a number of 
cytokines, including IL-6, IL-l, TNF and IFN-y (Hardy and Sawada, 1989; 
Miyaura et al., 1989; Philip and Epstein, 1986; Warner et al., 1987) . 
Autoamplification allows a cytokine produced by a particular cell to 
induce further production of the same cytokine by the original cell or 
bystander cells. Autoamplificaton of TNF may be an advantage to the 
host in a virus infection. TNF produced by activated macrophages 
167 
upon contact with viral antigen could upregulate its own expression 
and allow rapid production of high concentrations of TNF. This may 
then bring about local changes which are a prerequisite for the 
recruitment and activation of immunocompetent cells. For example, 
TNF induces the expression of cell adhesion molecules, such as 
ELAM-1, VCAM-1 and ICAM-1, at the surface of endothelial cells 
which could then function to arrest circulating lymphocytes at the site 
of infection (Bevilacqua et al., 1987; Osborn et al., 1989; Pober et al., 
1986). TNF could also enhance antiviral mechanisms by up-regulation 
of class I MHC expression which would result in more efficient action 
of antigen-specific CTL recruited from the circulation (Bukowski and 
Welsh, 1985; Lapierre et al., 1988). TNF may also act directly by 
inducing resistance to viral infection in uninfected cells at the site. The 
amplification of IFN-y production by the IFN-y encoding virus 
specifically acted on CD8+ T cells. This may be of particular relevance 
in a response to virus infection, where CD8+ cells are the main IFN-y 
producing cells at the height of the CTL response to primary infection 
(Ruby, 1993). As well as inducing an antiviral state in uninfected cells, 
the presence of IFN-y would induce greater expression of MHC and 
thus allow increased display of antigenic peptides and increase the 
efficiency of CTL. 
Mechanisms exist to amplify cytokine responses, for example auto- and 
paracrine induction of cytokine expression, as discussed above. 
However, mechanisms must also exist to down-regulate and limit 
cytokine expression to maintain a balance within the cytokine network. 
It is apparent that when cytokine production is sustained and/ or 
systemic, the cytokine contributes to the signs, symptoms and 
pathology of infectious and autoimmune diseases, as has been 
described for TNF (Balkwill, 1988; Beutler and Cerami, 1986). CD4+ T 
cells among the virus immune responder cell population had a 
negative influence on TNF production, as the removal of these cells 
led to an increase in TNF levels. Thus, these cells provided some 
mechanism to limit TNF levels within the cultures. The nature of this 
regulatory mechanism was not determined, although it was possibly a 
CD4 + T cell-derived cytokine. Several cytokines produced by CD4 + T 
cells have immunosuppressive activity. IL-4, IL-10 and TGF-~ are able 
to down-regulate macrophage functions involved in the effector phase 
of cell-mediated immunity (Sher et al., 1992), and IL-4 and IL-10 have 
demonstrated ability to down-regulate or inhibit TNF expression by 
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macrophages (Fiorentino, 1991b ). In contrast to these results , 
neutralization of IL-10 or stimulation of vaccinia virus immune cells 
with the IL-10 encoding virus had no significant effect on TNF 
production, while neutralization of IL-4 led to decreased TNF levels. 
This indicates that IL-4 and IL-10 were not involved in the negative 
regulation of TNF in these restimulated cultures of vaccinia virus 
immune cells. 
Several of the major findings described above can now be drawn 
together to provide a simple model describing the cellular interaction 
in the production of cytokines by restimulated virus immune T cells. 
CD4 + T cells were the major producer of IFN-y and exerted a negative 
influence on TNF production by CDB+ T cells. IFN-y production by 
CDB+ T cells was dependent on IL-2 and was enhanced by IFN-y. As 
CD4 + T cells produced both IL-2 and IFN-y upon restimulation, these 
cells play a central role in regulation of cytokine production. 
...... 
... 
...... 
...... 
... 
TNF 
IFN- y 
IFN- y 
-----t .. ~ positive regulation 
- - - .. negative regulation 
Figure 7.1. CD4+ T cell regulation of antiviral cytokine production by 
CDB+ T cells. 
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The Th1 and Th2 pattern of cytokine production was originally 
described using a panel of long-term mouse T helper cell clones. These 
two phenotypes have been confirmed in strong mouse immune 
responses and are mutually inhibitory (Mosmann and Coffman, 
1989a). IFN-y inhibits growth of Th2 cells, and IL-10 inhibits the 
synthesis of Th1 cytokines. An IL-4 encoding recombinant vaccinia 
virus is lethal when injected into normal female mice. The mice had a 
decreased CTL response indicating the IL-4 acted on the immune 
regulation of CTL activation and expansion (Andrew and Coupar, 
1992). Restimulation of the wild type vaccinia immune cells with 
either the IL-4- or IL-10-encoding virus did not, however, alter the 
pattern of cytokine production of the virus immune cells. Increased 
levels of IFN-y were produced in these cultures compared to cultures 
restimulated with wild type virus. Thus, the Th2 cytokine produced by 
the restimulating virus was not able to divert the IFN-y producing 
cells. This may reflect the fact that the cells undergoing restimulation 
were taken from mice at the peak of the CTL response to vaccinia virus 
infection. A vaccinia virus infection leads to the production of Th1 
phenotype, thus the cultured cells may have already committed to the 
Th1 phenotype. The results indicate the process of restimulation only 
activates cells to continue along this line of differentiation. 
The process of T cell activation requires that naive T cells receive two 
signals from the antigen presenting cell. The first signal is binding of 
antigen to the T cell receptor (Lafferty, 1977). The second is provided by 
the interaction of ligands on the surface of APC to specific counter 
receptors on the T cell (Liu and Linsley, 1992). In a secondary response, 
the costimulatory signals are able to be provided by bystander cells 
(Jenkins et al., 1988). In the model described, UV -irradiation of 
stimulator cells led to an increase in slope of cell number-dose 
response plots, compared to stimulation with viable cells. The 
increase in slope is indicative of cellular interaction among the 
responder cell population in the generation of the proliferative 
response. This suggests the UV-irradiated vaccinia virus-infected 
stimulator cells were not able to provide the costimulatory signals to 
the responder cells and that, as this was a secondary response, 
bystander cells among the immune responder cell population could 
provide the necessary signals. The receptor for vaccinia virus is 
thought to be the epidermal growth factor receptor (EGF-R) (Eppstein 
et al., 1985), and thus, vaccinia virus is able to infect a wide variety of 
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cell types, including fibroblasts, endothelial cells and epithelial cells in 
vtvo. However, costimulatory molecules, such as B7, heat stable 
antigen (HSA) are found on the surface of specialised antigen 
presenting cells. The results of this study would indicate that in the 
absence of costimulatory surface molecules on the virus infected cells, 
bystander cells are able to present the costimulatory signals to the 
activated T cells. The nature of the signal provided by the bystander 
responder cells was not investigated. 
Future Directions 
Using the in vitro model described here it would be possible to further 
investigate the nature of the costimulatory signals required by the 
immune cells to respond to virus presentation with cytokine secretion. 
Responder cell interaction was analysed by plotting cell number-
response lines, with the slope giving an indication of the requirement 
for interaction. A slope of 1 indicated all the necessary stimulatory 
signals were provided by the antigen presenting cells. An increase in 
slope revealed responder cell interaction to provide signals which were 
lacking, such as was observed in cultures stimulated with UV-
irradiated virus infected cells. A variety of recombinant vaccinia virus 
constructs are available. These viruses encode cytokines or molecules 
which may be necessary as costimulatory signals, such as B7 or CD40 
ligand. The work presented in Chapter 6 of this thesis indicates that 
recombinant vaccinia virus continue to produce the recombinant 
protein following UV-irradiation. Thus, it would be possible to infect 
naive spleen cells with a vaccinia virus recombinant and UV-irradiate, 
as described in Chapter 2. Cell number-response analysis of cultures 
stimulated with these cells would indicate whether the encoded gene 
replaced a need for responder cell interaction in the generation of a 
proliferative, or cytokine response. This would be observed as a 
decrease in cell number-response slope. This is a simple method for 
investigating the role of particular molecules, both cytokines and cell 
surface ligands, in the generation of an immune response. The results 
described in this thesis indicate that IL-2 was a limiting factor in the 
production of IFN-y. Therefore, analysis of the response generated 
using the IL-2 encoding virus as a source of stimulation and provision 
of the limiting factor would be interesting. 
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A further area of study is the investigation of the cytokine profile of 
mice infected with the recombinant IL-4 encoding virus . Virus 
expression of IL-4 inhibits the development of the CTL response and 
increases the pathogenicity of the virus in normal mice (Andrew and 
Coupar, 1992). It would be interesting therefore, to determine whether 
cells taken from these mice have generated a Th2 type response, as 
would be predicted when IL-4 is present at the early stage of T cell 
response (Swain, 1990b ). Also, results presented in Chapter 5 suggested 
that IL-4 may have enhanced TNF secretion by the restimulated 
vaccinia virus immune cells. IL-4 enhancement of TNF production 
during an immune response could also be studied in these mice and 
may provide further insight into the lethality of this recombinant 
vaccinia virus construct. 
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